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ABSTRACT
All heritable genetic variation is ultimately the result of mutations that have occurred in 
the past. Understanding the processes which determine the rate and spectra of new mutations is 
therefore fundamentally important in efforts to characterize the genetic basis of heritable disease, 
infer the timing and extent of past demographic events (e.g., population expansion, migration), or 
identify signals of natural selection. This dissertation aims to describe patterns of mutation rate 
heterogeneity in detail, identify factors contributing to this heterogeneity, and develop methods 
and tools to harness such knowledge for more effective and efficient analysis of whole-genome 
sequencing data.  
In Chapters 2 and 3, we catalog granular patterns of germline mutation rate heterogeneity 
throughout the human genome by analyzing extremely rare variants ascertained from large-scale 
whole-genome sequencing datasets. In Chapter 2, we describe how mutation rates are influenced 
by local sequence context and various features of the genomic landscape (e.g., histone marks, 
recombination rate, replication timing), providing detailed insight into the determinants of 
single-nucleotide mutation rate variation. We show that these estimates reflect genuine patterns 
of variation among de novo mutations, with broad potential for improving our understanding of 
the biology of underlying mutation processes and the consequences for human health and 
evolution. These estimated rates are publicly available at http://mutation.sph.umich.edu/.  
xv 
 
In Chapter 3, we introduce a novel statistical model to elucidate the variation in rate and 
spectra of multinucleotide mutations throughout the genome. We catalog two major classes of 
multinucleotide mutations: those resulting from error-prone translesion synthesis, and those 
resulting from repair of double-strand breaks. In addition, we identify specific hotspots for these 
unique mutation classes and describe the genomic features associated with their spatial variation. 
We show how these multinucleotide mutation processes, along with sample demography and 
mutation rate heterogeneity, contribute to the overall patterns of clustered variation throughout 
the genome, promoting a more holistic approach to interpreting the source of these patterns. 
In chapter 4, we develop Helmsman, a computationally efficient software tool to infer 
mutational signatures in large samples of cancer genomes. By incorporating parallelization 
routines and efficient programming techniques, Helmsman performs this task up to 300 times 
faster and with a memory footprint 100 times smaller than existing mutation signature analysis 
software. Moreover, Helmsman is the only such program capable of directly analyzing arbitrarily 
large datasets. The Helmsman software can be accessed at https://github.com/carjed/helmsman.  
Finally, in Chapter 5, we present a new method for quality control in large-scale whole-
genome sequencing datasets, using a combination of dimensionality reduction algorithms and 
unsupervised anomaly detection techniques. Just as the mutation spectrum can be used to infer 
the presence of underlying mechanisms, we show that the spectrum of rare variation is a 
powerful and informative indicator of sample sequencing quality. Analyzing three large-scale 
datasets, we demonstrate that our method is capable of identifying samples affected by a variety 
of technical artifacts that would otherwise go undetected by standard ad hoc filtering criteria. We 
have implemented this method in a software package, Doomsayer, available at 
https://github.com/carjed/doomsayer.
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Chapter I. 
Introduction
In the early 20th century, pioneers in the field of genetics synthesized Gregor Mendel’s 
laws of genetic inheritance and Charles Darwin’s theory of evolution into a unified theoretical 
framework, commonly known as the modern evolutionary synthesis [1]. The modern 
evolutionary synthesis postulates that genetic variation in the population—and, over a longer 
timespan, gradual evolutionary change—fundamentally originates with the acquisition of new 
heritable mutations. Hence, a deep understanding of the processes which generate these 
mutations (and the patterns of variation in rate and spectra thereof) is indispensably important in 
efforts to characterize the genetic basis of heritable disease and phenotypic variation [2], infer 
the timing and extent of past demographic events such as population expansion and migration 
[3], identify signals of natural selection [4], and numerous other active areas of research in the 
field of genomics.  
Many distinct endogenous and environmental sources of mutation have been documented 
(as reviewed in [5]). Notable examples include a propensity for C>T mutations at CpG 
dinucleotides due to spontaneous deamination at methylated cytosines [6, 7], G>T mutations 
resulting from oxidative damage of guanine [8], C>T mutations resulting from exposure to UV 
radiation [9], and DNA mispairing during replication [10]. Many of the context-dependent 
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effects that have been observed, however, have yet to be linked to specific mechanisms [5, 11–
13]. More fundamentally, the full extent of variation in mutation rates has not been exhaustively 
characterized, so our knowledge of the factors that contribute to the mutational landscape of the 
human genome remains rudimentary. 
Despite the field’s long-standing appreciation for the diversity and regional variation of 
mutation processes, it is only within the last decade, with the widespread availability of whole-
genome sequencing data and increasingly powerful computational resources, that cataloging the 
fine-scale variation in mutation patterns (and understanding the implications for human health 
and evolution) has become possible [12–14]. This dissertation aims to describe patterns of 
mutation rate heterogeneity in detail, identify factors contributing to this heterogeneity, and 
develop methods and tools to harness this knowledge for more effective and efficient analysis of 
whole-genome sequencing data.  
In Chapter 2, we present a detailed account of factors contributing to fine-scale patterns 
of variation in single-nucleotide mutation rates throughout the genome. This study leverages a 
powerful new approach to studying mutation patterns: rather than relying on de novo mutations 
ascertained from trio sequencing data (which are too sparse to precisely quantify granular 
mutation patterns), or common variants from unrelated individuals (which are affected by natural 
selection and biased gene conversion, processes that are difficult to disentangle from the 
underlying mutation signal), we analyze a large collection of extremely rare variants (ERVs) 
ascertained from a large-scale whole-genome sequencing dataset. These ERVs have the benefit 
of being abundant throughout the genome—in our dataset, we observe nearly 36 million ERVs in 
3,560 unrelated individuals. Further, theoretical models suggest that nearly all ERVs have arisen 
very recently in human history, thus their distribution is unlikely to have been strongly affected 
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by natural selection or biased gene conversion, so, in a sufficiently large sample, they accurately 
represent mutation events that have occurred within the last several dozen generations [15]. 
These data enable us to estimate how the mutation rate varies with respect to the local 
sequence context, considering up to 3 bases upstream and 3 bases downstream from the mutation 
site. We observe a remarkable heterogeneity in the mutation rates of these 7-mer sequence 
motifs, demonstrating that the broader sequence context at any given site is a key determinant of 
that site’s mutability. This has important implications for how we understand the specificity of 
damage and repair mechanisms in the genome and how these processes may have evolved over 
time. 
We then implement a series of regression models to show that the mutation rate at any 
given sequence motif is further influenced by various features of the genomic landscape (e.g., 
histone marks, recombination, replication timing), providing further insight into the determinants 
of mutation rate variation. Though previous studies have implied that the presence of a given 
feature will tend to result in a general increase or decrease in mutation rates (e.g., [13, 14]), we 
show that the mutagenic effect of a feature can in fact vary according to the sequence motif, 
suggesting that the mutational efficiencies of damage and repair mechanisms are influenced by 
nuanced characteristics of the genomic landscape.  
Finally, we present conclusive evidence that our ERV-derived mutation rate estimates are 
consistently more accurate at describing bona fide de novo mutation patterns than estimates 
derived from more common variants. This result underscores the benefits of using ERVs to 
understand ongoing mutation patterns in the human population and lays the groundwork for 
future tangential research questions concerning how the subsequent processes of natural 
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selection, biased gene conversion, and mutation rate evolution are also impacted by variation in 
local sequence context and genomic features. 
In Chapter 3, we elucidate the variation in rate and spectra of multinucleotide mutations 
(MNMs) throughout the genome, again leveraging rare singleton SNVs from whole-genome 
sequencing data as a proxy for recent mutation events. MNMs are essentially defined as two or 
more closely-spaced point mutations that occur simultaneously as part of a single mutation event 
[16], and are important to consider as a distinct class of mutations for several reasons. First, 
MNMs likely arise via a handful of specific mutational pathways and thus represent a unique 
outcome of genome instability [16]; second, although MNMs might superficially be considered 
indistinguishable from multiple closely-spaced single-nucleotide mutations arising through 
independent mutation events, MNMs have a distinct transversion-rich mutation signature [17], 
which increases their likelihood of pathogenic outcomes, making them uniquely implicated in 
the genetic architecture of human disease [18]; third, because MNMs generate multiple 
simultaneous changes to the genome, they may lead to more rapid evolutionary changes [19]; 
finally, failure to account for the spatially non-independent nature of MNMs can lead to false 
inference of signals of selection or past demographic events [20, 21]. 
We propose a novel statistical approach to infer the patterns and properties of MNMs in 
the human germline. Specifically, we model the spatial distribution of ERVs throughout the 
genome as a mixture of exponential processes, where each process is assumed to generate a 
subset of mutations occurring at a unique range of spatial proximities. We show that the 
properties of mutations attributable to two particular processes inferred through this statistical 
model are consistent with two well-known multinucleotide mutation processes: error-prone 
translesion synthesis (TLS) and repair of double-strand breaks (DSB) [21–23]. We provide a 
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detailed account of how MNMs resulting from these processes vary in their intrinsic properties 
and throughout the genome. This analysis shows that the spectrum of TLS-associated 
multinucleotide mutations varies dramatically as the inter-mutation distance increases, 
potentially indicating distinctive signatures of specific translesion polymerases. In addition, we 
describe how these TLS- and DSB-associated multinucleotide mutations vary throughout the 
genome and provide evidence that particular genomic features are associated with these patterns 
of regional variation. We conclude this chapter by exploring how the spatial clustering of rare 
variants is jointly affected by multinucleotide mutations, regional mutation rate heterogeneity, 
sample demography, and other factors, thereby demonstrating that a holistic understanding of 
these factors is necessary in efforts to interpret clustering patterns of rare variants throughout the 
genome. 
The field of human genomics is currently faced with several challenges in overcoming 
the substantial—and often unforeseen—computational bottlenecks that can occur when 
analyzing increasingly massive high-throughput sequencing datasets [24]. Modern catalogs of 
human genetic variation can easily exceed tens or hundreds of millions of variants, ascertained in 
the genomes of thousands or even hundreds of thousands of individuals. Most non-trivial 
computational tasks applied to such data must therefore be carefully optimized to minimize 
processing time, memory usage, and disk input/output bottlenecks. In Chapter 4, we focus on a 
particular computational method known as mutation signature analysis, first proposed by 
Alexandrov et al. [25], which has become a fixture in cancer genomics pipelines [26]. The 
purpose of mutation signature analysis is to jointly evaluate multiple cancer genomes and, based 
on the observed patterns of variation, make inference about the causal mutation mechanisms 
[25]. Most published programs for applying these methods, however, were developed and 
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optimized for relatively small datasets [27–31]. These programs are typically implemented as 
web servers, where users must upload their data over the internet [30, 31], or as packages in the 
R programming language, where the entire dataset must be loaded into memory to be analyzed 
[27–29]. Given the massive size of modern sequencing datasets, it is effectively impossible to 
perform mutation signature analysis using such programs—web servers typically only accept 
data uploads on the scale of megabytes (and even if larger datasets were accepted, they would be 
subject to severe network bandwidth bottlenecks), and all but the most powerful servers lack the 
physical memory necessary to analyze large datasets directly in memory, as required by existing 
implementations in R. 
To overcome these computational challenges, we develop Helmsman, a highly efficient 
software tool to infer mutational signatures in arbitrarily large datasets of genetic variation. For 
datasets small enough to be tractably analyzed with existing mutation signature analysis 
programs, Helmsman performs this task up to 300 times faster and with a 100-fold reduction in 
memory usage. Moreover, because the runtime and memory footprint of Helmsman scale 
linearly and independently with the number of variants and sample size, respectively, it is the 
only program currently available that is capable of directly performing mutation signature 
analysis on datasets where the size of the input data exceeds the physical memory capacity of the 
computer. The scalable nature of Helmsman ensures that mutation signature analysis will be 
tractable even for datasets larger than those presently available. 
A deep understanding of mutation rate heterogeneity also has important implications 
concerning the technical tasks of variant detection and quality control in high-throughput 
sequencing [32, 33]. In Chapter 5, we present a novel method to leverage detailed knowledge of 
mutation patterns as an effective and interpretable indicator of sample quality control in large-
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scale whole-genome sequencing datasets. Just as the concept of mutational signatures can be 
used to describe the mutational mechanisms operative in cancer genomes (as in Chapter 4), we 
show that signatures of various technical artifacts can manifest among the rare SNV spectra of 
individual samples or sequencing batches. Our method implements a combination of mutation 
signature analysis algorithms and unsupervised anomaly detection techniques to infer the 
presence of such error signatures and flag samples that are enriched for these signatures. 
Applying this method to multiple large-scale sequencing datasets, we demonstrate that these 
inferred error signatures often correspond to known error biases induced by various technical 
issues. Furthermore, we show that samples affected by these artifacts often went undetected by 
standard sample-level quality control measures, underscoring the efficacy of our method. 
Modern sequencing technology has enabled researchers and clinicians to catalog and 
study variation throughout the genome at an unprecedented scale. Because all genetic variation 
fundamentally originates with the acquisition of new mutations, an intimate knowledge of the 
processes which generate these mutations is essential to ensuring the observed patterns of genetic 
variation are interpreted accurately. This dissertation presents a detailed account of the patterns 
and properties of mutation processes operating throughout the human genome, many of which 
have heretofore not been characterized. We introduce powerful new computational methods that 
exploit this knowledge of mutation patterns to analyze large-scale genomic data more effectively 
and efficiently. Collectively, these studies have widespread implications both for understanding 
the biology of mutation processes and reshaping the ways in which we identify and interpret 
variation in the human genome.  
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Chapter II.  
Extremely rare variants reveal patterns of germline 
mutation rate heterogeneity in humans  
 Introduction1 
Germline mutagenesis is a fundamental biological process, and a major source of all 
heritable genetic variation (see [5] for a review). Mutation rate estimates are widely used in 
genomics research to calibrate variant calling algorithms [34], infer demographic history [35], 
identify recent patterns of genome evolution [36], and interpret clinical sequencing data to 
prioritize likely pathogenic mutations [37]. Although mutation is an inherently stochastic 
process, the distribution of mutations in the human genome is not uniform and is correlated with 
genomic and epigenomic features including local sequence context [12, 38], recombination rate 
[39], and replication timing [14]. Hence, there is considerable interest in studying the regional 
variation and context dependency of mutation rates to understand the basic biology of mutational 
processes and to build accurate predictive models of this variability.  
                                                 
 
1
This chapter is published as Carlson J, Locke AE, Flickinger M, Zawistowski M, Levy S, Myers RM, et al. 
Extremely rare variants reveal patterns of germline mutation rate heterogeneity in humans. Nat Commun. 
2018;9:3753. A full list of co-authors is provided in the published manuscript. 
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The gold standard for studying the germline mutation rate in humans is direct observation 
of de novo mutations from family-based whole-genome sequencing (WGS) data [14, 40–42]. 
These studies have produced accurate estimates of the genome-wide average mutation rate 
(~1 − 1.5 × 10−8 mutations per base pair per generation) and uncovered some of the mutagenic 
effects of genomic features. However, the inherently low germline mutation rate means family-
based WGS studies detect only 40-80 de novo mutations per trio sequenced [14, 40, 42], making 
it difficult to accumulate a dataset large enough to precisely estimate mutation rates and 
spectrum at a fine scale and identify factors that explain genome-wide variability in mutation 
rates. 
Other data sources for studying mutation patterns include between-species substitutions 
or within-species polymorphisms [11, 12, 39, 43–45]. However, because these variants arose 
hundreds or thousands of generations ago, their distribution patterns along the genome have been 
influenced by the subsequent long-term actions of many evolutionary forces, such as natural 
selection and GC-biased gene conversion (gBGC), a process in which recombination-induced 
mismatches are preferentially repaired to G/C base pairs, resulting in an overabundance of 
common A/T-to-G/C variants [41, 46, 47]. A further complication of estimating mutation rates 
with ancestrally older variants is that the endogenous mutation mechanisms themselves have 
likely evolved over time [48], so patterns of variation observed among these data may not 
necessarily reflect ongoing mutation processes in the present-day population. To minimize the 
confounding effects of selection, studies that estimated mutation rates from these data tended to 
focus on intergenic non-coding regions of the genome, which are less often the target of selective 
pressure. Nevertheless, even putatively neutral loci may be under some degree of selection [49–
51], and are susceptible to the confounding effects of gBGC and evolving mutation processes. 
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Consequently, these processes bias the resulting distribution of variation, making it difficult to 
determine which trends are attributable to the initial mutation processes, and which to subsequent 
evolutionary factors.  
We therefore adopt an approach that relies exclusively on extremely rare variants (ERVs) 
to study innate mutation patterns across the genome. Here we exploit a collection of ~35.6 
million singleton variants discovered in 3,560 sequenced individuals from the BRIDGES study 
of bipolar disorder (corresponding to a minor allele frequency of 1/7120=0.0001404 in our 
sample). Compared to between-species substitutions or common SNVs, these ERVs are 
extremely young on the evolutionary timescale (in a comparably-sized European sample, one 
study estimated the expected age of a singleton to be 1,244 years [52]), making them much less 
likely to be affected by evolutionary processes other than random genetic drift [5, 15, 41, 46]. 
ERVs thus represent a relatively unbiased sample of recent mutations and are far more numerous 
than de novo mutations collected in family-based WGS studies. 
Our results show that mutation rate heterogeneity is primarily dependent on the sequence 
context of adjacent nucleotides, confirming the findings of previous studies [12–14]. However, 
we demonstrate that our ERV-derived mutation rate estimates can differ substantially from 
estimates based on ancestrally older variants. Evaluating these differences in an independent 
dataset of ~46,000 de novo mutations, collected from two published family-based WGS studies 
[14, 42], we find that ERV-derived estimates yield a significantly more accurate portrait of 
present-day germline mutation rate heterogeneity. We further refine these estimates of context-
dependent mutability by systematically estimating how mutation rates of different sequence 
motifs are influenced by genomic features in wider surrounding regions, including replication 
timing, recombination rate, and histone modifications. Remarkably, we find that the direction of 
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effect for some genomic features depends on the actual sequence motif surrounding the mutated 
site, underscoring the importance of jointly analyzing sequence context and genomic features. 
Accounting for these granular effects of the genomic landscape provides even greater accuracy 
in describing patterns of variation among true de novo mutations. Our results suggest that trends 
of variation throughout the genome are shaped by a diverse array of context-dependent mutation 
pathways. This high-resolution map of mutation rate estimates, along with estimates of the 
mutagenic effects of genomic features, is available to the community as a resource to facilitate 
further study of germline mutation rate heterogeneity and its implications for genetic evolution 
and disease. 
Results 
ERV data source and quality control 
In the Bipolar Research in Deep Genome and Epigenome Sequencing (BRIDGES) study, 
we sequenced the genomes of 3,716 unrelated individuals of European ancestry to an average 
diploid-genome coverage of 9.6x. We identified and removed 156 samples which appeared to be 
technical outliers, resulting in a final call set of 35,574,417 autosomal ERVs from 3560 
individuals (Methods). Due to the relatively low coverage of our sample, we likely failed to 
detect millions more ERVs—a recent study [53] estimated the discovery rate for singletons in a 
sample of 4,000 whole genomes at 10x coverage to be ~65-85%. Quality control measures 
indicate that the ERVs we detected are high quality, with a Transition/Transversion (Ts/Tv) ratio 
of 2.00, within the commonly observed range for single nucleotide variants (SNVs) from WGS 
data [54] (Table A.1). Application of the 1000G strict accessibility mask [55] (which delineates 
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the most uniquely mappable genomic regions) or a more stringent mapping quality score filter 
(MQ>56) did not appreciably change the Ts/Tv ratio (1.97-2.01) (Table A.1). We estimate fewer 
than 3% of the 35,574,417 ERVs are false positives (Appendix A), similar to the validated 
singleton error rates of other sequencing studies using a similar technology [55–57]. In addition, 
we present evidence that erroneous calls among the ERVs are unlikely to be biased by motif-
specific genotyping error, mapping error, or mispolarization (Appendix A). 
Context-dependent variability in mutation rates 
The nucleotides surrounding a mutated site are a well-known predictor of variability in 
mutation rates across the genome [12, 13, 41]. The most detailed such analysis to date [12] 
considered the nucleotides up to 3 positions upstream and downstream from a variant site (i.e., a 
7-mer sequence context), and estimated substitution probabilities per heptameric motif using 
7,051,667 intergenic SNVs observed in 379 Europeans from phase 1 of the 1000 Genomes 
Project (hereafter referred to as the “1000G mutation rate estimates”). These estimates have the 
potential problem of being derived from variants across the entire frequency spectrum: among 
the intergenic SNVs used to estimate these rates, singletons and doubletons account for only 
~25% [12], so most variants occur at a higher frequency and thus likely arose hundreds or 
thousands of generations in the past. Over such a long time span, variants affected by cryptic 
selection, gBGC, or other evolutionary processes are more likely to have been fixed or 
disappeared, altering the distribution of observable variation. 
Because ERVs are assumed to have occurred very recently in human history, we asked if 
ERV-based mutation rate estimates differed from the 1000G estimates, and if so, whether our 
revised estimation strategy more accurately represents basal mutation processes. To answer these 
13 
 
questions, we first used the BRIDGES ERVs to estimate mutation rates according to mutation 
type (e.g., A>C, A>G, and so on) and local sequence context, considering the bases up to 3 
positions upstream and downstream from each variant site (Methods). We refer to a mutation of 
a given type centered at a given sequence motif as a “mutation subtype” (e.g., C[A>C]G is a 3-
mer subtype). Note that we are not estimating an absolute per-site, per generation mutation rate, 
but rather the relative fraction of each subtype containing an ERV within the BRIDGES data. We 
refer to rates calculated in this manner as “relative mutation rates,” and estimated these rates for 
all possible 1-, 3-, 5-, or 7-mer subtypes. 
ERV-derived relative mutation rate estimates for the six basic 1-mer mutation types 
reflect the expected higher mutability for transitions relative to transversions [5]. Splitting each 
mutation type into more granular subtypes reveals how additional patterns of mutation rate 
heterogeneity emerge as broader sequence contexts are incorporated (Fig. 2.1; Fig. A.1). Our 
ERV-based estimates confirm nearly all the hypo- or hypermutable motifs reported in previous 
studies [11, 12]. A subset of these are highlighted in Fig. 2.1a, including lower relative mutation 
rates for NNN[C>T]GCG subtypes and A>G subtypes in motifs containing runs of 4 or more A 
bases (shown in green boxes), and higher relative mutation rates for N[A>G]T, N[C>T]G, and 
CA[A>G]TN subtypes (pink boxes). Another notable example of context-dependent 
hypermutability is the set of NTT[A>T]AAA subtypes (Fig. 2.1b), also described previously 
[12]. Despite A>T mutations having the lowest relative mutation rate among 1-mer types, its 
NTT[A>T]AAA subtypes have a >6-fold higher rate than the 1-mer A>T relative mutation rate. 
Overall, the ERV-derived 7-mer relative mutation rates span a >400-fold range from 
0.0003 (CGT[A>T]CCG) to 0.1416 (ATA[C>T]GCA). For every 3-mer subtype, we found 
overwhelming evidence for heterogeneity in the relative mutation rates among their 16 respective 
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5-mer constituents (chi-squared tests; all 𝑃 < 10−231). Further, 1522 (99%) of the 1536 5-mer 
subtypes had significantly heterogeneous rates among their respective 7-mer constituents (chi-
squared tests; 𝑃 < 0.05) (Methods). 
 
Figure 2.1 Mutation rates vary according to sequence context (a) Heatmap of estimated relative mutation rates for all possible 
for A>G and C>T transition subtypes, up to a 7-mer resolution (High-resolution heatmaps for all possible subtypes are included 
in Fig. A.1). The leftmost panels show the relative mutation rates for the 1-mer types, and the subsequent panels to the right show 
these rates stratified by increasingly broader sequence context. Each 4x4 grid delineates a set of 16 subtypes, defined by the 
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upstream sequence (y-axis) and downstream sequence (x-axis) from the central (mutated) nucleotide. Boxed regions indicate 
motifs previously identified by Aggarwala and Voight as hypermutable (pink) or hypomutable (green), relative to their similar 
subtypes. (b) Zoomed-in view showing hypermutable NTT[A>T]AAA subtypes relative to other 7-mer A>T subtypes. 
Mutation rate estimates differ between ERVs and common SNVs 
We next compared the 7-mer relative mutation rates, estimated either from the BRIDGES 
ERVs or 1000G intergenic SNVs, to determine if our ERV-based estimates differ from 
previously reported patterns of mutation rate heterogeneity. Across all 24,576 7-mer mutation 
types, relative mutation rates were highly correlated between the two sets of estimates 
(Spearman’s r=0.95; Fig. 2.2a). However, when stratified by mutation type, these correlations 
were often much weaker (r=0.42 to 0.92; Fig. 2.2b). Considering differences in the estimated 
rates for each individual 7-mer subtype, we found 13% of 7-mer subtypes had differences of 
50% or more between the two estimates after normalization. These discrepancies did not occur 
randomly across subtypes (Fig. 2.2c). For example, relative mutation rates for CpG>ApG and 
CpG>GpG transversions were respectively 26% and 39% higher in the 1000G estimates 
compared to the ERV-derived estimates. Sequence context also affects relative mutation rate 
estimates for A>C and A>G subtypes: 1000G-derived estimates were significantly higher than 
ERV-derived estimates among GC-rich motifs (4-6 G/C bases in the +/-3bp flanking sequence) 
compared to low-GC motifs (3 or fewer flanking G/C bases) (t-tests; 𝑃 < 8.0 × 10−30) ( Fig. 
A.2; Table A.2). This observation is consistent with the known correlation between GC content 
and biased gene conversion [47, 58], though other evolutionary processes may also have 
contributed. 
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Figure 2.2 Discordance between ERV-estimated and common SNV-estimated mutation rates (a) Relationship between 7-
mer relative mutation rates estimated among BRIDGES ERVs (x-axis) and the 1000G intergenic SNVs (y-axis) on a log-log 
scale. We note that the strength of this correlation is driven by hypermutable CpG>TpG transitions. (b) Type-specific 2D-density 
plots, as situated in the scatterplot of (a). The dashed line indicates the expected relationship if no bias is present. (c) Heatmap 
showing ratio between the relative mutation rates for each 7-mer mutation subtype. Subtypes with higher rates among the 1000G 
SNVs (relative to ERV-derived rates) are shaded gold, and subtypes with lower rates in the 1000G SNVs are shaded green. 
Relative differences are truncated at 2 and 0.5, as only 2.5% of subtypes showed differences beyond this range. 
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We considered the possibility that these patterns of dissimilarity were simply due to 
technical differences between the BRIDGES and 1000G samples. To address this concern, we 
estimated 7-mer relative mutation rates using 12,088,037 variants with a minor allele count ≥10 
(MAC10+) in the BRIDGES sample and compared these estimates to the ERV-derived and 
1000G-derived estimates (Appendix A). Importantly, the MAC10+ 7-mer relative mutation rates 
were more closely correlated with the 1000G-derived estimates (overall: r=0.98; Fig. A.3a; type-
specific: r=0.87-0.98; Fig. A.3b), than with the ERV-derived estimates (overall: r=0.95; Fig. 
A.4a; type-specific: r=0.45-0.95; Fig. A.4b). Like the 1000G estimates, the MAC10+ estimates 
also showed higher rates of CpG transversions and A>G/A>C mutations in GC-rich motifs (Fig. 
A.4c), but between the MAC10+ and 1000G estimates, these differences were absent or much 
weaker (Fig. A.3c). 
Collectively, these results suggest that the dissimilarities between ERV-based and 
common SNV-based estimates are driven not by differences in the data source or analysis 
pipeline, but by differences in the allele frequencies of the variants used to estimate the rates. 
There are two plausible explanations for these differences: either 1) the ancestrally older variants 
included in the 1000G data are under the influence of evolutionary processes that have altered 
the relative frequencies among subtypes, or 2) even after our careful data cleaning and filtering, 
certain sequence motifs are enriched for false positive or false negative sequencing errors in the 
BRIDGES ERVs.  
These scenarios can be tested by comparing which set of estimates better describes the 
observed distribution of true de novo mutations. We reasoned that if biased sequencing errors 
have occurred, such spurious effects would occur more frequently among BRIDGES ERVs, as 
errors must be present in multiple individuals to manifest among the common variants included 
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in the 1000G data. In such a scenario, we would expect the 1000G estimates to explain the 
distribution of true de novo mutations more accurately. In contrast, if the relative mutation rate 
estimates have been influenced by evolutionary processes, such biases should have a stronger 
effect on the 1000G estimates and the ERV-derived estimates would provide a better fit. 
ERVs accurately predict de novo mutations 
We implemented this validation strategy by comparing how accurately different sets of 
relative mutation rate estimates predicted the incidence of 46,813 bona fide de novo mutations 
collected from two family-based WGS datasets: The Genomes of the Netherlands (GoNL) 
project [14] and the Inova Translational Medicine Institute Preterm Birth Study (ITMI) [42] 
(Methods; Fig. A.5). We set these de novo mutations against a randomly-selected background of 
1 million non-mutated sites, then applied logistic regression models using each set of relative 
mutation rate estimates (either ERV-based estimates at varying K-mer lengths, or 1000G-based 
7-mer estimates) to predict the log-odds of observing a de novo mutation at each of the 1,046,813 
sites. We evaluated model performance by two likelihood-based goodness-of-fit statistics: the 
Akaike information criterion (AIC), and Nagelkerke’s pseudo- R2 (Methods). Each model has 
one parameter, so the AIC of each model is −2 ⋅ 𝑙𝑜𝑔 − 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 + 2. 
Among ERV-based K-mer models, goodness-of-fit improved consistently with 
consideration for longer motifs, with the 7-mer model producing the best fit overall (Table 2.1). 
These trends did not change when varying the number of non-mutated sites (Table A.3) nor 
when applied exclusively to either the GoNL or ITMI mutations (Table A.4), indicating the 
regression was not merely fitting to cryptic errors in the validation data. To assess if our results 
are affected by mapping artifacts, we also re-estimated the ERV-based 7-mer relative mutation 
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rates after applying the 1000 Genomes strict accessibility mask (Appendix A). The masked and 
unmasked 7-mer rates are highly concordant, and most discrepancies appear to be an artifact of 
sampling variation due to fewer ERVs in the masked data (Fig. A.6). When applied to predict the 
de novo mutations, the masked rates produced a worse fit than the unmasked rates (Table 2.1), 
suggesting that the reduction in ERVs caused by applying the mask has a larger effect on the 
precision of our estimates than any mapping artifacts present in the unmasked data. We next 
analyzed each mutation type separately to determine if the same trend of improved goodness-of-
fit using longer K-mers held for different mutation types. In each of these type-specific 
validation models, the ERV-based 7-mer relative mutation rate estimates provided a significantly 
better fit than estimates in smaller K-mers (Table A.5). 
We then compared the goodness-of-fit of the BRIDGES ERV-based K-mer models with 
the 7-mer model based on 1000G intergenic SNVs. Although Aggarwala and Voight 
demonstrate that the 1000G 7-mer model significantly improves on 5-mer or 3-mer models [12], 
our results show that all ERV-based models (except the 1-mer model) predict de novo mutations 
more accurately than 1000G 7-mer model (Table 2.1). Considering each mutation type 
separately (Table A.5), we find that the performance of the 1000G 7-mer model is particularly 
weak among certain mutation classes: for A>C and A>G types, the 1000G 7-mer models provide 
a worse fit than ERV-derived 5-mer models, and for A>T and CpG>GpG types the fit is worse 
than ERV-derived 3-mer models. In each of the other C>N types, the 1000G 7-mer model 
performs comparably to the ERV-derived 7-mer model, indicating the inferred mutation patterns 
of these types are mostly consistent between the two datasets. These results thus support a 
scenario where, due to the influence of GC-biased gene conversion [46] or changing mutation 
processes [48], type- and subtype-specific patterns of variation among the 1000G-derived 
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estimates are less accurate than ERV-derived estimates in capturing ongoing patterns of germline 
mutability. 
 
Table 2.1 Goodness-of-fit statistics for mutation rate estimates applied to de novo testing 
data 
Mutation rate estimation strategy 
AIC ΔAIC†  
AIC 
rank* 
Nagelkerke’s 
R2 Subtype 
length 
Study Variant type 
1-mers BRIDGES ERVs 353,896 21,575 7 0.088 
3-mers BRIDGES ERVs 335,319 2998 4 0.118 
5-mers BRIDGES ERVs 332,861 540 3 0.124 
7-mers BRIDGES ERVs 332,321 0 1 0.126 
7-mers BRIDGES 
ERVs (passing 1000G 
strict mask) 
332,582 261 2 0.125 
7-mers BRIDGES MAC10+ 342,886 10,565 5 0.103 
7-mers 1000G Intergenic SNVs [12] 344,003 11,682 6 0.100 
†difference in AIC from the baseline BRIDGES 7-mer model 
*lower AIC rank indicates better model performance 
 
Subtype-specific mutagenic effects of genomic features 
Family-based sequencing studies have been instrumental in identifying genomic features 
that are associated with variation in the germline mutation rate [13, 14, 41]. However, these 
studies have only described the marginal effects of features on the entire spectrum of mutation 
and have not assessed if the effect of a genomic feature might vary according to the local 
sequence context. To determine how the mutation distribution varies across the genomic 
landscape, we selected 14 genomic features (Table A.6) and estimated the joint effects of these 
features on the mutation rate of each 7-mer subtype using multiple logistic regression 
(Methods). Subtypes with few observed ERVs have little power to detect significant 
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associations, so we estimated the effects of features only for the 24,396 of 24,576 (99.3%) 7-mer 
subtypes with at least 20 observed ERVs, resulting in 392,128 parameter estimates (Fig. A.7). 
We note that >84% of the 7-mer subtypes we evaluated contained >10 times as many ERVs as 
parameters estimated, so these estimates are unlikely to be an artifact of overfitting. To identify 
significant effects among the many associations tested, we applied a false discovery rate (FDR) 
cutoff of 0.05 to the p-values for each feature across all subtype-specific estimates. Of the 24,396 
7-mer subtypes analyzed, 3,481 had at least one genomic feature significantly associated with 
mutability, with 6,152 significant associations among 392,128 tests. 
Three features (H3K9me3 peaks, recombination rate, later replication timing) were 
associated with higher relative mutation rates across nearly all significantly associated 7-mer 
subtypes (Fig. 2.3a), consistent with previously reported mutagenic effects of these features: 
H3K9me3 marks are one of the strongest predictors of somatic SNV density [59, 60], and 
recombination and late replication timing are both correlated with higher germline mutation rates 
[14, 39]. In addition, four features (H3K36me3 peaks, DNase hypersensitive sites [DHS], GC 
content, CpG islands) were each associated with both higher and lower relative mutation rates, 
depending on the mutation type and, in some cases, the sequence motif. These features have been 
previously implicated in variation in germline or somatic mutation rates, but only as marginal 
effects, not type- or subtype-specific. H3K36me3 has been shown to regulate DNA repair 
machinery in vivo [61, 62]. DNase hypersensitivity was previously reported to be associated with 
increased germline mutation rates [13], though cancer genome studies have claimed DHS are 
susceptible to both increased and decreased somatic mutation rates [63, 64]. CpG islands were 
associated with ~3-fold lower mutation rates in 99% (1015/1024) of CpG>TpG 7-mer subtypes, 
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consistent with known patterns of DNA hypomethylation in CpG islands [65], but are associated 
with higher relative mutation rates in subtypes of other types. 
Finally, for CpG>TpG transition subtypes, lamin-associated domains were associated 
with higher relative mutation rates and three histone marks (H3K4me1, H3K4me3, and 
H3K27ac) were associated with lower relative mutation rates (Fig. 2.3b). These results are 
consistent with published findings of correlations between these features and DNA methylation: 
lamin-associated domains were previously found to associate with focal DNA hypermethylation 
in colorectal cancer [66], and H3K4me1, H3K4me3, and H3K27ac are known markers of DNA 
hypomethylation [67, 68]. Exonic regions were associated with lower relative mutation rates for 
~26% of CpG>TpG subtypes (Fig. 2.3b), consistent with findings of lower somatic SNV density 
in gene-rich regions [59], though it is unclear if this is also due to DNA hypomethylation. 
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Figure 2.3 Distributions of statistically significant mutagenic effects of genomic features. (a) Effects of 7 genomic features 
where associations with multiple mutation types were detected. For features with bidirectional effects, we separately plotted 
distributions of positive associations (OR > 1; above dashed line) and negative associations (OR < 1; below dashed line). The 
number of 7-mer subtypes within each type for which that feature is statistically significant in a positive or negative direction is 
shown above or below each distribution. Distributions are only shown for types with 10 or more 7-mer subtypes associated in the 
same direction. *Odds ratios for the 3 continuously-valued features (recombination rate, replication timing, and GC content) 
indicate the change in odds of mutability per 10% increase in the value of that feature. †Effects in CpG islands tend to be stronger 
than other features, so are shown on a wider scale. (b) Distributions of significant mutagenic effects for the 5 features only 
associated with CpG>TpG transitions. 
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Estimated effects of features predict de novo mutations 
We applied these 7-mer+features mutation rate estimates to predict the GoNL/ITMI de 
novo mutations, using the same evaluation framework described earlier. Model fit statistics 
indicate that the rates estimated from 7-mer sequence context and genomic features describe the 
distribution of de novo mutations significantly better than the 7-mer-only estimates (Fig. 2.4). 
When partitioned by mutation type, inclusion of genomic features improves model fit for 8 of the 
9 basic mutation types. These differences tend to be weaker among transversion types, likely 
because there were fewer de novo mutations of these types available (Fig. 2.4). Including 
genomic features had the largest effect on the prediction of CpG>TpG transitions, consistent 
with the expected associations between certain features and DNA methylation. Comparing the 
distribution of predicted mutations across basic types under different models, we find that all 
models generally recapitulate the observed distribution of de novo mutations, but the 1000G 7-
mer model predicts a notably higher proportion of CpG>NpG mutations (Fig. A.8a). Stratifying 
by 3-mer subtype, the 1000G 7-mer predictions also tend to be more dissimilar from the de novo 
distribution than ERV-based 7-mer+features predictions (Fig. A.8b).  
To further demonstrate that effects of genomic features described in Fig. 2.3 are 
supported by bona fide de novo mutation data, we pooled all subtypes found to be associated 
with each feature in a positive or negative direction and respectively tested for an enrichment or 
depletion of GoNL/ITMI de novo mutations in regions covered by that feature (Methods). We 
found 10 of the 20 tests were statistically significant in the expected direction (chi-squared tests; 
𝑃 < 0.05), confirming that, at a coarse level, many of the subtype-specific effects of genomic 
features inferred using ERVs are recapitulated among true de novo mutations (Table A.7).  
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Figure 2.4 Comparison of goodness-of-fit for different mutation rate estimation strategies. For each mutation type and each 
model 𝑖, we calculated ∆𝐴𝐼𝐶𝑖 = 𝐴𝐼𝐶𝑖 − 𝐴𝐼𝐶𝑚𝑖𝑛 as a measure of relative model performance, with lower values of ∆𝐴𝐼𝐶 
indicating better fit to the GoNL/ITMI de novo mutation data. ∆𝐴𝐼𝐶 is shown on the horizontal axis on an arcsinh scale. For each 
mutation type, the best-fitting model thus has a ∆𝐴𝐼𝐶 = 0. Models with ∆𝐴𝐼𝐶 < 10 (grey-shaded area) are considered 
comparable to the optimal model, whereas models with ∆𝐴𝐼𝐶 > 10 are considered to explain substantially less variation than the 
optimal model [69]. 
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Germline mutation rates mirror somatic mutation processes 
The rate heterogeneity between mutations of the same type suggests that distinct mutation 
mechanisms underlie some of the feature-subtype associations detected by our model. However, 
mechanisms for specific mutation signatures have mostly been studied for somatic mutations in 
cancer, and the degree to which these mechanisms affect germline mutations is generally 
unknown. In the following, we show two examples where the germline mutation rates from our 
data are consistent with mutation mechanisms observed in cancer. Moreover, we hypothesize a 
previously undescribed mechanism for germline point mutations.  
In cancer genomes, H3K36me3-marked regions are targeted by the error-prone DNA 
polymerase eta (POLH, also known as pol η) [62]. Human POLH is particularly biased towards 
generating A>G mutations at sites flanked by weak (A or T, denoted as W) bases [70]; 
consequently, H3K36me3-marked regions are enriched for W[A>G]W mutations in various 
cancers [62]. In our data, among the 403 7-mer subtypes showing significant positive 
associations with H3K36me3-marked regions, a significant majority (270, or 67%) are A>G 
subtypes (exact binomial test; 𝑃 < 1.09 × 10−111). Within the 270 positively-associated A>G 
subtypes, 175 (65%) are W[A>G]W 3-mer subtypes, significantly more than expected by chance 
(exact binomial test; 𝑃 < 4.12 × 10−43).Thus, our results suggest the H3K36me3-mediated 
POLH mutation signature also appears in the germline.  
Active transcription factor binding sites (i.e., occurring in DHS) are also prone to 
elevated somatic mutation rates in various cancers, likely because bound transcription factors 
make DNA inaccessible to nucleotide excision repair (NER) machinery [64, 71]. For example, 
the CCAAT motif is a highly specific binding target for the trimeric nuclear factor Y (NF-Y) 
complex [72], and active NF-Y binding sites show a >3.2-fold enrichment for somatic mutations 
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in melanomas [64]. Our results indicate that transcription factor binding may also explain motif-
specific hypermutability in the germline. Among the 7-mer subtypes positively associated with 
DHS, CCA[A>G]TNN subtypes show a 1.1 to 1.3-fold enrichment (Wald test; 𝑃 < 2 ×  10−4), 
and the CCA[A>G]TNN de novo mutation rate in the GoNL/ITMI dataset is 1.7-fold higher 
when occurring within DHS versus non-DHS regions (1-df chi-squared test; 𝑃 < 0.0055). 
Finally, we and others [12] observed that NTT[A>T]AAA subtypes have >6-fold higher 
mutation rates than other A>T subtypes (Fig. 2.1b). We note that the TTAAAA hexamer is the 
canonical insertion target for Long Interspersed Element 1 (LINE-1, or L1) retrotransposons, and 
is nicked by the L1-encoded ORF2p endonuclease at the antisense 3’-ApT-5’ dinucleotide [73]. 
These nicks produce T-rich 3’ flap structures, which can be recognized and removed by NER 
machinery, inhibiting L1 insertional mutagenesis, but leaving an A-rich single-strand break [74]. 
In transcriptionally active regions of the genome, such lesions are usually repaired by high-
fidelity NER pathways [75], but in nucleosomal DNA, where NER activity is impaired, the 
lesions are likely bypassed by error-prone translesion synthesis (TLS) polymerases [64]. Our 
results show NTT[A>T]AAA mutations are reduced >3-fold when occurring in DHS (Wald test; 
𝑃 < 2.0 × 10−26). We hypothesize that the context-dependent mutation signature in our data is 
the result of damage induced by L1 retrotransposons and subsequent errors of the TLS 
polymerase. This model is consistent with observing higher NTT[A>T]AAA mutation rate 
outside of DHS, where NER activity may be impaired and lesions must be bypassed by error-
prone TLS during replication. Additionally, according to the “A-rule” [76], TLS polymerases 
preferentially pair abasic sites with adenine. Hence, mutations generated by errors of the TLS 
polymerase explain the preponderance of A>T (but not A>G or A>C) mutations at the 
NTTAAAA motif. 
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Discussion 
The main motivation of our study is to understand the genome-wide variation of germline 
mutation rates in humans. We bring to this task two innovations: first, we take advantage of 
large-scale WGS data, focusing on extremely rare variants as a potentially more powerful data 
source than currently available collections of de novo mutations [13, 14, 40, 42] or common 
variants [11, 12]. Second, building upon previous attempts to holistically model the relationship 
between sequence context, genomic features, and mutation rate, we estimate fine-scale 
mutagenic effects of multiple genomic features. Unlike previous studies, which estimated the 
impact of genomic features by treating all single-nucleotide mutation subtypes in aggregate [13], 
we allow for the possibility that mutation rates of sequence motifs are differentially affected by 
these features.  
Our results not only confirm the previously reported hypermutable effects of specific 
sequence contexts and genomic features, but also demonstrate that many feature-associated 
effects previously only described in somatic cells are present in the germline. Moreover, our 
approach identifies certain genomic features, including H3K36me3 peaks, DNase hypersensitive 
sites, and CpG islands, that may act to both suppress and promote mutability depending on the 
mutation type and sequence context, providing insight into the causal mechanisms of germline 
mutation rate heterogeneity across the genomic landscape.  
The subtype-specific effects of genomic features we report likely represent only a 
fraction of the effects across the genome, due to the limited power of detecting associations 
among rarer subtypes. A larger dataset of ERVs will likely reveal additional cases of association 
and will enable further study of mutation patterns among longer sequence motifs, additional 
genomic features, and interactions or nonlinear effects thereof. We also note several of the 
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genomic features used in our study were assayed in somatic cell lines or aggregated over 
multiple cell types. The currently available data for these features only crudely approximates the 
true genomic variation in germ cells, so the effects we estimated have likely regressed towards 
the mean. Generating precise maps of genomic features within male and female germ cell 
lineages may further uncover mutagenic mechanisms unique to the germline. Despite these 
limitations, the fine-scale effects of sequence context and genomic features reported here provide 
the most accurate map to date of germline mutation variation, as demonstrated by their improved 
ability to predict genuine de novo mutation patterns. 
Even without accounting for the effects of genomic features, our ERV-derived mutation 
rate estimates for 7-mer subtypes are consistently more accurate than those based on mostly 
common SNVs from 1000 Genomes Project data [12]. Remarkably, even coarser estimates—the 
ERV-derived 5-mer and 3-mer rates—predict the spectrum of de novo mutations more accurately 
than the 1000G 7-mer estimates, demonstrating the merit of ERVs as a refined data resource for 
studying innate mutation patterns. Some of the improvement is likely the result of reduced 
sampling error, as our ERV dataset is larger than the 1000G dataset. Nevertheless, this result has 
two important implications. First, it suggests that high-frequency variants in presumably neutral 
genomic regions are influenced by biased evolutionary processes, such as selection and gBGC, 
or these variants arose via past mutational processes that are now inactive [48]. Second, this 
reaffirms the high quality of ERVs in our data: the potential errors due to calling or mapping 
biases among these ERVs are likely weaker than the evolution-driven biases affecting the older 
variants. The larger sample, young allelic age, and high quality of ERVs together result in a 
demonstrably more accurate appraisal of recent or ongoing patterns of mutability than common 
SNVs.  
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Because the germline mutation rate is a critical parameter in the study of genetic 
variation, we envision a wide range of applications that stand to benefit from incorporating our 
genome-wide map of mutation rate estimates. Currently, many methods that rely on simulating 
“baseline” mutations, such as the pathogenicity scoring algorithm CADD [77] and coalescent 
simulator ms  [78], do not account for context-dependent mutation rate differences. Likewise, 
clinical applications for differentiating disease-causing mutations from background variation 
require a precise estimate of the expected de novo mutation rate, but even the most advanced of 
these only consider differences in 3-mer or 7-mer sequence contexts, and are based on intergenic 
SNVs from 1000 Genomes data [12, 79]. Incorporating more accurate sequence- and feature-
dependent estimates of mutation rates may lead to more realistic simulations and greater 
confidence in the inferences made by these methods. Another relevant area of research where our 
results might be applicable is the study of how germline mutation mechanisms have evolved over 
time [48, 80, 81]. If mutator phenotypes have frequently arisen throughout the evolutionary 
history of humans (as hypothesized by [48]), the effects of mutational modifiers have likely been 
extremely subtle, manifesting as granular context-specific mutation signatures. Our results, 
which describe the present-day pattern of mutation rate heterogeneity in Europeans, provide a 
wealth of potential hypotheses for investigating how these mutation processes have been shaped 
by past evolution. 
To facilitate the use of our genome-wide mutation rate estimates in other analysis and 
simulation pipelines, we have created a genome browser track to visualize these estimates at a 
single-base resolution alongside other genomic data. Ultimately, the refined mutation patterns 
from ERVs and the detailed dissection of context-feature effects serves as a quantitative 
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foundation for better understanding the molecular origins of mutation rate heterogeneity and its 
consequences in heritable diseases and human evolution. 
Methods 
Sample description  
The BRIDGES sample contains 3,927 unrelated European American bipolar disorder 
cases and controls. The cases and controls from the Centre for Addiction and Mental Health 
(CAMH) in Toronto (n=830), the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 
and King’s College London in London, U.K. (n=845) [82], the Genomic Psychiatry Cohort 
(GPC) (n=1,151) [83], and the Prechter Repository (n=363) [84] were collected as previously 
described, as were the STEP-BD cases (n=304), obtained from the NIMH repository [85], and 
the Minnesota Center for Twin and Family Research (MCTFR) study controls (n=434) [86]. In 
all studies, DNA was extracted from blood-based samples. All human research was approved by 
the relevant institutional review boards and conducted according to the Declaration of Helsinki. 
All participants provided written informed consent. 
 
Sample library preparation  
The concentration of each DNA sample was measured by fluorometric means 
(PicoGreen, Thermo Fisher, Woburn, MA, USA) followed by agarose gel electrophoresis to 
verify the integrity of DNA. Six-hundred nanograms of DNA was sheared with acoustic shearing 
(Covaris, Woburn, MA, USA) to an average size of 400nt. Following shearing, the samples are 
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transformed to a sequencing library using standard protocols to create a paired-end 
library. Briefly, sheared DNA was end-repaired, A-tailed and ligated with Illumina adaptors 
(New England Biolabs, Ipswitch, MA, USA). Following ligation, indexed primers were used to 
amplify the final libraries for each sample. Each sample received two indexes: 96 i7 indexes 
were used to identify each sample in each 96-well reaction plate while a single i5 index was used 
for each plate. This combination of indexes uniquely coded all samples in the project when both 
the i7 and i5 indexes were read during sequencing. Following six cycles of PCR (Kapa 
Biosystems, Wilmington, MA, USA), libraries were purified and quality controlled by assaying 
the final library size using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, 
USA) and quantitating the final library via real-time PCR (Kappa Biosciences). A single peak 
between 300-400bp indicates a properly constructed and amplified library ready for 
sequencing. PCR cycles for amplification are kept to a minimum to minimize PCR duplication 
rate and maximize library complexity.  
Sequencing  
Sequencing was performed per Illumina protocol, essentially as described by [87]. 
Libraries were pooled in sets of 12 samples and each pool sequenced on a single lane of a HiSeq 
2500 flowcell using version 3 Illumina chemistry at paired-end 100nt read lengths. Each library 
pool was loaded at 13pM to generate 160-180M paired reads per lane. Multiple flowcells of the 
library pools were performed to generate a final data set with an average coverage of 9.6x per 
sample. 
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Sample filtering and data quality control 
Among the 3,927 samples attempted, three failed library preparation and were not 
sequenced. We removed an additional 162 samples due to quality issues: five with imbalanced 
read counts between read 1 and read 2, four with improperly generated BAM files, 16 that had an 
average coverage <3x, and 137 due to high contamination (FREEMIX or CHIPMIX score >3% 
using VerifyBAMID [88]). For samples that failed for multiple reasons, we report a single 
category for simplicity. 
Among these 3,762 samples, reads were mapped to Build 37 of the human reference 
genome (including decoy sequence [55]), with alignment and variant calling performed using the 
GotCloud pipeline [33]. After variant calling, we applied additional sample-level filtering as 
described below to obtain the 3,716 included in our analysis. We first excluded 10 case samples 
that were not phenotyped as type 1 bipolar disorder (removed solely for consistency with 
ongoing analyses of the BRIDGES data that do require phenotypes). We identified and removed 
an additional 23 samples that showed evidence of sample swaps in VerifyBAMID [88], but had 
not been excluded from variant calling. We next computed continental-ancestry PCA coordinates 
by projecting BRIDGES samples in the coordinate space of the 1000 Genomes phase 1 samples 
[89]. We dropped 11 samples identified as PC ancestry outliers, defined by PC1<0.01 or 
PC2<0.025. We then checked for relatedness using the ?̂? statistic (i.e., estimation of pairwise 
identity-by-descent based on LD-pruned SNPs), computed in plink [90]. Nearly all pairwise 
sample comparisons were consistent with being unrelated, with ?̂? < 0.05 for 99.9% of sample 
pairs. Two samples were dropped due to relatedness, as the ?̂? between these was 0.5, indicating 
the two were full siblings. 
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These filters reduced the sample to 3,716 individuals, in which we called 37,470,516 
autosomal singleton SNVs in the mappable genome (i.e., non-N reference bases in the GRCh37 
reference genome) that passed the variant-level filtering criteria implemented in the GotCloud 
pipeline [33]. Prior to performing our analyses, we examined how these 37.5 million ERVs were 
distributed across individual samples to identify and remove individuals that showed abnormal 
patterns of variation due to systematic sequencing errors or batch effects. In brief, we adapted the 
non-negative matrix factorization (NMF) technique described by [91] to summarize the 
distribution of ERVs unique to each individual as a composite of 3 distinct “signatures.” For 
each of the 3,716 individuals in our sample, we calculated a vector of 96 3-mer relative mutation 
rates (described below) using only the ERVs observed in that individual, generating a 3,716 x 96 
rate matrix. Decomposition of this matrix via NMF produces a 3,716 x 3 matrix describing the 
relative contribution of each signature to the observed mutation spectrum per individual. Because 
we assume the relative mutation rate of any given subtype should be similar across individuals, it 
follows that the contribution of a given NMF signature should also be similar. We removed 156 
individuals where one or more signatures had a contribution >2 standard deviations away from 
the mean contribution of that signature calculated across all individuals, reasoning that ERVs 
observed in these individuals are more likely to be errors. The final sample used in our analyses 
thus consists of 3,560 individuals, in which we identified 35,574,417 singletons. Additional 
details of this filtering strategy are described in Appendix A.  
Mutation subtypes and calculation of relative mutation rates 
Each of the 35,574,417 singletons can be classified into one of 6 basic mutation types, 
defined by the reference and alternative allele: A>C, A>G, A>T, C>T, C>G, and C>A. The 
35 
 
notation of A>C includes both A-to-C mutations and complementary T-to-G mutations. For each 
mutation type, we further define a set of mutation subtypes by the bases flanking the variant site. 
Since there are 4 possible bases at both the +1 position and the -1 position, there are 4x4=16 
possible 3-mers containing each basic mutation type at the central position, producing 6x16=96 
3-mer subtypes. Likewise, there are 6x44=1,536 5-mer subtypes, and 6x46=24,576 7-mer 
subtypes. To simplify notation, we denote a subtype by the sequence motif containing either an 
A or a C as the reference base at the central position (e.g., either CGT[A>X]TCG or 
CGT[C>X]TCG). 
For each K-mer subtype, we divided the number of ERVs observed at the central position 
of the K-mer by the number of times the K-mer is seen in the mappable autosomal regions of the 
reference genome; we term this proportion the estimated relative mutation rate. K-mers in the 
reference genome were counted by a 1-bp sliding window, so that every possible occurrence of 
that K-mer was accounted for (e.g., a run of 4 As is counted as two AAA 3-mers shifted by one 
base). For example, we observed 7,548 C>T or G>A autosomal singletons occurring in an 
ATACGCA or TGCGTAT 7-mer motif (the underlined base indicates the variant site) and there 
are 53,314 such motifs in the autosomal reference genome where this subtype of mutation could 
be observed, yielding a relative mutation rate estimate of 7,548/53,314=0.1416 for the 
ATA[C>T]GCA subtype. 
Testing for heterogeneity of relative rates 
As each K-mer can be split into 16 possible (K+2)-mers that share the same internal 
motif but differ in their terminal bases, the relative mutation rate for each K-mer subtype is the 
weighted mean of the rates found among its 16 possible (K+2)-mer constituent subtypes. To 
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assess the heterogeneity of relative mutation rates among each set of 16 (K+2)-bp constituent 
subtypes that share the same K-bp motif, we performed a chi-squared test for uniformity of these 
rates, with each test having 15 degrees of freedom. 
Mutation prediction model and validation   
To evaluate the accuracy of different mutation rate estimation strategies, we applied the 
estimated rates to predict the incidence of 46,813 de novo mutations using logistic regression. 
These de novo mutations were published by two independent studies: 11,020 de novo mutations 
detected in 258 Dutch families by the Genomes of the Netherlands (GoNL) project [14], and 
35,793 de novo mutations from 816 families sequenced by the Inova Translational Medicine 
Institute (ITMI) Premature Birth Study [42]. We combined the observed mutations with 1 
million randomly selected sites from the mappable autosomal regions of the reference genome to 
serve as a non-mutated background, reasoning that ~20 non-mutated sites for each actual de 
novo mutation would be sufficient to minimize sampling noise in the set of non-mutated sites; 
we also repeated this procedure with 500,000, 2 million, and 3 million randomly selected sites to 
tell if the trends we observed were affected by the size of the non-mutated background. Because 
each non-mutated site can be ambiguously considered as the background for 3 different mutation 
types, we divided the 1 million non-mutated sites into 3 non-overlapping sets. We designated 
A/T and C/G reference bases in the first set (consisting of 333,334 unique sites) as non-mutated 
A>G and C>T types, respectively, and so on for the second set (A>C or C>G types), and the 
third set (A>T or C>A types), each of which contained 333,333 unique sites. Hence, we 
considered a total of 1,046,813 testing sites (1,000,000 unmutated sites and 46,813 de novo 
mutations), each with one possible mutation event, in our prediction models. 
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Now let 𝑖 = {1, … ,1046813} be an index for the 1,046,813 testing sites. We coded 𝑑𝑖 =
1 if site 𝑖 is a de novo mutation and 𝑑𝑖 = 0 otherwise. If a set of estimated relative mutation rates 
reflects the underlying mutation process, we expect that the odds of a given site for carrying a de 
novo mutation increases with the estimated relative mutation rate of that site. To assess this 
expectation for all sets of mutation rate estimation strategies (e.g., ERV-based or 1000G-based 7-
mer estimates), we annotated each testing site 𝑖 with the relative mutation rate estimated under 
strategy 𝑀 (𝑟𝑖,𝑀), and used logistic regression to model the probability of a de novo mutation at 
each site as a function of these rate estimates, where 𝛼0 is the intercept term and 𝛼1 is the 
regression coefficient: 
𝑙𝑛(
𝑃𝑟(𝑑𝑖 = 1)
𝑃𝑟(𝑑𝑖 = 0)
) = 𝛼0 + 𝛼1𝑟𝑖,𝑀                        (1) 
The probability of a mutation at each testing site can then be calculated as: 
𝑃𝑟(𝑑𝑖 = 1) =
1
1 + 𝑒𝛼0+𝛼1𝑟𝑖,𝑀
                        (2) 
The overall likelihood of model 𝑀, given the observed data, is the product of the probability 
values over all 1,046,813 sites:  
𝐿𝑀 = ∏
𝑑𝑖=1
1
1 + 𝑒𝛼0+𝛼1𝑟𝑖,𝑀
∏
𝑑𝑖=0
𝑒𝛼0+𝛼1𝑟𝑖,𝑀
1 + 𝑒𝛼0+𝛼1𝑟𝑖,𝑀
      (3) 
Using this likelihood, we evaluated model fit by the Akaike Information Content (AIC), where 𝑝 
is the number of parameters in equation (1) (because all models are based on a single covariate 
of mutation rates, 𝑝 = 1 in all cases): 
𝐴𝐼𝐶𝑀 = 2𝑝 − 2𝑙𝑛 (𝐿𝑀)                            (4) 
For each model, we also calculate Nagelkerke's R2: 
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𝑅𝑀
2 =
1 − {
𝐿0
𝐿𝑀
}2/𝑁
1 − {𝐿0}2/𝑁
                             (5) 
Here, 𝐿0 is the likelihood of a null intercept-only model with no covariates.  
Because these likelihood-based goodness-of-fit statistics are calculated across all the 
basic mutation types combined, they do not provide information about which types benefit most 
strongly from using expanded sequence motifs. For example, it is possible that any improvement 
to the overall goodness-of-fit is elicited by context-dependent heterogeneity of a single mutation 
type, whereas other types might not be significantly affected by using longer sequence motifs, 
and do not contribute to the improved model fit. To identify these type-specific trends, we 
stratified our testing data by each of the basic mutation types. To account for the known 
hypermutability of cytosine at CpG dinculeotides, we separated C>T, C>G, and C>A mutations 
into CpG and non-CpG types, for a total of 9 basic mutation types. For each type, we repeated 
the 3-mer, 5-mer, and 7-mer models on only the sites of that type. Within each set of type-
specific models, we again compared the goodness-of-fit using AIC and Nagelkerke's R2. Note 
that because the absolute values of AIC and Nagelkerke's R2 are a function of the number of data 
points included in the model, these statistics cannot be directly compared between type-specific 
models, where the number of data points vary.  
Estimating effects of local genomic features  
We estimated the effect of 14 genomic features (data sources for these features are 
described in Table A.6) on the relative mutation rate of each 7-mer subtype using the following 
logistic regression framework. Let 𝐾 be the index across all 7-mer subtypes with 20 or more 
observed singletons (𝐾 ∈ {1, … ,24396}). Let 𝑗𝐾 be the index across all sites that are centered at 
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the 7-mer motif that could produce a mutation of subtype 𝐾, and let 𝑍𝑗𝐾 = 1 if the site carries a 
singleton of subtype 𝐾 and 𝑍𝑗𝐾 = 0 otherwise. We annotated each site of the considered subtype 
for 14 genomic features, generating predictors 𝐹𝑗𝐾,1, … , 𝐹𝑗𝐾,14. We treated 11 of these features as 
binary variables (seven histone marks, lamin-associated domains, CpG islands, DNase 
hypersensitive sites, exons), setting the predictor 𝐹𝑗𝐾,𝑔  = 1, 𝑔 ∈ {1, … ,11} if the central site of 
the motif was inside the specified regions and 𝐹𝑗𝐾,𝑔  = 0 otherwise. For the 3 continuous features 
(recombination rate, replication timing, surrounding GC content), we set the predictor 𝐹𝑗𝐾,𝑔, 𝑔 ∈
{12,13,14} to the mean value of that feature in a 10kbp window centered at the site. Because the 
inferred effect of some features may be confounded by correlation with read depth and calling 
rates (e.g., GC content [92]), we included read depth at the central site of the 7-mer as covariate 
𝐹𝑗𝐾,𝐷𝑃. For each 7-mer subtype 𝐾, we then evaluated the effect of the genomic predictors on the 
log odds of mutability for each site 𝑍𝑗𝐾  using the following logistic regression equation:  
𝑙𝑛(
𝑃𝑟(𝑍𝑗𝐾 = 1)
𝑃𝑟(𝑍𝑗𝐾 = 0)
) = 𝛽0
𝐾 + 𝛽1
𝐾𝐹𝑗𝐾,1 + ⋯ + 𝛽14
𝐾 𝐹𝑗𝐾,14 + 𝛽𝐷𝑃
𝐾 𝐹𝑗𝐾,𝐷𝑃           (6) 
where (𝛽1
𝐾, … , 𝛽14
𝐾 ) are effects of the 14 considered genomic features on the mutation rate of 
subtype K, and 𝛽𝐷𝑃
𝐾  is the effect of the local sequencing depth. The intercept of this model, 𝛽0
𝐾, 
represents the feature-adjusted relative mutation rate for the considered 7-mer subtype. We 
performed this logistic regression and obtained parameter estimates in R v3.2.3 using the 
speedglm() function from the speedglm package. We performed this procedure for each of the 
𝐾 ∈ {1, … ,24396} 7-mer subtypes, obtaining effect size estimates and standard errors for 16 x 
24,396 parameters. Note that we did not consider estimating interaction effects between the 14 
genomic features, as estimating all 2-way interactions would require an additional 14*(13-
1)/2=91 parameters per subtype-specific regression, which would lead to overfitting concerns. 
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To generate a map of mutation rates across the genome, we used the estimated regression 
coefficients to predict the relative mutation rate (i.e., probability of observing a singleton) at each 
site j where a mutation of a given 7-mer subtype could occur: 
𝑃𝑟(𝑍𝑗𝐾 = 1) =
𝑒𝑥𝑝(𝛽0
𝐾 + 𝛽1
𝐾𝐹𝑗𝐾,1 + ⋯ + 𝛽14
𝐾 𝐹𝑗𝐾,14 + 𝛽𝐷𝑃
𝐾 𝐹𝑗𝐾,𝐷𝑃)
1 + 𝑒𝑥𝑝(𝛽0
𝐾 + 𝛽1
𝐾𝐹𝑗𝐾,1 + ⋯ + 𝛽14
𝐾 𝐹𝑗𝐾,14 + 𝛽𝐷𝑃
𝐾 𝐹𝑗𝐾,𝐷𝑃)
           (7) 
Because there are three possible mutations at every site, we predict 3 independent mutation 
probabilities (one for each possible alternative allele). For example, for a site centered at a 
ACGATTG motif, we predict probabilities for A>C, A>G, and A>T alleles, using the parameters 
estimated from those models. This prediction uses all estimated effects, not just the effects 
determined to be statistically significant. We note that we did not generate predictions for sites 
within 5Mbp of the start/end of a chromosome, because recombination rate data were not 
available for these regions [93].  
To assess if inclusion of these genomic features improved upon the 7-mer mutation rate 
estimates in describing the true distribution of germline mutability, we again tested this model’s 
ability to predict the known de novo mutations from the GoNL [14] and ITMI [42] studies. We 
annotated each of the 𝑖 = {1, … ,1046813} testing sites with the predicted mutation rate, 
𝑃𝑟(𝑍𝑖𝐾 = 1), and calculated the goodness-of-fit using equations 1-5 with this parameter as the 
predictor. Note that the GoNL/ITMI data included de novo mutations within the 5Mbp telomeric 
regions where we could not estimate effects of genomic features. Rather than excluding sites in 
these regions from our goodness-of-fit comparison, we simply assigned the marginal 7-mer 
relative mutation rate as the predicted value for these sites, to ensure models were compared 
using identical data.  
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Data and code availability  
Predicted mutation rates based on sequence context and genomic features at each site 
have been formatted as a UCSC Genome Browser track, which can be accessed at 
http://mutation.sph.umich.edu.  
All custom scripts used in downstream data processing and analyses are available at 
https://github.com/carjed/smaug-genetics. A web-based utility and command-line code for 
annotating a variant call format (VCF) file of genetic variants with estimated 7-mer mutation 
rates can be accessed at http://www.jedidiahcarlson.com/mr-eel/.  
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Chapter III. 
Patterns and properties of multinucleotide mutations in 
the human germline
Introduction 
Many methods in population and evolutionary genetics rely on the assumption that 
single-nucleotide variants (SNVs) are spatially independent from one another—that is, each 
observed SNV is assumed to have arisen through its own unique mutation event. Several recent 
studies, however, have estimated that approximately 1-5% of human germline single-nucleotide 
mutations are in fact the result of multinucleotide mutation events which simultaneously generate 
multiple point mutations, separated by relatively short distances ranging from 1 to 20,000 base 
pairs (bp) [13, 14, 17, 18, 21–23], violating the common assumption that SNVs are spatially 
independent from one another.  
Failure to account for these multinuceotide mutations (MNMs) can cause serious 
confounding in efforts to identify regions of positive selection [20] or inference of population 
demographic history [21]. In addition, MNMs are important to consider as a distinct class of 
mutations for a variety of other reasons. First, MNMs are inherently characterized by properties 
that do not exist for single-nucleotide mutations, namely that they consist of multiple point 
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mutations and span multiple bases of mutated and non-mutated sequence. Collectively, these 
properties define what we refer to as the intrinsic mutation rate of MNMs. For simple MNMs 
consisting of just two constituent point mutations, the intrinsic mutation rate is effectively an 
inverse linear function of the inter-mutation distance (i.e., shorter inter-mutation distances 
correspond to higher intrinsic mutation rates). Because MNMs can result from a variety of 
distinct mechanisms, the intrinsic mutation rate is a crucially important property for 
understanding the biological processes underlying MNMs throughout the genome [17, 21–23, 
94].  
Due to the unique mechanistic origins of MNMs, they also exhibit distinctive mutation 
spectra and a general tendency to be enriched for transversion mutations [21–23]. Consequently, 
MNMs are more likely to have deleterious effects when occurring within coding regions and 
may play a significant role in the etiologies of various heritable diseases [18, 95]. Additionally, 
because MNMs inherently affect multiple bases in the genome, they have been hypothesized to 
contribute to accelerated evolution [19, 96]. Understanding the mechanistic origins of MNMs, 
their intrinsic properties, and their distribution throughout the genome therefore stands as an 
important task for explaining the demographic and evolutionary history of humans and 
deciphering the genetic architecture of complex traits. 
Like most studies of single-nucleotide germline mutation patterns in humans, 
investigations into the patterns and properties of MNMs have largely relied on de novo mutations 
identified by whole-genome or whole-exome sequencing of families [14, 17, 18, 22, 23]. 
Although such datasets are widely considered to be the gold standard for characterizing mutation 
processes active in present-day human populations, they are not well-suited for understanding 
fine-scale variation of these mutation patterns [97]. This is particularly true for MNMs, which 
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are inherently rare events—on average, assuming a genome-wide multinucleotide mutation rate 
of 3.9 x 10^-9 [17], we expect each individual to carry only 1-2 de novo MNMs in their entire 
genome. Consequently, even the largest published trio sequencing studies to date have only been 
capable of ascertaining fewer than 2,000 de novo MNMs [22, 23]. 
An alternative strategy that has been used to study MNMs is to investigate spatially 
clustered common variants that occur in perfect linkage disequilibrium (LD) in population-based 
samples [19, 21]. These studies have ascertained tens of thousands of perfect-LD SNP pairs that 
likely arose via multinucleotide mutation events (compared to only hundreds or thousands of de 
novo MNMs identified through trio sequencing strategies), and thus are better poised to 
characterize granular properties of MNMs. However, due to the effects of recombination over 
many generations, this approach is limited in scope to MNMs whose constituent point mutations 
are very closely spaced (e.g., <100bp, though these studies often restrict their analyses to even 
shorter intervals [21]), and thus cannot adequately describe mutation processes which generate 
MNMs with lower intrinsic mutation rates. 
We recently demonstrated that extremely rare variants (ERVs), ascertained from 
relatively large samples of unrelated individuals, are a powerful data source for studying 
germline mutation patterns [97]. ERVs represent mutations that have accumulated very recently 
in the population and, in sufficiently large samples, the vast majority of ERVs are young enough 
that their distribution has been virtually unaffected by natural selection and biased gene 
conversion. The putatively young age of ERVs also means that MNMs whose constituent 
mutations occur further apart are less likely to have been disrupted by recombination events. 
ERVs therefore may be a particularly useful resource to investigate fine-scale properties of 
MNMs. 
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In this study, we propose a simple statistical model to describe the patterns of spatial 
clustering observed among ERVs. We apply this model to a collection of 32,144,732 ERVs 
ascertained from 2,000 whole genomes sequenced as part of the Trans-Omics for Precision 
Medicine (TOPMed) study and show that the spatial distribution of ERVs throughout the 
genome can be explained accurately and parsimoniously as a mixture of four distinct processes. 
We find that two of these processes exhibit patterns in their intrinsic mutation rate and spectra 
that are indicative of two distinct multinucleotide mutation mechanisms known to be active in 
the human germline. Deeper analysis of these putative MNMs reveals that they are remarkably 
diverse in their intrinsic properties and genome-wide distribution and are influenced by various 
features of the genomic landscape, elucidating many previously unknown characteristics of 
MNMs. The patterns of variation among MNMs also appear to differ slightly between human 
populations, potentially indicating differences in endogenous or environmental mutation 
mechanisms. Finally, because each of these processes represents, to varying degrees, the joint 
influence of independent single-nucleotide mutations, multinucleotide mutations, and the 
demographic history of the sample, this model enables us to unambiguously quantify the extent 
to which each of these factors contributes to the observed clustering patterns of singletons. 
Results 
The TOPMed data 
From the 11,759 unrelated individuals sequenced in freeze 3 of the TOPMed study, we 
selected the subset of 1,000 individuals with the highest proportion of European ancestry, and 
1,000 with the highest proportion of African ancestry, with global ancestry inferred using 
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RFMIX [98] (Methods). We chose a sample size of N=1,000 for each subsample for two 
reasons: first, to restrict each subsample to individuals with relatively homogeneous ancestral 
backgrounds, and second, to limit the incidence of parallel mutations at hypermutable sites, 
which can alter the underlying spectra of rare variants in large samples [99]. In each subsample, 
we recalculated the minor allele counts of each SNV independently and identified 13,351,172 
singleton variants in the European subsample, and 18,793,562 singletons in the African 
subsample. 
Inter-singleton distances show evidence of mutational non-independence 
We first summarized the spatial distribution of these singletons by calculating the 
successive distances between each set of singletons unique to each individual (Methods). The 
median inter-singleton distances in Africans and Europeans were 61,897bp and 102,952bp, 
respectively, reflecting the differences in the total number of singletons observed in each 
subsample. Next, we compared the empirical distribution of these inter-singleton distances to the 
distribution we would expect under a simple model of mutational independence, where all 
singletons are assumed to have arisen independently through a single random mutation process 
(Methods). Consistent with patterns of spatial clustering observed among both de novo 
mutations [17] and single nucleotide polymorphisms [21], we find that the empirical distribution 
of inter-singleton distances in the TOPMed data is heavily enriched for closely-spaced intervals 
that are relatively uncommon under the naive uniparametric models (Fig. 3.1). 
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Figure 3.1 Comparison of observed and expected inter-singleton distance distributions. Observed distributions are shown in 
solid lines, and expected distributions under a single-parameter exponential model are shown in dotted lines. The rate parameters 
for the expected distributions are based on the median number of singletons per individual, as observed in the European and 
African ancestry subsamples. (𝜃𝐸𝑈𝑅 = 4.5 × 10−6;  𝜃𝐴𝐹𝑅 = 6.3 × 10−6). 
 
Modeling the spatial distribution of singletons as a mixture of exponential 
processes 
Prior studies have established that MNMs are a non-trivial source of clustering among 
single-nucleotide variants [19–21, 100], so a logical explanation for the poor fit of the 
uniparametric model is that it simply does not account for singletons that arose through non-
independent multinucleotide mutation events. It is widely understood that different mechanisms 
produce MNMs with distinct ranges of intrinsic mutation rates [16]. The inter-singleton distance 
distribution can therefore be considered as a mixture of a finite number of mutation processes, 
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where each process is presumed to generate some fraction of singletons occurring with a unique 
intrinsic mutation rate. Explicitly modeling the effects of these processes, however, would 
require prior knowledge of the number of operative multinucleotide mutation mechanisms, their 
intrinsic mutation rates, and what fraction of mutations are attributable to each underlying 
mechanism. Though these properties have been described for a limited number of 
multinucleotide mutation mechanisms [16, 17], their joint effects on the spatial distribution of 
rare variants have not been characterized. 
We hypothesized that the empirical inter-singleton distance distribution could be used to 
estimate the parameters of such a mixture model, and that the properties of these inferred mixture 
components would reflect properties of the underlying multinucleotide mutation processes and 
their effects on the spatial distribution of singletons throughout the genome. To further explore 
this hypothesis, we iteratively fit mixture models to the observed distribution of inter-singleton 
distances in each of the 2,000 individuals in our sample, starting with two mixture components 
and increasing the number of inferred components until the goodness-of-fit plateaued 
(Methods). Each mixture component consists of two parameters: lambda, describing the relative 
contribution of this component to the overall number of inter-singleton intervals, and theta, 
describing the intrinsic mutation rate of singletons inferred to have been generated by this 
particular process. Using this strategy, we found that the majority (98%) of individual singleton 
distributions were best modeled by a four-component (eight-parameter) mixture, so we fixed the 
number of components per individual at four for our subsequent analyses. As predicted, this 
mixture model fit the observed data substantially better than the single-parameter exponential 
model (Fig. B.1), indicating these four components accurately explain the majority of variation 
in the observed inter-singleton distance distribution. Moreover, the estimated parameters of these 
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four mixture components were highly homogeneous across individuals, with virtually no overlap 
in the ranges of the four rate estimates, suggesting the same underlying processes were 
contributing to the inter-singleton distance distributions in all individuals (Fig. 3.2). We note 
that, with the exception of the component 1 rate parameter, all of the parameters for each of the 
four components differed significantly between the African and European ancestry subsamples 
(Table B.1).  
Because we assume that the majority of singletons arise as independent mutations, we 
interpret the mixture component with the highest lambda value (i.e., that which contributes the 
most to the observed inter-singleton distance distribution) as corresponding to the independent 
point mutation process. Hence, we consider mixture component 4 to represent this independent 
point mutation process. We interpret the remaining three components as corresponding to 
processes which generate closely-spaced clustering patterns among the ERVs. Components 1 and 
2 were of particular interest, as the intrinsic mutation rate estimates of these components were 
within the range typically used to define MNMs (i.e., <20,000bp) and appeared to directly 
implicate two distinct multinucleotide mutation mechanisms. Mixture component 1, which has a 
median intrinsic mutation rate of 1 singleton every 4bp, appears to reflect MNMs occurring 
through translesion synthesis (TLS), an error-prone process in which specialized polymerases 
bypass DNA lesions during replication [101]. TLS has been widely studied as a source of 
multinucleotide mutations, and most studies agree that MNMs with constituent point mutations 
separated by very short distances of 1-30bp are largely attributable to this mechanism [16, 17, 
48, 101]. Mixture component 2 captures singletons occurring at a median intrinsic mutation rate 
of ~1 per 3,541bp. The intrinsic mutation rate of this component appears to correspond to that of 
MNMs resulting from hypermutability of single-stranded DNA intermediates that occur during 
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the repair of double-strand breaks (DSB), the constituent point mutations of which are typically 
separated by distances of 1,000-5,000bp [22, 23]. Unlike the other three mixture components, the 
parameters of mixture component 3 do not suggest an obvious biological interpretation. The 
presence of this component (with a median intrinsic mutation rate of ~1 singleton per 66,389bp) 
indicates that many singletons are spatially clustered at distances that cannot be explained by 
either independent mutation processes or known multinucleotide mutation processes. The 
potential sources of this cryptic clustering pattern are discussed later in this chapter.  
 
 
Figure 3.2. Parameter estimates for exponential mixture models. Each point represents one of the four components in one of 
the 2,000 individuals in the sample, colored by the majority ancestry of that individual. The rate of the component is shown 
across the x-axis, and the proportion that component contributes to the mixture on the y-axis (on a log-log scale). Marginal 
histograms show the distribution of the lambda and rate parameters for each component. 
 
Properties of clustered singletons correspond to known MNM mechanisms  
In addition to generating MNMs occurring at distinct ranges of intrinsic mutation rates, 
the processes of translesion synthesis and DSB repair are also known to exhibit unique mutation 
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spectra. Error-prone TLS is particularly prone to generating MNMs enriched for A>T and C>A 
transversions [17, 21], and MNMs resulting from DSB repair have been found to correspond to 
unusually high rates of C>G transversions [22, 23]. Therefore, if components 1 and 2 ascertained 
from our mixture model are genuinely associated with TLS and DSB mutation processes, we 
would expect that the known mutation spectra of these two mechanisms are reflected in the 
spectra of singletons we attribute to each of these components. To address this, we calculated the 
probability of component membership for each singleton (according to the mixture parameter 
estimates for the individual in which that singleton was observed) and assigned each singleton 
into one of the four components accordingly (Methods). We then tabulated the frequencies of 
the 6 basic mutation types (A>C, A>G, A>T, C>A, C>G, and C>T) in each of the 4 mixture 
components across the 2 ancestry subsamples and determined the mutation spectrum (i.e., the 
proportion of singletons of each basic mutation type) among each of these 8 groups (Fig. 3.3). 
This analysis revealed that the spectrum of component 1 singletons was heavily enriched 
for transversions, particularly A>T and C>A, consistent with the typical spectrum of TLS-
associated MNMs [17, 21] (Fig. 3.3). As described by Jonsson et al. [23] and Goldmann et al. 
[22], DSB-associated MNMs exhibit a strong enrichment of C>G transversions. If this process is 
contributing to the clustering patterns associated with mixture component 2 in our model, we 
should expect to see a similar enrichment of C>G transversions among the singletons assigned to 
this component. The observed spectrum of component 2 singletons was consistent with this 
expectation (Fig. 3.3) 
Component 1 singletons in the African ancestry subsample appeared to have an even 
stronger transversion bias than those in the European ancestry subsample: A>T and C>A 
transversions respectively accounted for 13.2% and 15.8% of all component 1 singletons in 
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Africans, but only 11.5% and 14.1% of component 1 singletons in Europeans. Component 2 also 
showed slight differences between the two subsamples, with individuals of European ancestry 
tending to have a greater proportion of C>G transversions (10.9%) than individuals of African 
ancestry (10.3%). Testing for overall differences in the spectra between the two subsamples, we 
found that both the spectra of both components 1 and 2 differed significantly (5-df chi-squared 
tests;𝑃 < 7.8 ×  10−188). 
 
 
Figure 3.3. Mutation spectra of mixture components. For each of the four mutation components, we calculated the relative 
frequencies of the 6 basic mutation types in the African and European subsamples. 
 
The multinucleotide mutation spectrum varies with the intrinsic mutation rate 
Analyzing the spectra of each discrete mixture component provides a useful means of 
confirming that processes inferred by our model carry the signatures of known multinucleotide 
mutation mechanisms but may obscure more subtle patterns of variation in the multinucleotide 
mutation spectrum. For example, Besenbacher et al. found that when MNMs are binned into 
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discrete categories according to their intrinsic mutation rate, the mutation spectrum varies 
dramatically [17]. The authors concluded that the mutation spectrum of multinucleotide 
mutations is a function of the intrinsic mutation rate [17]. This study, however, classified MNMs 
into only six bins according to the inter-mutation distance of their constituent point mutations 
(1bp, 2-10bp, 11-100bp, 101-1,000bp, 1,001-5,000bp, and 5,001-20,000bp) [17]. Because the 
singletons in our data outnumber the de novo mutations analyzed by [17] by several orders of 
magnitude, we classified singletons into 1bp bins for inter-mutation distances <100bp, 100bp 
bins for distances between 100-20,000bp, and 1,000bp bins for distances >20,000bp, and 
investigated how the mutation spectra varied over these granular classifications. 
This analysis showed that the mutation spectrum of putative MNMs undergoes several 
dramatic shifts as the intrinsic mutation rate decreases (Fig. 3.4). For putative tandem mutations 
(i.e., MNMs consisting of two immediately adjacent nucleotide changes), we observed the 
expected excess of A>T and C>A transversions, corresponding to the known signature of 
GA>TT and GC>AA mutations attributable to DNA polymerase zeta [21]. For putative MNMs 
with an inter-mutation distance of 2bp (e.g., CAC > GAG), the spectrum shifted immediately 
towards higher rates of A>G transitions and lower rates of C>A transversions. The spectrum 
continued to fluctuate as the intrinsic mutation rate decreases. For instance, the proportion of 
A>G transitions increased from 15% among tandem mutations to 30% in MNMs with an 
intrinsic mutation rate of 1/3-1/5bp, and A>T transversions decreased from the third most 
abundant type among tandem mutations (~18%) to the least common type among MNMs with an 
intrinsic mutation rate of 1/11bp (~9%).  
The rank-order of relative frequencies for the 6 basic types eventually stabilized around 
an intrinsic mutation rate of 1/12bp (though still with high proportions of all 4 transversion 
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types), but MNMs with larger inter-mutation distances continued to exhibit relatively high rates 
of C>G transversions, consistent with the expected signature of DSB-associated MNMs [22, 23]. 
As the intrinsic mutation rate decreased, the high proportion of C>G transversion gradually 
tapered off until the intrinsic mutation rate reaches approximately 1/10,000bp, at which point the 
spectrum became nearly indistinguishable from that of unclustered singletons. 
In the human genome, there are at least 5 DNA polymerases capable of translesion 
synthesis [101], so one plausible explanation for the extreme variation in spectra of TLS-
associated MNMs is that different TLS polymerases, each of which has distinct error biases, tend 
to produce MNMs with distinct intrinsic mutation rates. Once the intrinsic mutation rate of 
putative MNMs drops below 1/100bp, however, the mutation spectra is quite stable, suggesting 
that DSB-associated MNMs exhibit the same C>G mutational bias, regardless of how closely the 
constituent point mutations occur. Though different mechanisms are typically assumed to 
correspond to distinct (and often non-overlapping) ranges of intrinsic mutation rates [16], we 
emphasize that these results do not preclude the possibility that the spectrum of MNMs with an 
intermediate range of intrinsic mutation rates (for example, between 1/10 and 1/100) might 
reflect MNMs that  have been generated both by TLS-associated and DSB-associated mutation 
processes.  
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Figure 3.4. Variation in mutation spectra as a function of intrinsic mutation rate. We classified each singleton according to 
the minimum distance to the nearest singleton in the same individual. To ensure the spectra at each distance were supported by 
sufficiently many singletons, we classified singletons into 1bp bins for inter-mutation distances <100bp, 100bp bins for distances 
between 100-20,000bp, and 1,000bp bins for distances >20,000bp. For clarity, these three bin resolutions are plotted in separate 
panels from left to right. These spectra were calculated separately for the African (top panels) and European (bottom panels) 
subsamples. 
 
Identification of multinucleotide mutation hotspots and associated genomic 
features 
To characterize how these clustering patterns varied throughout the genome, we counted 
the number of singletons assigned to each component in non-overlapping 1 megabase pair (Mbp) 
windows and applied a 3-state Hidden Markov Model (HMM) to these frequency sequences to 
segment the genome into regions of cold, neutral, or hot spots for each component (Methods). 
Putative hotspots for component 2 singleton clusters showed a nearly perfect overlap with 
genomic loci previously found to be enriched for DSB-associated MNMs, specifically on chr2p, 
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chr8p, chr9p, and chr16p/q [22, 23] (Fig. 3.5). In addition, we identified several previously 
uncharacterized hotspots for these clusters, generally occurring in the subtelomeric regions of 
chr3p, chr4p, chr7p, chr9q, chr19p, chr20q, chr21q, and chr22q (Fig. B.3). These hotspots were 
consistently detected in both the African and European ancestry subsamples. The tendency for 
these hotspots to occur near the ends of chromosome arms reflects evidence from several studies 
that have shown subtelomeric regions are widely enriched for DSBs in eukaryotic genomes (as 
reviewed by [102]). The densities of component 1, 3 and 4 singletons tended to be relatively 
uniform throughout the genome (Fig. B.2, Fig. B.4, Fig. B.5), though we note that many of the 
same regions found to be enriched for component 2 singletons were classified as hotspots for 
component 3 singletons and cold spots for component 4 singletons.  
 
Figure 3.5. Genomic hotspots of component 2 clustered singletons. Each bar indicates a 1Mbp window on chromosomes 2, 8, 
9, and 16. The height of the bar indicates the total proportion of component 2 singletons that occur in that window. The shade of 
each bar indicates the inferred state (hot, neutral, or cold) from the Hidden Markov Model applied over all chromosomes. Similar 
plots for all autosomal chromosomes are shown in Fig. B.3. 
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Next, we investigated whether the genome-wide variation in the density of each 
component was associated with various features of the genomic landscape. Using negative 
binomial regression models, we estimated the effects of 11 genomic features on the genome-
wide density of each component (Methods). The results of these regression models are 
summarized in Fig. 3.6. The strongest predictor of component 1 density was the presence of CpG 
islands. Because CpG islands typically co-occur with gene promoters [103], this association 
suggests that promoter regions might be uniquely susceptible to MNMs generated by translesion 
synthesis. Moreover, because CpG islands are typically unmethylated [103], this result provides 
evidence against the possibility that component 1 singleton clusters are merely artifacts of CpG 
hypermutability. CpG islands also showed weaker positive associations with component 2 
density and were negatively associated with the densities of components 3 and 4, indicating that 
CpG islands have a general tendency to be enriched for clustered singletons. Similarly, 
H3K4me1, a histone mark associated with decreased DNA methylation [104, 105], was 
positively associated with component 1 density, but negatively associated with the densities of 
components 2, 3, and 4. Components 2 and 3 both showed significant negative associations with 
exon density, potentially indicating a general depletion of mutations in actively-transcribed genes 
due to transcription-coupled repair processes [106], though we do not exclude the possibility that 
strong purifying selection has contributed to a depletion of singletons in gene-rich regions. 
The remaining features we analyzed tended to have a significant effect in the same 
direction either for components 1, 2, and 3 (but not 4) or components 2, 3, and 4 (but not 1). 
H3K27me3 and H3K9me3, two histone marks associated with transcriptional silencing in sperm 
cells [107], were positively associated with components 1, 2, and 3. One of the strongest 
predictors of components 2, 3, and 4 was H3K4me3, a histone modification that is known to 
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correspond to an increased frequency of DSBs in the genomes of yeast, mice, and human cells 
[108–110], as well as decreased DNA methylation [67]. Four features (DNase hypersensitivity, 
lamin-associated domains, H3K27ac, and H3K9ac) also showed significant positive associations 
with the densities of components 2, 3, and 4. All 4 components showed a weak but significant 
positive relationship with histone mark H3K36me3. Collectively, these results demonstrate that 
different features of the genomic landscape likely play varying roles in shaping the genome-wide 
distribution of singleton clustering patterns. 
 
 
Figure 3.6. Estimated effects of genomic features on regional density of clustered singletons. The regression coefficients 
(Beta values) are based on negative binomial regression models. Statistically significant associations (P<0.05) are marked with a 
*. 
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Validation with de novo mutation data 
To further validate these singleton clustering patterns as evidence of multinucleotide 
mutation processes, we applied our mixture deconvolution method to a collection of 71,769 de 
novo mutations, ascertained from 869 parent-offspring trios sequenced from freeze 5 of the 
TOPMed study (Methods). Because each individual possesses too few de novo mutations for us 
to perform this mixture deconvolution on a per-individual basis, we estimated the model 
parameters based on the distribution of inter-mutation distances aggregated across all individuals 
of a given ancestry. In both the African and European ancestry subsamples, the goodness-of-fit 
plateaued at 3 mixture components. Notably, the intrinsic mutation rate estimates of the first two 
components were within the same range as the rate estimates of components 1 and 2 from the 
singleton mixture model (Table 3.1). 
 
Table 3.1 Mixture parameter estimates for de novo mutation distance distributions 
 AFR EUR 
 Intrinsic rate lambda Intrinsic rate lambda 
Component 1 1/4.89bp 0.010 1/4.04bp 0.008 
Component 2 1/5.07kbp 0.014 1/5.83kbp 0.011 
Component 3 1/25.6Mbp 0.976 1/23.2Mbp 0.981 
 
These components also exhibited mutation spectra similar to the spectra of components 1 
and 2 identified in the singleton mixture model, namely an enrichment for A>T and C>A 
transversions among component 1 de novo mutations, and an enrichment for C>G transversions 
among component 2 de novo mutations (Fig. 3.7). Testing for overall differences in the spectra 
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between the two subsamples, we found that neither component 1 nor component 2 differed 
significantly in spectra (5-df chi-squared tests;𝑃 > 0.86). As with component 4 inferred from the 
singleton mixture model, we interpret component 3 from this de novo mixture model to represent 
the background independent single-nucleotide mutation process. 
 
 
Figure 3.7. Mutation spectra of de novo mutation mixture components.  
Other factors explaining the clustering patterns of singletons 
Comparing the mixture parameters estimated from the singleton data with those 
estimated from de novo mutation data, we note two prominent discrepancies. First, the de novo 
mutations are accurately explained by just three mixture components, which we interpret as 
corresponding to the background independent mutation process (component 3), DSB-associated 
MNMs (component 2), and TLS-associated MNMs (component 1). Though the same three 
processes are implicated as unique mixture components contributing to the spatial variation of 
singletons in the TOPMed data, we consistently required an additional mixture component (with 
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an intrinsic mutation rate and lambda parameter intermediate to mixture components 2 and 4) to 
explain the observed distribution of inter-singleton distances.  
In addition, the lambda parameters of mixture component 2 were notably lower among de 
novo mutations than among singletons, despite the similarities between intrinsic mutation rate 
parameters for these components. This discrepancy suggests that singletons are clustered at 
distances <20,000bp more often than we would expect if these are purely driven by 
multinucleotide mutation processes. Indeed, 31% and 42% of singletons in the TOPMed 
European and African ancestry subsamples occurred within 20,000bp of another singleton in the 
same individual, whereas past trio sequencing studies (and our present analysis of the TOPMed 
freeze 5 trios) suggest that only ~2-3% of de novo point mutations arise through multinucleotide 
mutation events [17, 22]. We note this discrepancy diminishes as the inter-singleton distance 
decreases: singletons occurring less than 100bp apart accounted for ~2% of all singletons, which 
is much closer to a prior estimate (1.8%) of the proportion of de novo point mutations expected 
to occur at such distances [21]. Tandem singletons account for 0.3% of singletons in the 
TOPMed data, which is within the range of previously-established tandem mutation rate 
estimates, typically around 0.2-0.4% [17, 111]. 
We propose two possible explanations for this enrichment of spatially-clustered 
singletons, both of which relate to the fact that singletons represent mutations that have 
accumulated in the population over the course of several past generations. First, we show that a 
substantial proportion of clustering can occur purely by chance due to the demographic history of 
the sample, even when all mutations are independent and generated by a single mutation process 
with uniform rate. Second, we demonstrate how these clustering patterns can arise stochastically 
through regional variation in the mutation rates. 
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By definition, a singleton variant occurs on an external branch of the coalescent tree 
describing the demographic history of a given sample of individuals. Assuming the mutation rate 
is constant over time, it follows that the number of singletons observed in each individual is a 
linear function of the external branch length (where the external branch length represents the 
amount of time in which new singleton variants, private to that individual, could have arisen). 
Individuals corresponding to longer external branches are therefore presumed to have 
accumulated more singletons, and hence are more likely to exhibit spatially-clustered 
independent singletons purely by chance. Intuitively, when the inter-singleton distances of all 
individuals in the sample are analyzed in aggregate, we would expect to see a general enrichment 
for spatially-clustered independent singletons. 
To quantify the extent to which singleton clustering is attributable to the demographic 
history of the sample, we simulated the inter-singleton distance distribution as a mixture of 1,000 
components, where the rate and lambda parameters of each component corresponded to the 
frequency of observed singletons in one of the individuals of a given ancestry from the TOPMed 
sample (Methods). Under this simulation, approximately 8.7% of singletons in the European 
ancestry subsample and 11.9% of singletons in the African ancestry subsample occurred within 
20,000bp of another singleton in the same individual. Differences in sample demography would 
therefore appear to explain the discrepancy in the lambda parameters of singleton mixture 
components 2, 3, and 4, as shown in Fig. 3.2. 
We also simulated the effect of external branch length heterogeneity on singleton 
clustering patterns under a general coalescent model, not specific to the observed singleton 
frequencies of individuals in the TOPMed sample. Using the msprime coalescent simulation 
library in Python [112], we simulated a sample of 1,000 diploid European genomes under a 
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feasible model of European demographic history [52] (Methods). This simulation generated 
795,907 single-nucleotide variants, 432,597 (54.4%) of which were singletons (note that this 
abundance of singletons is to be expected for rapidly-expanding populations [52, 57]). 
Examining the inter-singleton distances of these simulated singletons, we found that 8.3% of 
singletons occurred within 20,000bp of another singleton in the same simulated individual. We 
attribute the slight discrepancy to uncertainty in the parameters implemented in this coalescent 
simulation. This simulation was particularly sensitive to the mutation rate we selected—varying 
the mutation rate from 1 × 10−8 to 2 × 10−8 increased the fraction of clustered singletons from 
8.3% to 15.9%. 
Assuming 3% of singletons are the result of multinucleotide mutation events and 8-10% 
occur at distances <20,000bp apart purely by chance due to heterogeneity of external branch 
lengths in the sample, this leaves more than half of the observed inter-singleton clusters in the 
TOPMed data (accounting for 31% of all singletons) unexplained. We hypothesized that the 
remaining clustering can be explained by regional heterogeneity in mutation rates. Consider, for 
example, a genomic region containing two singletons that arose independently in different 
generations. Based on the above coalescent simulations, if the underlying genome-wide average 
single-nucleotide mutation rate doubles from 1 × 10−8 to 2 × 10−8, the probability that these 
singletons are separated by 20,000bp or less is expected to increase from 0.083 to 0.159. 
As a proof of concept, we simulated the effects of mutation rate heterogeneity based on 
the per-individual empirical singleton frequencies from the TOPMed data as before, but here 
assumed that 10% of the genome is subject to a 2-fold increase in mutation rate. Under this 
simulation scenario, the fraction of singletons occurring <20,000bp from another singleton in the 
same individual increased from 8.7% to 9.5% in the European ancestry subsample and from 
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11.9% to 13.0% in the African ancestry subsample. If we instead assume 10% of the genome is 
subject to a 10-fold increase in mutation rate, the fraction of clustered singletons increases to 
13.8% in the European ancestry subsample and 17.9% in the African ancestry subsample. These 
simulations demonstrate that regional heterogeneity in the rate of independent mutation 
processes can have a profound impact on the clustering patterns of SNVs observed throughout 
the genome.  
Discussion 
Multinucleotide mutations are a nontrivial source of genetic variation in the human 
genome, with unique mechanistic origins and a complex mutational footprint. In this study, we 
have investigated the spatial distribution of rare singleton SNVs throughout the genome with the 
goal of characterizing the fine-scale properties of MNMs, their variation throughout the genome, 
and how they influence the overall patterns of rare genetic variation. We showed that, in nearly 
all individuals, singleton densities can be parsimoniously represented as a mixture of just four 
basic processes. We provide extensive evidence that two of these processes appear to represent 
the effects of two particular multinucleotide mutation mechanisms: error-prone translesion 
synthesis (TLS), and errors induced during the repair of double-strand breaks (DSB). 
There are several other properties of MNMs that we did not consider here, but that may 
prove useful in a deeper characterization of the causal mechanisms. First is the order in which 
the constituent point mutations occur within each MNM. Our analyses focused only on 
describing the basic mutation spectra (based on the 6 possible single-nucleotide mutation 
categories) of constituent point mutations, without taking into account their inherent ordering. 
Considering the ordered arrangements of the constituent point mutations of MNMs, however, it 
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is possible to classify MNMs into 6x6=36 possible categories, each of which could be 
independently analyzed for variation in their intrinsic mutation rate or genome-wide distribution. 
This granular classification strategy has already proven useful in confirming the distinctive 
tandem mutation signature of DNA polymerase zeta, which has a strong bias towards generating 
GA>TT and GC>AA mutations [17, 18, 21], but similar effects of other multinucleotide 
mutation processes have yet to be described. Furthermore, preliminary evidence from [94] and 
[18] has suggested that the composition and sequence of the non-mutated bases upstream, 
downstream, and within each MNM may carry additional information about the underlying 
mechanisms. We also note that, because our model is based on inter-singleton distance 
distributions and not discretely-defined mutation clusters, we do not attempt to describe the 
patterns and properties of MNMs consisting of more than 2 constituent point mutations. 
Similarly, a subset of MNMs have been shown to consist of complex combinations of point 
mutations and short insertions or deletions (indels) [17], potentially arising through other distinct 
mechanisms. Cataloging and analyzing these features of MNMs may help further elucidate 
relationship between different mutation signatures and the underlying multinucleotide mutation 
processes and provide insight into the extent to which each mechanism contributes to the overall 
burden of MNMs throughout the genome. 
We have also investigated how singleton clusters ascribed to particular MNM processes 
vary regionally throughout the genome, confirming the presence of known DSB-associated 
mutation hotspots on chromosomes 2, 8, 9, and 16 [22, 23], as well as several novel hotspots 
with similar characteristics occurring in subtelomeric regions of other chromosomes (Fig. 3.5). 
These results fall into a broader body of evidence that telomeres are particularly prone to DSBs 
[102]. We found these regional patterns of clustering to be associated, to varying degrees, with 
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other features of the genomic landscape, such as CpG islands and exon density (Fig. 3.6), 
suggesting these features play a role in promoting or suppressing multinucleotide mutation 
mechanisms. We also observed that all 7 histone marks we considered were associated with 
different clustering patterns, consistent with earlier findings that chromatin structure affects the 
activity of both Y-family translesion polymerases in vitro [113] and DSB repair machinery 
[114]. Further experimental work is necessary to determine precisely how specific 
multinucleotide mutation mechanisms are impacted by the presence or absence of these features. 
Our analysis of spatially non-independent mutations (and their distribution throughout the 
genome) might also be adapted to studying the patterns of temporally non-independent 
mutations, where mutations in one generation increase the likelihood of mutations in subsequent 
generations. Temporal non-independence of mutations can occur when damage and repair genes 
themselves acquire mutations that influence their efficacy or particular error biases. There is a 
growing body of evidence to suggest that the ongoing evolution of these genes has played a 
prominent role in shaping the observed patterns of human genetic variation [48, 80, 81, 115, 
116]. These studies have proposed that, with sufficiently large samples of de novo mutations or 
rare variants, it may be possible to map loci responsible for variation in the rate or spectra of 
single-nucleotide variants [48, 116]. Given that MNMs are often attributed to very specific 
mutational pathways, implicating a handful of genes [16], we speculate that inter-individual 
variation in the rate and intrinsic properties of MNMs might be especially indicative of the 
presence of such mutator alleles. 
Our use of unphased singletons in these analyses precluded our ability to confirm 
conclusively that any given cluster of singletons arose via a past multinucleotide mutation event, 
because unphased singletons, by nature, could also arise in different generations or on different 
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haplotypes. When we applied our statistical model to a new dataset of over 70,000 de novo 
mutations, however, we found strong evidence that two of the same processes responsible for 
singleton clustering patterns (i.e., components 1 and 2, which we interpreted as signatures of 
TLS-associated and DSB-associated multinucleotide mutations) were also responsible for de 
novo mutation clustering patterns. These similarities suggest that, even though many clustered 
singletons likely arose independently, our mixture modeling strategy successfully recovers the 
signals of past MNM events. 
We concluded this study by demonstrating that patterns of clustering among singleton 
SNVs are not only the result of multinucleotide mutation processes, but also reflect the 
demographic history of the sample and variation in the local mutation rate. Through simulations, 
we estimated that approximately a third of inter-singleton intervals <20,000bp are purely 
attributable to variation in the demographic history of the sample. Assuming ~10% of inter-
singleton intervals <20,000bp are the result of MNM events, this leaves over half of these 
intervals unexplained. We provided a proof-of-concept simulation to demonstrate that this 
remaining proportion of singleton clusters can be explained in part by stochastically-occurring 
clusters of independent singletons caused by variation in single-nucleotide mutation rates 
throughout the genome.  
Other factors not considered here, such as selection, biased gene conversion, and 
evolving mutation rates over time are also expected to contribute to singleton clustering patterns. 
Because the signals of natural selection [50], biased gene conversion [117], local ancestry (and, 
more specifically, the external branch lengths) [118], single-nucleotide mutation rates [97] and 
multinucleotide mutation rates (Fig. 3.5) are continuously variable throughout the genome, we 
expect that in any given region there is a unique balance in the relative contributions of these 
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factors to the spatial distribution of singletons and other SNVs. Therefore, a deep understanding 
of how patterns of genetic variation are jointly influenced by regional heterogeneity and non-
independence of mutation processes (both spatial and temporal) will play an important role in 
efforts to unambiguously discern signals of selection or demographic history. 
Methods 
Data 
The TOPMed Freeze 3 dataset contains PCR-free, whole-genome sequencing data for 
11,759 unrelated individuals. Global ancestry estimates for seven super-populations were 
obtained using RFMIX [98]. For our analyses, we selected two independent subsamples of 1,000 
individuals European and African ancestry (>0.9), and recalculated the allele counts within each 
independent subsample. We chose to limit the subsample size to N=1000 for two reasons: first, 
to ensure each subsample shared homogenous ancestry, and second, to prevent biasing the 
singleton mutation spectra from recurrent mutations that occur in large samples [99]. 
Mixture Model Parameter Estimation 
For each individual 𝑖, we collected the set of 𝑆 singletons unique to that individual (with 
singleton status determined relative to other individuals from the same population subsample). 
Assuming singletons occur independently at a constant rate 𝜙𝑖, we can model the probability of 
observing 𝑆 singletons in individual 𝑖 as a Poisson process: 
 𝑓(𝑠𝑖) = 𝑒
−𝜙𝑖𝐺(𝜙𝑖𝐺)
𝑆𝑖/𝑆𝑖!  
where 𝐺 is the size (in base pairs) of the mappable autosomal regions of the genome. 
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Then let 𝐷𝑖 be a random variable describing the distance (in base pairs) between successive 
singletons in individual 𝑖. 𝐷𝑖 follows an exponential distribution with rate 𝜃𝑖 = 1/𝜙𝑖: 
𝑓(𝑑𝑖) = 𝜃𝑖𝑒
−𝜃𝑖𝑑𝑖 
Now suppose the set of 𝑆𝑖 singletons are generated by 𝐾 > 1 independent Poisson processes. For 
the subset of 𝑆𝑖,𝑘 singletons resulting from process 𝑘, the successive distances 𝐷𝑘 between these 
singletons follow an exponential distribution with rate 𝜃𝑖,𝑘: 
 𝑓𝑘(𝑑𝑖;  𝜃𝑖,𝑘) = 𝜃𝑖,𝑘𝑒
−𝜃𝑖,𝑘𝑑𝑖 
Then the distribution of inter-singleton distances across all 𝑆𝑖 singletons is parameterized as a 
mixture of these 𝐾 component distributions, given by: 
𝑓(𝑑𝑖; 𝜆𝒊, 𝜽𝒊) = ∑ 𝜆𝑖,𝑘 𝑓𝑘(𝑑𝑖; 𝜃𝑖,𝑘)
𝐾
𝑘=1   
where 𝜃𝑖,1 < 𝜃𝑖,2 <. . . < 𝜃𝑖,𝐾and 𝜆𝑖,𝑘 = 𝑆𝑖,𝑘/𝑆𝑖 is the proportion of singletons resulting from 
process 𝑘, such that ∑ 𝜆𝑖,𝑘
𝐾
𝑘=1 = 1. 
We estimate the parameters of this mixture (𝜆𝑖,1, . . . , 𝜆𝑖,𝐾, 𝜃𝑖,1, . . . , 𝜃𝑖,𝐾) using the 
expectation-maximization (EM) algorithm as implemented in the mixtools R package [119]. To 
identify an optimal number of mixture components, we iteratively fit mixture models for 
increasing values of K and calculated the log-likelihood of observed data D given the parameter 
estimates (?̂?𝑖,1, . . . , ?̂?𝑖,𝐾, 𝜃𝑖,1, . . . , 𝜃𝑖,𝐾), stopping at K components if the log-likelihood failed to 
increase by more than 10: 
𝑙𝑜𝑔(𝐿(?̂?𝒊, ?̂?𝑖 | 𝐷𝑖 , 𝐾 + 1)) − 𝑙𝑜𝑔(𝐿(?̂?𝑖, 𝜃𝑖  | 𝐷𝑖, 𝐾)) < 10  
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Classifying singletons by process-of-origin 
Now let 𝑘𝑖,𝑗indicate which of the four processes generated singleton 𝑗 in individual 𝑖.  We 
calculated the probability of being generated by process 𝑘 as: 
𝑝(𝑘𝑖,𝑗 = 𝑘 | 𝑑𝑖
∗;  𝑘 ∈ {1, . . . ,4}) =
𝑝(𝑑𝑖
∗, 𝑘)
𝑝(𝑑𝑖
∗)
=
𝜆𝑖,𝑘 𝑓𝑘(𝑑𝑖; 𝜃𝑖,𝑘)
∑ 𝜆𝑖,𝑘 𝑓𝑘(𝑑𝑖; 𝜃𝑖,𝑘)
4
𝑘=1
 
Where 𝑑𝑖
∗ = 𝑑𝑖,𝑗 ∧ 𝑑𝑖,𝑗−1is the minimum of the distance either to the next singleton (𝑑𝑖,𝑗) or the 
previous singleton (𝑑𝑖,𝑗−1). We then classified the process-of-origin for each singleton per the 
following optimal decision rule: 
?̂?𝑖,𝑗 = 𝑎𝑟𝑔 𝑚𝑎𝑥𝑘∈{1,...,4}𝑝(𝑘 | 𝑑𝑖,𝑗
∗ ) 
 
Identification of mixture component hotspots using Hidden Markov Models 
Once each singleton was assigned to one of the four mixture components, we counted the 
number of singletons per individual per component in non-overlapping windows of length 1 
million base pairs (Mpb) throughout the genome. In order to mitigate spurious signals caused by 
differences in local ancestry, in each window we omitted data from any individuals whose 
singleton frequencies were >2 standard deviations from the mean frequency across all 
individuals. We then assigned each window to one of three state (hot, neutral, or cold) with a 3-
state Hidden Markov Model, as implemented in the depmixS4 package in R [120]. 
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Modeling the relationship between MNM density and genomic features 
In each 1Mbp window, we calculated the average signal for 11 genomic features 
(H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K4me3, H3K9ac, H3K9me3, exon density, 
DNase hypersensitivity, CpG island density, lamin-associated domain density), using the source 
datasets described in [97] (see Table A.6). For each mixture component, we then applied the 
following negative binomial regression model to estimate the effects of each feature on the 
density of that component in 1Mbp windows: 
𝑙𝑜𝑔(𝑌) = 𝛽0 + 𝛽1𝑋1+. . . +𝛽11𝑋11 
Where Y is the number of singletons of mixture component j and 𝑋1, . . . , 𝑋11 are the signals of 
each of the 11 genomic features. 
Note that although recombination rate and replication timing were analyzed in [97], we 
excluded these features from these regression models because the corresponding datasets 
typically exclude, at minimum, the first and last 5Mbp of each chromosome. Many of the 
hotspots identified by our HMM segregated near the ends of chromosome arms, so including 
these features in our regression models would force these hotspots to be excluded, potentially 
biasing the estimated effects of other genomic features. 
De novo mutation calling 
The TOPMed Freeze 5 data contained 1,675 parent-offspring trios. Among these trios, 
we considered de novo mutations to be any single-nucleotide variants that were exclusive to the 
offspring (i.e., not observed in either parent), provided the variant occurred at a site that was 
covered by an average read depth of 10 or higher and did not have a missing genotype in either 
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parent. We then restricted our analyses to autosomal de novo mutations ascertained in offspring 
determined to have >85% African or European ancestry. 
Empirically-based simulations 
To quantify the effects of external branch length heterogeneity on singleton clustering 
patterns, we simulated singletons under the following model. First, we can consider the 𝑁𝑖 
singletons in individual i to follow a Poisson(𝜙𝑖) distribution, where𝜙𝑖 =
𝑁𝑖
𝐺
 (here, G indicates 
the total number of mutable bases in the mappable autosomal regions of the reference genome). 
Consequently, the distances between successive singletons in individual 𝑖 are expected to follow 
an exponential distribution with rate 𝜃𝑖 = 1/𝜙𝑖 . For each individual 𝑖, we randomly drew 𝑁𝑖 
inter-singleton distances from the corresponding 𝑒𝑥𝑝(𝜃𝑖) probability distribution. 
We adapted this simulation strategy to simulate inter-singleton distances under a model 
of regional mutation rate heterogeneity. Here, inter-singleton distances were assumed to come 
from a 2-component mixture model. We randomly drew 0.9 × 𝑁𝑖 inter-singleton distances from 
an 𝑒𝑥𝑝(𝜃𝑖) distribution, and 0.1 × 𝑁𝑖distances from an 𝑒𝑥𝑝(𝑀 × 𝜃𝑖) distribution, where this 
second distribution represents 10% of singletons in individual i originating in genomic regions 
subject to a M-fold increase in single-nucleotide mutation rate. 
Coalescent simulations 
We used msprime [112] to simulate 2,000 European chromosomes (100Mbp in length) 
using a demographic model with parameter estimates reported by [52]. We performed 
simulations using a per-site, per generation mutation rate ranging from 1 × 10−8 to 2 × 10−8. 
Because our aim was to compare these simulated singletons to unphased singletons in the 
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TOPMed data, we randomly assigned each of the 2,000 haploid samples into one of 1,000 
diploid pairs, and recalculated the inter-singleton distances per diploid sample, ignoring the 
chromosome on which each simulated singleton originated.  
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Chapter IV. 
Helmsman: fast and efficient mutation signature analysis 
for massive sequencing datasets
Introduction2 
The spectrum of somatic single-nucleotide variants (SNVs) in cancer genomes carries 
important information about the underlying mutation mechanisms, providing insight into the 
development, evolution, and etiology of the cancer cell populations [121]. Evaluating these 
patterns of variation, referred to as “mutational signatures,” has become an important task in 
precision oncology, as mutational signatures can be used both to refine cancer diagnoses and 
identify effective targeted therapies [122].  
Several software programs have been developed to identify and evaluate the mutational 
signatures present in cancer genomes [27–29]. Most methods consider 96 mutation subtypes, 
defined by the type of base change (C>A, C>G, C>T, T>A, T>C, T>G) and the trinucleotide 
sequence context (e.g., C[T>G]T, C[C>A]T, and so on) [25]. Mutation signature analysis 
methods express the observed mutation spectrum in each sample as a linear combination of K 
                                                 
 
2
This chapter is published as a preprint at Carlson J, Li J, Zöllner S. Helmsman: fast and efficient generation of 
input matrices for mutation signature analysis. bioRxiv. 2018;:373076. 
75 
 
distinct mutational signatures, where the signatures are inferred directly from the input data, or 
taken from external sources such as the COSMIC mutational signature database [121]. These 
programs typically start with an input file, often in a standard format such as Variant Call Format 
(VCF) or Mutation Annotation Format (MAF), containing the genomic coordinates of each SNV 
and the sample(s) in which they occur. As a first step, these SNVs must be summarized into a 
NxS mutation spectra matrix, M, containing the frequencies of S different SNV subtypes in each 
of N unique samples (where the 𝑀𝑖,𝑗 entry indicates the number of observed SNVs of subtype j 
in sample i). Most methods are implemented as R packages and must read the entire input file 
into memory prior to generating the mutation spectra matrix. For large input files, containing for 
example millions of SNVs and hundreds or thousands of samples, the memory required for this 
step can easily exceed the physical memory capacity of most servers, rendering such tools 
incapable of directly analyzing large datasets. To circumvent these computational bottlenecks, 
researchers must either limit their analyses to small samples, pool samples together, or develop 
new software to generate the mutation spectra matrix. Presently, the largest studies to perform 
mutation signature analysis have included millions of mutations in thousands of whole cancer 
genomes [26, 121], but these studies have pooled individual samples into ~30 distinct cancer 
types, potentially obscuring the presence of mutation signatures unique to individual cancer 
genomes or more granularly defined cancer types. 
Implementation 
To overcome the limitations of existing mutation signature analysis tools, we have 
developed a Python application, named Helmsman, for rapidly generating mutation spectra 
matrices and performing mutation signature analysis on arbitrarily large datasets. Helmsman 
accepts either VCF or MAF files as input. 
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For each SNV in a VCF file, Helmsman identifies the mutation type based on the 
reference and alternative alleles, then queries the corresponding reference genome for the 
trinucleotide context of the SNV, determining subtype j. The genotypes of the N samples for this 
SNV are represented as an integer array, with the number of alternative alleles per sample coded 
as 0, 1, or 2 according to the observed genotype [123]. Helmsman then updates the jth column of 
the mutation spectra matrix by vectorized addition of the genotype array (i.e., 𝑀𝑖,𝑗 is incremented 
by 1 if individual 𝑖 is heterozygous but does not change if individual 𝑖 is homozygous for the 
reference allele). Consequently, Helmsman’s processing time is independent of sample size and 
scales linearly with the number of SNVs. The only objects stored in memory are the array of N 
genotypes for the SNV being processed and the Nx96 mutation spectra matrix, so memory usage 
is independent of the number of SNVs and scales linearly with sample size. 
Additional Features 
In addition to being optimized for speed and low memory usage, Helmsman includes 
several features to accommodate various usage scenarios and minimize the amount of pre-
processing necessary to analyze large mutation datasets. For example, if input data are spread 
across multiple files (e.g., by different sub-samples or genomic regions), Helmsman can process 
these files in parallel and aggregate them into a single mutation spectra matrix, providing 
additional performance improvements and avoiding the need to generate intermediate files. 
Similarly, in certain applications, it may be desirable to pool similar samples together (e.g., by 
tumor type) when generating the mutation spectra matrix. Helmsman can pool samples on-the-
fly, without needing to pre-annotate or reshape the input file with the desired grouping variable. 
Helmsman also includes basic functionality for extracting mutation signatures from the 
mutation spectra matrix using non-negative matrix factorization (NMF) or principal component 
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analysis (PCA) functions from the nimfa [124] and scikit-learn [125] Python libraries, 
respectively. Alternatively, Helmsman can generate an R script with all code necessary to load 
the output matrix into R and apply existing supervised and unsupervised mutation signature 
analysis packages (e.g., SomaticSignatures or deconstructSigs) without requiring users to 
perform the computationally expensive task of generating this matrix from within the R 
environment. All features are described in detail in the online documentation. 
Results 
We compared Helmsman’s performance to that of three published R packages: 
SomaticSignatures [27], deconstructSigs [28], and signeR [29]. We also considered several other 
tools, and discuss their performance in Appendix C. For our tests, we generated a small VCF 
file (2.7MB compressed with bgzip) containing 15,971 germline SNVs on chromosome 22 from 
2,504 samples sequenced in the 1000 Genomes Project phase 3 [55], and measured the runtime 
and memory usage necessary for each program to generate the mutation spectra matrix. We also 
attempted to run each program using the full chromosome 22 VCF file from the 1000 Genomes 
Project, containing 1,055,454 SNVs in 2,504 individuals. The number of SNVs in this VCF file 
is comparable to those of the large somatic SNV datasets analyzed in [121] and [26]. 
All programs generated the same mutation spectra matrices. Helmsman processed the 
small VCF file in 8 seconds, with a memory footprint of 140MB, and the full VCF file in 482 
seconds (corresponding to a linear increase for ~60x more variants) with no increase in memory 
usage as the sample size remained the same. In contrast, to process the small VCF file, 
SomaticSignatures took 227 seconds with a memory footprint of 18GB, deconstructSigs took 
2,376 seconds and 7.5GB of memory, and signeR took 1,740 seconds and 10.2GB of memory 
(Fig. 4.1). None of these R packages were able to load the full VCF file due to memory 
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allocation errors. All other tools we considered showed similar performance bottlenecks when 
compared to Helmsman (Appendix C; Fig. C.1). 
 
Figure 4.1. Performance comparison for generation of the mutation spectra matrix by different programs. For Helmsman 
and three other mutation signature analysis tools (SomaticSignatures, deconstructSigs, and signeR), we measured the maximum 
memory usage in megabytes (a) and processing time in seconds (b) required to generate the 2,504 x 96 mutation spectra matrix 
from a VCF file containing 15,971 SNVs in 2,504 samples from the 1000 Genomes project. 
 
To further highlight the speed and efficiency of Helmsman for large datasets, we 
evaluated the entire set of 36,820,990 autosomal biallelic SNVs from the 1000 Genomes phase 3 
dataset (14.4 GB when compressed with bgzip). Using 22 CPUs (one per chromosome VCF 
file), Helmsman generated the mutation spectra matrix in 64 minutes (approximately 1.5 seconds 
per sample), with each process requiring <200MB of memory. 
Conclusions 
As massive sequencing datasets become increasingly common in areas of cancer 
genomics and precision oncology, there is a growing need for software tools that scale 
accordingly and can be integrated into automated workflows. Our program, Helmsman, provides 
an efficient, standardized framework for performing mutation signature analysis on arbitrarily 
large, multi-sample VCF or MAF files. For small datasets, Helmsman performs this task up to 
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300 times faster than existing methods and is the only tool that can be directly applied to modern 
large sequencing datasets. 
Availability of data and materials 
The chromosome 22 VCF file from the 1000 Genomes Phase 3 study used in evaluating 
the software is available in the 1000 Genomes FTP repository at 
ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/. The small VCF file is available on 
the project home page at https://github.com/carjed/helmsman/tree/master/data. The MAF file 
used to compare performance of the Maftools and Mutation-Signatures software (described in 
the Supplementary Material) is available from The Cancer Genome Atlas data repository at 
https://portal.gdc.cancer.gov/legacy-archive/files/15ce66c6-0211-4f03-bd41-568d0818a044. 
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Chapter V.  
Doomsayer: quality control for whole-genome sequencing 
data using mutation signature analysis
Background 
Detection of genetic variants by whole-genome sequencing (WGS) is a complex task 
consisting of several experimental and computational processing steps [126]. Rigorous quality 
control (QC) must be performed at each stage of the sequencing pipeline to limit the influence of 
false positive variants and batch effects in downstream analyses [127]. While many applications 
are devoted to QC of raw sequencing data, mapped reads, and individual variants, methods for 
assessing the overall quality of each sample are a crucial, yet often overlooked, step to ensure 
that downstream analyses are performed on clean, unbiased data [128]. 
A common strategy for evaluating the quality of individual samples is to calculate 
various sample-level metrics which act as surrogates for sequencing quality, then remove 
samples which exhibit extreme values of one or more of these statistics based on guidelines 
established by previous studies [128]. One of the most widely-used quality metrics is the 
transition:transversion (Ti:Tv) ratio, calculated as the number of transition single nucleotide 
variants (SNVs) (purine ↔ purine or pyrimidine ↔ pyrimidine) divided by the number of 
transversion SNVs (purine ↔ pyrimidine) [129]. Prior studies have suggested that high-quality 
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genome-wide human sequencing data should have a Ti:Tv ratio of approximately 2.0-2.1 [54]. 
The Ti:Tv ratio is particularly useful for sample-level QC because it is often directly impacted by 
erroneous SNV calls—if we assume that errors occur at random with no biases towards 
transitions or transversions, then a sample whose SNV calls consist entirely of errors should have 
a Ti:Tv ratio near 0.5, because there are 8 possible transversions and only 4 possible transitions. 
So, a Ti:Tv ratio below 2.0 suggests that some of the included variants are random errors. 
There are two major limitations to using the Ti:Tv ratio for sample QC, however. First, 
the assumption that sequencing errors are purely random is inaccurate. Certain technical artifacts 
are known to exhibit unique type-specific and motif-specific error profiles, such as a slightly 
elevated A>C error rate inherent to many Illumina sequencers and a tendency for higher miscall 
rates at bases preceded by a GGC motif [130, 131]. Because the Ti:Tv ratio does not differentiate 
by SNV type (e.g., C>G versus C>A transversions) or by sequence context, it lacks the 
sensitivity to distinguish these subtler patterns of error. Further, because the Ti:Tv ratio parses 
SNVs into only two categories, the Ti:Tv ratio can appear to indicate a high-quality sample even 
when the underlying data disagree. Consider an extreme case where a sample’s SNV calls 
consist entirely of T>C transitions and T>G transversions. These SNVs could still have a Ti:Tv 
ratio within the acceptable range of 2.0-2.1, but the SNVs clearly do not represent what we 
would expect for a normal human genome. 
Second, because sequencing errors often manifest as rare, low-frequency SNVs [132], 
sample-level Ti:Tv ratios are most informative when calculated exclusively on rare SNVs 
occurring at low frequencies in the population [33]. Moreover, the Ti:Tv ratio is sensitive to the 
number of samples sequenced [95], and particularly so when considering only rare SNVs [99]. 
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Consequently, an acceptable range for the Ti:Tv ratio of rare SNVs is a moving target, and the 
consensus of 2.0-2.1 is almost certainly too conservative for most modern sequencing studies. 
Filtering criteria for other sample-level QC metrics are similarly difficult to establish. 
Summary statistics which measure specific technical issues, such as GC-biased coverage and 
sample contamination, are influenced by the environment in which DNA samples are collected, 
stored, and sequenced [88, 133]. Measures of genotype concordance are another useful QC 
statistic, but can only be used in studies where samples are genotyped on multiple platforms, and 
vary according to the sequencing platform, variant calling algorithm, depth of coverage, and 
genotyping array [134]. Due to the vast range of factors that can vary between different whole-
genome sequencing studies, guidelines suggested in one study may not translate well to future 
studies [128].  
Here we present a novel computational method for performing unsupervised outlier 
detection in whole-genome sequencing studies. We have implemented this method in a software 
package called Doomsayer (Detection Of Outliers using Mutation Signature AnalYsis in 
Extremely Rare variants). Our method provides several benefits over traditional supervised 
outlier detection approaches, including: 1) Doomsayer is agnostic to sequencing platform, 
sample size, and other study conditions, 2) accounts for potential type- and motif-specific error 
biases, 3) focuses exclusively on rare SNVs, and 4) provides a means of interpreting potential 
error biases present among the rare SNV calls in a sample. 
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Results 
Overview of the method 
The outlier detection procedure we have designed and implemented in Doomsayer is 
inspired by a popular computational method in cancer genomics known as mutation signature 
analysis, used to characterize mutational processes unique to various cancer types [25, 121, 135]. 
This method starts by classifying SNVs into one of 96 3-mer subtypes, defined according to the 
type of base substitution (e.g., C>A, T>G, and so on) and the flanking nucleotides in the 
reference sequence (e.g., CCT>CAT, CTT>CGT, and so on). Note that for simplicity each 
subtype is referred to by the substitution occurring at the pyrimidine of the base pair, so 
CCT>CAT SNVs are counted together with G>T SNVs occurring at the reverse complement of 
the CCT motif (i.e., AGG> ATG and CCT>CAT are equivalent). The relative frequencies of 
these subtypes within each sample are referred to as the mutation spectrum. For our QC 
purposes, we specifically focus on singleton SNVs (i.e., SNVs unique to a given sample with a 
minor allele count of 1). The singleton SNV spectra for the N samples are compiled into a Nx96 
matrix M, where the 𝑀𝑖,𝑗 entry indicates the relative proportion of observed SNVs of subtype 𝑗 
in sample 𝑖. The next step is to approximate the observed singleton SNV spectrum of each 
sample as a linear combination of R mutation signatures, where R<<96. These signatures (and 
their relative contributions to the singleton SNV spectrum of each sample) are ascertained by 
applying various dimensionality reduction algorithms to the M matrix; the most commonly used 
algorithms for this task are principal component analysis (PCA) or nonnegative matrix 
factorization (NMF). 
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Just as we assume the Ti:Tv ratio of germline SNVs to be consistent between samples 
(and interpret extreme values of the Ti:Tv ratio as evidence of higher error rates), Doomsayer 
relies on the assumption that the 3-mer SNV spectra (and the contributions of the decomposed 
signatures thereof) are also consistent between samples. This assumption is well-supported by 
results from family-based sequencing studies, which have shown that there is little inter-sample 
heterogeneity in the 3-mer mutation spectra of de novo germline mutations [41]. Hence, when 
summarizing the observed singleton SNV spectra as a linear combination of R underlying 
signatures, if the contributions of these signatures in a given sample are heavily skewed, we 
interpret this as an indicator of technical artifacts that have resulted in error biases throughout 
that sample’s sequence.  
Therefore, the final step in our outlier detection process is to determine which samples 
exhibit signature contributions that are considered extreme relative to other samples in the 
dataset. To this end, we apply two unsupervised anomaly detection algorithms to the results of 
the signature deconvolution procedure and flag as outliers any samples classified as anomalous 
by these algorithms. Finally, we provide an option to generate a diagnostic report, containing 
interactive plots and summary information about the flagged outliers, to assist users in 
interpreting the underlying patterns in the outliers’ singleton SNV spectra and compare these 
differences to the non-outlier samples. A graphical summary of the Doomsayer workflow is 
presented in Fig. 5.1, and each stage is described in greater detail in the Methods. 
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Figure 5.1. Summary of the Doomsayer workflow. Users must provide an input VCF file (or multiple files), along with a 
corresponding fasta-formatted reference genome file. Doomsayer then generates the singleton SNV spectra matrix, performs 
matrix decomposition to identify the common signatures in the data, then applies anomaly detection methods to identify samples 
with anomalous contributions of one or more signature. Finally, the intermediate output generated by this pipeline is passed to an 
R script which generates an HTML-formatted diagnostic report containing further information about the singleton SNV spectra 
of the flagged outliers. 
 
Doomsayer identifies signatures of GC-biased coverage and oxidative damage in 
the BRIDGES dataset 
To demonstrate the efficacy of our method, we applied Doomsayer to a whole-genome 
sequencing dataset of N=3,765 unrelated individuals of European ancestry, sequenced as part of 
the Bipolar Research in Deep Genome and Epigenome Sequencing (BRIDGES) study [97]. 
These samples had already passed through several standard QC procedures applied to the raw 
data and aligned reads (e.g., removal of duplicated reads and recalibration of base quality scores 
[33]) and individual variant calls (using the default hard filters of the GotCloud variant calling 
pipeline followed by a support vector machine filter trained on known SNVs from dbSNP as 
positive examples and SNVs that failed multiple hard filters as negative examples [33]). In 
addition, we performed preliminary sample-level filtering for population outliers, highly 
contaminated samples, improperly generated BAM files, and sequences with low coverage or 
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imbalanced read counts (as described in [97]). This dataset contained approximately 36 million 
singleton SNVs, or an average of ~10,000 singletons per sample. Note that the analyses 
presented here were based on this preliminary version of the BRIDGES data (N=3,765 samples) 
and the results contributed to determining which samples to include in the final release of the 
BRIDGES data (containing N=3,560 samples) [97]. 
Using the default parameters (stringency threshold tau=0.05; sample must be flagged by 
both anomaly detection algorithms to be considered an outlier), Doomsayer identified 157 
outliers (Fig. 5.2). Hierarchical clustering of the flagged outliers (and their observed singleton 
SNV spectra) assigned these samples into one of three major clusters (Fig. 5.2a), with members 
of each cluster exhibiting similar patterns of enrichment or depletion for particular 3-mer 
subtypes. Outliers in the first cluster contain an excess of C>A singletons, a well-known artifact 
of oxidative DNA damage resulting from the buffering conditions during DNA sonication [136, 
137], as well as CTN>CAN transversions and GCN>GTN transitions. The latter subtypes may 
be an indicator of an error phenomenon known as T-accumulation, in which adenine and 
cytosine tend to be miscalled at higher rates as thymine during later sequencing cycles [130]. A 
second cluster show a much stronger enrichment for C>A transversions, but no enrichment for 
T>A and C>T singletons as observed in the first cluster. A third cluster of outliers show a 
general tendency to contain more singletons at A:T base pairs than G:C base pairs, compared to 
the non-outlier samples.  
Each of the three outlier clusters segregated along one or two of the top 3 principal 
component axes (Fig. 5.2b). Outlier clusters 1 and 2 had higher scores along principal 
component 1, whereas outlier cluster 3 had higher scores along principal component 2. Principal 
component 3 appeared to separate outlier clusters 1 and 2. We note that the set of outliers 
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determined by the first 3 principal components were highly concordant with those determined 
using a rank 3 non-negative matrix factorization, with 87.2% of PCA-detected outliers also being 
detected when using the NMF algorithm. Similarly, increasing the number of principal 
components to 4 or 5 had little effect on the set of outliers, with 92.4% and 88.6% overlap, 
respectively.  
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Figure 5.2. Summary of outliers in the BRIDGES data. a. Heatmap showing the relative enrichment or depletion for each of 
the 96 3-mer subtypes (columns) in each of the 174 flagged outliers (rows). The color in each cell indicates the fold-difference of 
the contribution of the subtype in that sample, calculated relative to the mean contribution of that subtype across all non-outlier 
samples. The scale is truncated to +/-5-fold difference. Outliers fall into one of three major clusters, indicated by the colored bar 
below the dendrogram to the right of the heatmap: high C>A transversions, GCN>GTN transitions, CTN>CAN transversions 
(green), high C>A transversions (blue), and high T>N transitions and transversions (red). b. Pairwise scatterplots of the first 3 
principal components. Each dot indicates an individual, with non-outlier samples colored grey and outliers colored according to 
the cluster membership indicated in a. Marginal distributions for each component are shown in the diagonal panels. 
 
BRIDGES outliers are supported by other QC statistics  
We corroborated our findings by examining other sample-level summary statistics that 
are often used to differentiate low-quality samples. We examined nine such statistics: average 
depth-of-coverage, GC-bias scores (an indicator of whether coverage is systematically lower 
GC-rich regions [92]), median insert size, number of bases sequenced with base quality score 
>20 (q20bases), and percent of reads with a mapping quality score of 0 (zeromap), all obtained 
using the QPLOT software [138]; sample contamination, measured using the CHIPMIX software 
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[88]; and total singletons, heterozygosity, and singleton Ti:Tv ratio, all obtained using the vcfast 
submodule of the EPACTS software [139]. We hypothesized that if the samples flagged as 
outliers by our method were truly affected by quality issues, they would likely differ from non-
outlier samples across these established sample-level summary statistics. 
When we compared the distributions of these QC statistics between the non-outlier 
samples and the three major outlier clusters detected by Doomsayer, we found that each outlier 
cluster showed anomalous distributions of one or more of these statistics (Fig. 5.3). Samples in 
outlier cluster 1, characterized by a combination of modestly higher proportions of C>A 
transversions and certain C>T and T>A subtypes, showed lower singleton Ti:Tv ratios. Samples 
in outlier cluster 2, with very high proportions of C>A transversions, showed lower singleton 
Ti:Tv ratios, lower median insert sizes and slightly elevated contamination scores. Samples in 
outlier cluster 3, with high proportions of T>N singletons, tended to have higher GC bias scores, 
lower heterozygosity, and higher overall singleton counts. 
These results are further supported by an orthogonal quality control analysis of the 
BRIDGES data, where we found that 27 of the 35 cluster 3 outliers also carried an unusually 
large number (>500) of artefactual copy number variants (CNVs) (Zawistowski et al., in 
preparation). These 27 samples originated from Prechter sub-study of the BRIDGES 
Consortium, and 25 of these were sequenced on the same plate (Table D.1), suggesting a 
systematic batch effect led to both the excess of A>N singletons and CNV artifacts.  
Outlier clusters 1 and 2 also showed evidence of batch effects. In outlier cluster 1, three 
plates (two from the Prechter study and one from the USC study) accounted for 54 of the 75 
outliers. We note that the two plates from the Prechter study (accounting for 30 of these 54 
cluster 1 outliers) were the same as those which suggested batch effects among the cluster 3 
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outliers. In outlier cluster 2, two different plates containing samples from the Prechter study 
accounted for 24 of the 38 outliers. 
 
 
Figure 5.3. Comparison of QC metrics for outliers. Boxplots comparing the distributions of other sample-level summary 
statistics (contamination [measured by CHIPMIX], average coverage, number of doubletons, GC bias, median insert size, and 
number of singletons) of non-outlier samples and the three outlier clusters detected by our method. 
 
Error signatures in the 1000 Genomes sample 
Next, we applied Doomsayer to N=2,504 human genomes sequenced in phase 3 of the 
1000 Genomes Project [55]. Because these data have gone through extensive cleaning and QC 
measures, we ran Doomsayer with more stringent criteria, setting the stringency threshold tau to 
be 0.01 (i.e., no more than 1%, or 25 samples, would be flagged as outliers). Under these 
conditions, Doomsayer identified 19 samples as outliers. These results are again based on the 
first 3 principal components. 
A single sample, HG01149, occupied its own outlier cluster and contained a large excess 
of C>A transversions, suggesting the presence of the same oxidative damage signature 
implicated in outlier clusters 1 and 2 from the BRIDGES data. We note that this sample was also 
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flagged as an outlier in a previous analysis of rare variant signatures in 1000 Genomes Phase 3 
data, based on f2 (i.e., doubletons, with an allele count of 2) and f3 (i.e., tripletons, with an allele 
count of 3) variants [81], though that study did not indicate the nature of the particular signature 
found to be overrepresented in HG01149. Three other outliers showed a similar enrichment for 
C>A singletons, suggesting they too might have been affected by oxidative damage, albeit to a 
much lower degree than what we observed in HG01149. 
The fifteen remaining outliers showed an enrichment for T>G transversions, particularly 
at NTT trinucleotide motifs. Importantly, these outliers were unrelated and from diverse 
populations (Table D.2), and so did not appear to be recapitulating any of the population-specific 
rare variant signatures described by Mathieson and Reich [81]. Mathieson and Reich also 
performed a PCA-based analysis of singleton SNVs from 300 individuals sequenced by the 
Simons Genome Diversity Project and found that principal components 1 and 2 differentiated 
cell-line versus non-cell-line derived samples, suggesting that cell line artifacts may substantially 
influence the observed rare variant spectrum in a given sample [81]. We repeated this analysis 
using singleton SNVs from the 1000 Genomes samples and found that blood-derived and LCL-
derived samples tended to separate along principal component 3 (Fig. D.1). Moreover, the outlier 
samples enriched for T>G singletons had some of the highest scores for principal component 3, 
supporting Mathieson and Reich’s claim and providing further evidence that our outlier detection 
method is capable of capturing these cryptic technical artifacts. 
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Application to PCR-free whole-genome data 
Several important advances in sequencing technology have occurred since the BRIDGES 
and 1000 Genomes datasets were generated, namely the use of PCR-free library preparation 
methods and increasing accessibility of high-coverage sequencing. Both of these advances have 
significantly reduced the incidence of technical artifacts in next-generation sequencing data, 
particularly in the identification and analysis of rare variants [140]. To assess how well our 
method performs on such data, we applied Doomsayer to high-coverage (~30x), PCR-free 
whole-genome sequencing data from N=3,286 individuals in the Framingham Heart Study, 
sequenced as part of the Trans-omics in Precision Medicine (TOPMed) consortium. We 
excluded 389 samples with fewer than 1,000 singleton SNVs. As with the 1000 Genomes 
dataset, we used more stringent outlier detection criteria, setting tau=0.01. 
Our anomaly detection criteria identified a preliminary set of 27 outlier samples. 
Application of the secondary cluster-based filtering criteria (Methods) found only a single 
outlier cluster, containing seven samples, was significantly enriched for multiple 3-mer subtypes 
when compared to the non-outlier samples (Fig. D.2). Specifically, these outliers were enriched 
for T>A and T>G transversions at NTT and NTA motifs, with a particularly strong enrichment at 
the C[T>G]T subtype (Fig. D.2). 
Coincidentally, all 7 of these outliers were parents within 7 different parent-offspring 
trios sequenced in the Framingham Heart Study. This enabled us to assess whether the singleton 
SNV spectra of these samples was the result of genuine biological differences or technical 
artifacts. We hypothesized that if these patterns of variation were biological in nature, the 
enriched T>A and T>G variants should be transmitted at normal Mendelian proportions. In that 
case, the spectra of singleton SNVs in the outlier parents (i.e., variants not transmitted to the 
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offspring) should be similar to that of the private doubleton SNVs shared between an outlier 
parent and their offspring (i.e., transmitted variants). Significant differences would violate the 
law of Mendelian transmission and indicate that the singleton SNV spectra in the outlier parents 
is driven by technical artifacts. Among the 7 parent-child dyads, we identified 25,550 private 
doubleton SNVs (compared to 36,045 singleton SNVs in the parents) and compared the spectrum 
to that of the outlier singleton spectrum using chi-squared tests for equal proportions across the 6 
basic SNV types (Table 5.1). Results of this test were highly significant (P<5.1e-70), indicating 
the non-transmitted SNV spectra in the outlier parents were likely enriched for sequencing 
errors. These differences were even more significant when considering the full 96-subtype 3-mer 
spectra (P<9.1e-81). In contrast, when we compared the spectra of SNVs transmitted from outlier 
parents to their offspring in these 7 trios with that of the non-transmitted SNVs unique to the 7 
non-outlier parents, we found no evidence of significant differences in either the 1-mer (chi-
squared test; 5df; P=0.16; Table D.3) or 3-mer (chi-squared test; 95df; P=0.45). These additional 
tests confirmed that the spectra of SNVs shared by offspring with their outlier parents were of 
high quality and unlikely to contain other cryptic error signatures. 
Table 5.1. 1-mer spectra of non-transmitted and transmitted SNVs in the FHS outliers 
SNV Type Frequency in non-transmitted SNVs 
(% of total) 
Frequency in transmitted SNVs  
(% of total) 
C>A 3920 (10.9%) 2495 (9.8%) 
C>G 2979 (8.3%) 2328 (9.1%) 
C>T 12572 (34.9%) 9888 (38.7%) 
T>A 3118 (8.6%) 1718 (6.7%) 
T>C 9592 (26.6%) 7193 (28.2%) 
T>G 3864 (10.7%) 1928 (7.5%) 
Total 36045 25550 
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Discussion  
Doomsayer provides a new approach to quality control in next-generation sequencing 
studies that circumvents many of the limitations of standard sample-level QC strategies. By 
leveraging information about the spectra and sequence context of rare single nucleotide variants, 
Doomsayer effectively identifies outliers and batch effects that may go undetected by more 
simplistic supervised QC procedures.  
In our analyses of the BRIDGES, 1000 Genomes, and Framingham Heart Study datasets, 
we found compelling evidence that Doomsayer identifies low-quality samples that went 
undetected by previously-applied QC checks. In both the BRIDGES and 1000 Genomes datasets, 
we identified samples with an abnormal excess of C>A singletons, presumed to stem from 
oxidative damage that occurred during sample preparation, suggesting this may be a common 
artifact in whole-genome sequencing data where PCR was used to amplify the DNA of each 
sample. Many of the outliers detected in the BRIDGES dataset were sequenced in the same 
plates, indicating that our method may be particularly powerful for identifying cryptic batch 
effects. Outliers in the 1000 Genomes data also included samples with an abnormal excess of 
A>N singletons, possibly indicating artifacts of sequencing DNA obtained from cell lines rather 
than fresh tissue. Our findings of such artifacts in the 1000 Genomes dataset may have broader 
implications for genomics research, as the 1000 Genomes data are widely used as a benchmark 
of known genetic variation for tasks ranging from genotype imputation to population genetics 
inference to development of pathogenicity scoring algorithms. Research involving rare SNVs 
from the 1000 Genomes data may be particularly susceptible to spurious signals or subtle biases 
caused by including these outliers. 
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In the Framingham Heart Study dataset, we identified 7 samples with significantly 
elevated rates of T>G singletons. Because the offspring of these samples were also sequenced, 
we were able to compare the spectra of transmitted and non-transmitted SNVs and confirm the 
presence of a cryptic error signature shared by these outlier samples. Intriguingly, the singleton 
SNV spectrum of these outliers was quite similar to that of the outliers in the 1000 Genomes 
dataset that we speculate were affected by cell-line artifacts. None of the Framingham Heart 
Study outliers, however, were sequenced from cell lines, so the origin of the error signature 
remains unclear. These findings demonstrate that our method is an effective means of quality 
control and sequencing error detection even when applied to high-coverage data prepared with 
PCR-free protocols. 
There are a few limitations of our method that bear further discussion. First, as with all 
post hoc computational QC methods, our method is no replacement for careful study design and 
rigorous quality control throughout the earlier stages of the sequencing pipeline. Because 
unsupervised anomaly detection algorithms assume that anomalous samples account for a 
relatively small fraction of the data, severe quality issues, affecting a large fraction of samples, 
can be underestimated.  
Related to this point, unsupervised anomaly detection also runs the risk of being overly 
conservative or liberal with flagging outliers. Though one of our main motivations in developing 
Doomsayer was to improve the objectivity of sample-level QC practices and provide deeper 
investigation of potential quality issues, the decision of which samples to exclude from 
downstream analyses remains inherently subjective. These decisions must often be balanced 
against competing considerations such as loss of power in downstream analyses due to sample 
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size reduction and the financial and practical feasibility of resequencing samples deemed to be 
low-quality. 
Second, Doomsayer is unlikely to be an effective means of sample-level QC in whole-
exome sequencing datasets. In studies containing a few thousand individuals, a single exome is 
expected to contain roughly 100 singleton SNVs. Because Doomsayer parses singleton SNVs 
into 96 distinct subtypes, a single exome will not carry enough observations per subtype to 
confidently summarize the 3-mer singleton SNV spectrum. As a potential means of 
circumventing this limitation, we have included a feature in Doomsayer to pool groups of 
samples together and perform outlier detection on a per-group rather than per-individual basis. 
With this feature, Doomsayer can still be used to detect systematic batch effects in whole-exome 
sequencing datasets. 
Third, we acknowledge that several recent studies have found evidence that different 
human populations tend to have slightly different spectra among higher-frequency SNVs, 
suggesting rapidly evolving mutational processes [48, 81, 115]. Though these findings might 
appear to challenge our assumption that the singleton SNV spectra are consistent between 
individuals regardless of population, our analysis of the 1000 Genomes data show that the 
detected outliers come from diverse ancestral backgrounds. Nevertheless, in future studies that 
use Doomsayer for QC in cohorts with heterogeneous ancestries, it may be prudent to evaluate 
each population separately to avoid conflating genuine population differences in singleton SNV 
spectra with technical artifacts present among the singleton SNV calls. 
Finally, we emphasize that Doomsayer is specifically designed for evaluating the quality 
of germline, not somatic, genomes. The genomes of somatic cells are exposed to a variety of 
mutagenic processes, so what might be considered an anomaly in a collection of diverse somatic 
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genomes may very likely be due to differing levels of exposure to different mutagenic processes. 
However, Doomsayer may still be useful in instances where the somatic genomes are 
homogeneous in cell type and exposure (for example, lung tumors collected from individuals 
who smoke tobacco). In such a case, we advise users carefully assess their data and apply other 
appropriate QC measures to evaluate whether outliers are due to technical artifacts, or whether 
they represent distinct etiological differences. 
 
Conclusions 
We here present Doomsayer, a novel method for performing unsupervised sample-level 
quality control in large-scale next-generation sequencing studies through the use of mutation 
signature analysis. We provide evidence that the spectrum of singleton SNVs in an individual 
genome is sensitive to a variety of systematic error processes. Our method to evaluate this 
spectrum thus allows not only for the identification of problematic samples, but also deeper 
investigation of how the single-nucleotide variant calls might be affected by cryptic technical 
artifacts. We anticipate that this method, when applied in conjunction with rigorous quality 
control throughout the sequencing and data cleaning process, will help improve the veracity of 
both old and new next-generation sequencing datasets, leading to more robust and replicable 
scientific results. 
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Methods 
Analysis pipeline 
Doomsayer is implemented in Python and accepts one or more variant call format (VCF) 
files containing the variants to analyze. Each variant site in the input VCF file(s) must contain 
columns indicating the genotypes for each individual; the VCF file(s) cannot be in a “sites only” 
format. Doomsayer assumes that the input VCF file has already gone through standard variant-
level filtering provided by the variant caller, and by default will only analyze singleton SNVs 
(with an allele count of 1) which have passed prior variant-level filters (i.e., with a PASS value 
in the FILTER field of the VCF file), though each of these options can be adjusted by the user. 
Other non-SNV variant types (e.g., indels) are ignored. Users may also perform any desired 
preprocessing of the VCF file using other programs (e.g., bcftools [34]) and pipe the output 
directly to Doomsayer. 
Each SNV in the VCF file that meets the specified criteria is annotated with two 
properties: 1) the substitution type, defined by the major and minor allele, and 2) the 
trinucleotide sequence context, defined by querying a fasta-formatted reference genome file and 
identifying the bases immediately upstream and downstream from the variant site. The 
substitution type and trinucleotide sequence context jointly define the 3-mer subtype for that 
SNV. As each qualifying SNV in the VCF file is processed, the entries of the Nx96 SNV spectra 
matrix, M, are incremented accordingly. Doomsayer relies on the cyvcf2 [123] and pyfaidx [141] 
Python libraries for parsing VCF and fasta files, respectively. Once all qualifying SNVs in the 
input VCF(s) have been counted, each row of the M matrix (containing the frequencies of 96 
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SNV subtypes for each individual) is scaled by its sum, producing a new matrix, 𝑀′𝑁 × 96, where 
the 𝑀′𝑖,𝑗 entry indicates the fraction of singletons of subtype j in genome i.  
Decomposing the singleton SNV spectra matrix 
By default, Doomsayer will then perform principal component analysis (PCA) on the M’ 
matrix, using functions from the scikit-learn Python library [125]. Users can optionally perform 
non-negative matrix factorization (NMF) instead, in which case Doomsayer will decompose the 
matrix into the approximate product of two smaller matrices, 𝑊𝑁 × 𝑅 and 𝐻𝑅 × 96, where R is the 
number of signatures, 𝑊𝑁 × 𝑅 indicates the relative contributions of each signature to the spectra 
of each sample, and 𝐻𝑅 × 96 indicates the loadings of the 96 3-mer subtypes within each of the R 
signatures, essentially as described by Alexandrov et al. [25]. The NMF decomposition in 
Doomsayer is implemented using functions from the nimfa Python library [124]. The code for 
processing VCF files and performing matrix decomposition was modified from our somatic 
mutation signature analysis software, Helmsman [142].  
Unsupervised outlier detection 
To identify individuals whose singleton SNV signatures appear abnormal and indicative 
of potential quality issues, Doomsayer applies two unsupervised anomaly detection algorithms to 
the data contained in the 𝑊𝑁 × 𝑅 signature matrix. A brief summary of these algorithms is 
provided below; a more detailed description of each can be found at [143]. In each case, the user 
must specify a tolerance threshold, tau, indicating the maximum fraction of samples to flag as 
potential outliers. By default, tau is set to 0.05, meaning no more than 5% of samples will be 
flagged as outliers by a given method. Unless specified by the user, Doomsayer applies both 
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anomaly detection algorithms and flags as outliers any samples that fail both decision criteria; 
users can optionally choose a more liberal filter, in which a sample flagged by either algorithm 
will be returned as outliers, or consider only those samples flagged by a specific algorithm. 
The first anomaly detection algorithm is known as elliptic envelope filtering. If we 
assume the distribution of the R signature scores (i.e., the columns of the W matrix) follow a 
multivariate Gaussian distribution, the elliptic envelope method estimates the covariance 
structure of the data and fits an R-dimensional ellipsoid that covers (1-tau)*100% of individuals. 
Samples falling outside the boundary of this ellipsoid are flagged as outliers.  
The second algorithm implemented is an isolation forest. This algorithm uses random 
forests to recursively partition the rows of the W matrix, forming a tree structure. Samples with 
very similar singleton SNV spectra will require many more partitions to isolate into individual 
leaf nodes than samples with more unique singleton SNV spectra, which can be isolated using 
relatively few partitions. The isolation forest method therefore flags as outliers the tau*100% of 
samples that are isolated with the shortest paths on this tree. 
After determining which samples qualify as outliers, Doomsayer generates two text files, 
doomsayer_keep.txt and doomsayer_drop.txt, each containing a list of sample IDs that passed 
and failed the anomaly detection procedure, respectively. These files can be used in downstream 
analysis programs, such as bcftools [34] and PLINK [90].  
Visualization and diagnostic reports 
The optional diagnostic report generated by Doomsayer provides three interactive plots 
for users to better understand how the singleton SNV spectra of the flagged outliers differ from 
non-outliers. First, Doomsayer generates a heatmap showing the relative enrichment or depletion 
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of each of the 96 3-mer subtypes in each of the outlier samples (as in Fig. 5.2a). We apply 
hierarchical clustering to the rows and columns of this heatmap (using Ward’s method [144]) to 
group together samples (rows) with similar singleton SNV spectra, and subtypes (columns) that 
tend to be enriched or depleted together. A dendrogram is displayed next to the rows of this 
heatmap to illustrate the structure of these sample clusters. Outliers are assigned into one of R 
major sample clusters (where R is the pre-specified number of SNV signatures analyzed), 
determined by identifying the R innermost nodes below the root node of the dendrogram. 
Second, Doomsayer generates pairwise scatterplots of the first R principal components or 
NMF signature scores, depending on which dimensionality reduction algorithm was specified (as 
in Fig. 5.2b). Each sample is represented by a point in each subplot—outlier samples are colored 
according to the major cluster classifications determined by the hierarchical clustering procedure 
described above, and non-outlier samples are colored grey. This figure shows where the outliers 
fall in the R-dimensional space, and which of the R signatures appear to separate certain groups 
of outliers from the non-outlier samples. 
Third, the diagnostic report will include a figure showing side-by-side barplots of the 
observed singleton SNV spectra for the non-outlier samples and each of the outlier clusters. For 
each outlier cluster and each of the 96 3-mer subtypes, Doomsayer will perform a t-test to 
determine if the mean proportion of SNVs of that particular subtype differs from that of the non-
outliers. Subtypes that differ significantly after multiple testing (P<0.05/[R*96]) are highlighted 
in this figure to show which subtypes are most strongly under- or over-represented within each 
outlier cluster. Optionally, Doomsayer can use these results to generate a more stringent list of 
outliers, where only samples within outlier clusters exhibiting statistically significant differences 
for 4 or more of the 96 subtypes are considered to be low-quality. 
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Additional features 
Doomsayer includes several additional features and options that were not applicable to 
the analyses presented in this manuscript. These features are described in detail in the online 
documentation, available at https://www.jedidiahcarlson.com/docs/doomsayer/.  
 
Availability of data and materials 
Source code for Doomsayer, along with detailed documentation, is freely available at 
https://github.com/carjed/doomsayer under the MIT license. Doomsayer is also available as a 
pre-built Docker image from https://hub.docker.com/r/carjed/doomsayer/, and an interactive 
cloud-based environment and tutorial can be accessed at 
https://mybinder.org/v2/gh/carjed/doomsayer/master.  
Data availability for the BRIDGES dataset is described in [97]. Data for the 1000 
Genomes Phase 3 sample were downloaded from ftp://ftp-
trace.ncbi.nih.gov/1000genomes/ftp/release/20130502/.  Data for the TOPMed Framingham 
Heart Study sample are available on the NCBI dbGaP database under accession number 
phs000974.v3.p2.  
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Chapter VI.  
Discussion
The rate at which new mutations occur is of central importance to studies of genetic 
variation, heritable disease, and genome evolution. In this dissertation, we have extensively 
investigated fine-scale patterns of mutation rate heterogeneity in humans, providing a nuanced 
portrait of how single-nucleotide and multinucleotide mutation processes shape the patterns of 
variation throughout the genome. We also have developed computational methods to harness 
information about mutation rate heterogeneity to improve various aspects of genomics research. 
In this section, we review the key findings and insights of each study and discuss their broader 
significance and implications for future research. 
In Chapter 2, we introduced a novel approach for investigating fine-scale germline 
mutation patterns, by studying the properties of extremely rare variants (ERVs) ascertained from 
large whole-genome sequencing datasets. This study relied on the intuition that ERVs are an 
unbiased representation of recent mutation events that have occurred in the population. This 
intuition, along with the fact that ERVs are abundant throughout the genome, enabled us to study 
patterns of mutation rate variation at an exceptionally fine resolution. Specifically, we used these 
ERVs to extensively quantify how mutation rates vary with respect to local sequence context and 
various other features of the genomic landscape. These patterns of variation led to several 
important findings concerning the biological mechanisms of mutation. In particular, we 
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discovered that the mutability of many sequence motifs appears to be modulated by the presence 
of particular genomic features. This result substantially enhances our understanding of how these 
features impact mutation rates--up to this point, studies had only attempted to describe whether a 
given feature tends to results in a uniform increase or decrease in mutability in a given region, 
with no regard for motif-specific effects [13]. In addition to improving our basic understanding 
of how different mutation processes are affected by genomic context, the map of estimated 
mutation rates that we generated in this study has immediate relevance for a range of 
applications, such as interpreting variants associated with heritable diseases, inferring signals of 
natural selection, calibrating variant detection algorithms, and improving simulations of genetic 
variation. We note that the estimates we have generated in this study have already been 
incorporated in a number of such applications [145–147]. 
Because the data for the genomic features considered in these analyses were largely 
assayed from somatic cell lines, our estimates are admittedly crude, and do not necessarily reflect 
the precise mutational landscape of male and female germ cells. Future investigation of the 
mutagenic effects of genomic features will certainly benefit from assaying these features directly 
in sperm and egg cells. Further, our use of ERVs precluded our ability to differentiate mutation 
patterns unique to the male or female germline or how these mutation patterns might be 
influenced by parental age—these effects can only be evaluated through de novo mutations 
where the parental origin is known [14, 23, 40–42]. We also note that our choice to focus on 
mutation rates defined by a 7-mer sequence context was driven by practical concerns, not 
necessarily biological insights (though a paper published during the development of our study 
did demonstrate that 7-mers capture important patterns of variation [12]). It is entirely possible 
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that an even broader sequence context is necessary to capture the full range of sequence-
dependent variation in germline mutation rates. 
In Chapter 3, we investigated the phenomenon of multinucleotide mutations in the human 
germline, again relying on singleton SNVs as a proxy for recent mutation events. Here, we 
introduced a novel statistical model to describe the inter-singleton distance distribution as a 
mixture of four exponential processes. We showed that two of these inferred processes are 
characteristic of two particular multinucleotide mutation mechanisms known to be active in the 
human germline, namely error-prone translesion synthesis (TLS) and repair of double-strand 
breaks (DSB). 
We next analyzed how each of the four inferred processes contributing to the inter-
singleton distance distribution varied regionally throughout the genome. This analysis confirmed 
the presence of all previously-reported hotspots for DSB-associated MNMs [22, 23] and 
identified several novel hotspots associated with this process, often occurring in the subtelomeric 
regions of many other chromosomes. We further explored how these genome-wide clustering 
patterns of germline mutations associate with other features of the genomic landscape. Similar to 
our findings in Chapter 2, the results of this analysis showed that various genomic features are 
likely to subtly influence the efficacy of multinucleotide mutation mechanisms (or subsequent 
repair processes). These results also evince potential similarities between somatic and germline 
mutation processes, such as our finding that CpG islands tend to be enriched for TLS-associated 
singleton clusters, reminiscent of a recent study that found promoter regions in various cancers 
are targeted by translesion polymerase eta [62]. More generally, the effects of genomic features 
will be an important consideration in future studies of mutation rate heterogeneity. 
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We concluded Chapter 3 by investigating how sample demography and variation in the 
single-nucleotide mutation rate also contribute to singleton clustering patterns throughout the 
genome. Through simulations, we estimate that approximately a third of clustered singletons 
(<20,000bp apart) are purely attributable to sample demography, and much of the remaining 
clustering may be due to regional heterogeneity in single-nucleotide mutation rates. We 
acknowledge that clustering patterns can also result from a variety of other processes, such as 
selection, biased gene conversion, and evolving mutation processes. This presents many 
opportunities for future research to dissect precisely how much each of these factors contributes 
to observed patterns of genetic variation at any given genomic region, ultimately improving the 
accuracy and precision of inference in population and evolutionary genetics applications. 
One particularly important aspect of this study was our comparison of how 
multinucleotide mutation patterns differ between individuals with different ancestral 
backgrounds. The vast majority of studies of genetic variation published in the last 20 years have 
focused almost exclusively on individuals of European ancestry, which both perpetuates health 
disparities for underrepresented populations and causes researchers to miss important biological 
insights [148, 149]. Our understanding of human germline mutation patterns is no exception to 
this problematic trend: nearly all of the whole-genome trio sequencing studies published thus far 
have been restricted to individuals of European ancestry, with three of the largest samples 
coming from Iceland [23], Great Britain [41], and the Netherlands [14]. This lack of diversely-
sampled populations calls into question the extent to which the results of these studies can be 
generalized to individuals with different ancestral backgrounds. The largest currently published 
whole-genome trio sequencing study to contain samples of diverse ancestry comes from the 
Inova Translational Medicine Institute [150]. This dataset has been used extensively to 
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characterize germline mutation patterns [22, 42, 151], but these studies have notably not 
attempted to describe how mutation patterns vary according to the ancestry of each individual. 
By deeper consideration for how mutation patterns vary between populations, future studies 
stand to gain substantial scientific insights into the causes and consequences of mutation 
processes while also ensuring that any subsequent applications for improving human health are 
equitable for minority populations and help reduce health disparities. 
Another logical extension of the work presented in Chapters 2 and 3 is to investigate the 
regional variation and clustering patterns of other classes of mutations, such as short insertions or 
deletions (collectively referred to as indels) or larger structural variants (SVs). These classes of 
mutations, however, are often difficult to genotype and map with certainty using short-read 
sequencing technologies [152]. Emerging sequencing technologies, such as nanopore sequencing 
and other long-read platforms [153], have shown promising capability for detecting indels and 
SVs. We anticipate that widespread adoption of these technologies will enable exciting new 
discoveries about the processes underlying these mutations and their implications for 
understanding human health and evolution. 
Though our analyses have primarily focused on describing germline mutation patterns 
averaged across many individuals, these mutation patterns do in fact differ from person to 
person. One of the most salient extensions of the work presented in Chapters 2 and 3 will be a 
deeper investigation of how and why germline mutation rates and patterns vary between 
individuals. Like other complex traits, the mutation patterns unique to each genome are the result 
of multiple genetic and environmental factors. By studying how these “mutational phenotypes” 
vary throughout the population, it may be possible to identify specific genetic variants that 
influence endogenous mutation processes and isolate the mutation signatures that result from 
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distinct environmental exposures. Such findings will be essential for unmasking how mutation 
processes have evolved over time and elucidate a deeper understanding of the etiologies of 
various diseases. 
The first task of this endeavor is to define and quantify the mutational phenotype(s) of 
interest. Prior studies of inter-individual variation in mutation patterns have focused on the 
genome-wide average mutation rate or basic mutation spectrum per individual as the primary 
mutational phenotype (e.g., [40, 116]). In this dissertation, we have characterized many 
additional mutation patterns that can be phenotyped on an individual basis, such as the granular 
(e.g., 7-mer) mutation spectrum, the magnitude of mutagenic effects for various genomic 
features, clustering patterns, intrinsic mutation rates of MNMs, etc. These mutational phenotypes 
represent only a few of the many ways in which mutation data can be collected and quantified. 
For example, the de novo mutations observed in an individual arose over multiple cellular 
generations in the paternal and maternal germlines, so the mutational phenotype may therefore 
be defined more stringently by inferring the stage of germline development and the parent-of-
origin in which the phenotype of interest emerged.  
The concept of mutational phenotypes goes beyond simply cataloging the extent of 
variation and has obvious implications for studying how mutation mechanisms have evolved 
over time. If a germline mutation alters the efficacy of endogenous DNA damage or repair 
mechanisms (for example, affecting the catalytic domain of a mismatch repair gene), all 
individuals who inherit that allele will be subject to the resulting mutational outcome, be it an 
increased mutation rate, altered mutation spectrum, or emergence of new mutation hotspots. 
Over time, through the processes of genetic drift and natural selection, mutator alleles may rise 
to appreciable frequencies in the population, such that distantly related individuals share the 
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same distinct mutational phenotype. Recent work has demonstrated that past shifts in the 
mutation spectrum are indeed detectable, suggesting the presence of mutator alleles [48, 80, 81], 
but these studies have yet to isolate which genetic polymorphism(s) (if any) are associated with 
these shifted mutation spectra. Identifying the mutator alleles responsible for these ongoing 
evolutionary changes will be an important challenge for the field going forward. 
As mentioned above, mutational phenotypes are jointly affected by both genetic and 
environmental factors. Unlike other complex traits, however, heritable mutational phenotypes 
can carry signatures of non-heritable environmental factors. Consider a scenario where an 
environmental mutagen causes an increase in C>T mutations in the germline. The offspring of 
individuals exposed to this mutagen will of course carry more C>T mutations than expected, so 
the offspring's offspring will also carry more C>T heterozygous sites, even if they were never 
exposed to the same mutagen that affected their grandparents' germ cells. This example 
demonstrates that the mutational phenotype can serve as a window into the past to identify not 
only mutator alleles affecting endogenous mutation processes, but also exogenous mutagenic 
processes active in the environment at specific times in history. 
Our singleton-based approach to studying mutation patterns may prove particularly useful 
in future attempts to identify these historical mutation patterns. Because de novo mutations are 
so rare, it is difficult to collect a sample large enough to systematically test for mutator alleles 
that are active in the present generation. Singletons, however, represent mutations that have 
accumulated over several generations, so the effects of any mutator alleles will have 
compounded in this time, meaning that there is potentially a strong enough signal to establish an 
association (with the caveat that meiotic recombination is also acting during the time in which 
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singletons accumulate, so the mutational signal resulting from a given mutator allele will only be 
present on the same haplotype as the mutator allele itself).  
Inter-individual variation in mutation patterns can also be an important indicator of 
disease risk. For example, germline mutation rates are known to increase as parents age [5], a 
phenomenon which has been implicated in multiple complex and highly heritable disorders, such 
as autism and schizophrenia [40]. Characterizing the host of genetic and environmental factors 
that influence the inter-individual variation in mutation patterns stands as an important task in the 
quest to understand the etiologies of complex diseases, with the potential for rapid adoption in 
the fields of genetic counseling and precision medicine. 
A central thesis of this dissertation is that an understanding of germline mutation rate 
patterns is fundamental to nearly every aspect of genome analysis. In Chapters 4 and 5, we 
shifted our focus towards developing computational methods designed to incorporate a detailed 
understanding of mutation rate heterogeneity to improve common bioinformatics tasks in 
genomics research. One such method, known as mutation signature analysis, is arguably one of 
the most important computational methods to have emerged from the field of cancer genomics, 
and over a dozen software tools incorporating this method have been published in the last 5 years 
[27–31, 154–160]. When we attempted to apply these tools to very large datasets, however, it 
quickly became apparent that none of the existing software were suitable for analyzing datasets 
containing thousands of samples and millions of variants. This computational bottleneck led to 
the development of Helmsman, an extremely fast and memory-efficient program for performing 
mutation signature analysis, described in Chapter 4. Through the use of efficient programming 
practices and carefully optimized data processing, Helmsman achieves a level of performance 
that is orders of magnitude faster and more memory-efficient than other mutation signature 
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analysis programs. We anticipate that Helmsman will prove useful in cancer genomics and 
precision oncology, where increasingly massive datasets are leading to demand for fast, 
automated software. 
Though Helmsman is extensively documented and intentionally designed to be accessible 
to users with a range of bioinformatics expertise and/or computational resources, some users may 
not be comfortable with using command-line programs or may not have access to the 
computational environment necessary to take full advantage of Helmsman’s parallel processing 
capability. Many bioinformatics applications have moved towards a model of providing users 
with a graphical web interface that is linked to cloud-based servers to perform the 
computationally-intensive processing. Although Helmsman was not released specifically as a 
cloud-based application, we have already incorporated aspects of this strategy, making it 
available at a Docker container that can be deployed with minimal software/hardware 
dependencies on virtually any server, either locally or on the cloud. Once deployed, Helmsman 
can be run through an interactive Jupyter notebook directly in a web browser, without end users 
needing to touch a terminal. In the future, we hope to assess the evolving needs of users and 
introduce additional features and optimizations accordingly.  
In Chapter 5, we presented another practical application of mutation rate heterogeneity. 
Here, we developed a novel method and software for performing quality control in whole-
genome sequencing datasets, based on the analysis of the singleton SNV spectra across samples. 
The development of this method was guided by our intuition that, if underlying germline 
mutation processes are similar throughout the human population, the spectra of genuine 
biological variation should be similar between samples. This idea is conceptually similar to using 
the Ti:Tv ratio in each sample as an indicator of data quality—just as we expect the transition 
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and transversion SNVs in each sample to be distributed in a particular ratio, we extend this 
expectation to consider the distribution of SNVs across 96 3-mer subtypes.  
Applying this method to the BRIDGES and 1000 Genomes Phase 3 datasets, we 
identified several noteworthy quality issues that went undetected by earlier QC procedures. Chief 
among these was our discovery that several samples in both datasets carried a signature of 
oxidative DNA damage, characterized by an excess of C>A transversions. These findings add to 
a growing body of evidence that errors resulting from oxidative damage are pervasive in 
sequencing datasets where DNA was amplified using PCR [137, 161]. In the BRIDGES dataset, 
we also found evidence of batch effects, wherein multiple samples prepared or sequenced at the 
same time carried similar error signatures. Although the careful experimental design of the 
BRIDGES study likely mitigated any spurious associations caused by these batch effects (which 
could occur if cases and controls were not balanced across each batch), this finding is a strong 
reminder that batch effects exclusively impacting cases or controls have the potential to cause 
serious (and in some cases, irreparable, as described in [162]) confounding of downstream 
analyses. 
Our method also proved effective for identifying quality issues present in PCR-free, high-
coverage sequencing data from the Framingham Heart Study. Though the extent of the quality 
issues in the FHS dataset was far less dramatic than what we observed in the BRIDGES and 
1000 Genomes datasets (both of which used low-coverage sequencing of PCR-amplified DNA), 
these results demonstrate that our method’s usefulness extends beyond retrospective analysis of 
older sequencing data, and is sensitive enough to detect cryptic error biases present among 
modern sequencing datasets with inherently lower error rates. Thus, we anticipate our method 
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will continue to be useful for quality control in ongoing and future studies that use the latest 
sequencing protocols. 
We acknowledge the inherent limitations of using unsupervised anomaly detection 
algorithms in our method—because we make no prior assumptions about which samples are 
high-quality and which are affected by error biases, our outlier detection strategy may be 
ineffective in datasets where error signatures are diffused throughout the samples. In the future, it 
may be desirable to incorporate some form of supervised learning algorithm where we explicitly 
query the singleton SNV spectra of each sample for known error signatures. 
In sum, this dissertation contributes new and nuanced insight into the underlying patterns 
of variation in human mutation processes. We show how different mutation mechanisms 
contribute to observed patterns of variation, highlighting a diverse range of potential applications 
which stand to benefit from this new-found knowledge. We anticipate that these studies will 
continue to enhance our ability to use whole-genome sequencing as a window into human history 
and a tool for improving human health.  
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Appendix A: Supplementary Material for Chapter II
Identification of outlier samples 
For the 3,716 individuals that passed our initial sample-level filters, we summarized the 
per-sample distribution of extremely rare variants (ERVs) across 3-mer subtypes and used this 
information to flag individuals that showed abnormal patterns of variation indicative of 
systematic sequencing errors or batch effects. In brief, we adapted the non-negative matrix 
factorization (NMF) technique described by Alexandrov et al. [25] to deconvolute the 3-mer 
mutation spectra as a composite of 3 distinct “signatures.” Assuming the population has been 
susceptible to the same mutation processes over the timespan in which ERVs have accumulated, 
we expect that the relative contribution of the 3 NMF signatures is stable across individuals. 
Applying this strategy, we identified 156 individuals where one or more signatures had a 
contribution >2 standard deviations away from the mean contribution of that signature 
(calculated across all individuals). 
These outliers exhibited one of two distinct signatures indicative of error biases. The first 
signature, characterized by an unusually high proportion of C>A and G>T singletons, was 
overrepresented in 112 of these samples, consistent with patterns of oxidative damage that are 
known to occur during DNA shearing, likely due to the presence of reactive contaminants [137]. 
The second signature, characterized by depleted rates of C>N and G>N ERVs, was 
overrepresented in the remaining 44 samples. Further investigation of the samples carrying this 
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signature showed many had higher GC bias scores (i.e., systematically lower depth of coverage 
in GC-rich regions), likely resulting in lower calling rates for C>N and G>N types. Moreover, 24 
of the 44 samples were sequenced in the same batch, and the remaining 20 samples were 
distributed across only 8 of the 48 other batches, indicating that these coverage biases and 
resulting error signatures clustered by batch. To limit the confounding effects of nonbiological 
variation present in the data, we excluded the 156 samples displaying either of these error 
signatures. Note that doubletons in the pre-filtered sample that would have become singletons in 
the post-filtered sample were not included in our analysis. Many of these variants are likely true 
doubletons in the BRIDGES sample and hence present in the population at a higher frequency 
(i.e., having arose further in the past) than the average singleton, so retaining these ambiguous 
variants might inadvertently affect the distribution of variants. 
Estimation of false discovery rate by Ts/Tv statistics 
We estimate the false discovery rate among BRIDGES ERVs using the following method. 
(1) Let 𝑇𝑆𝑜 = 𝑇𝑆𝑡 + 𝑇𝑆𝑓 be the number of observed transitions (23,733,766), consisting of 
both true positives (𝑇𝑆𝑡), and false positives (𝑇𝑆𝑓)  
(2) Let 𝑇𝑉𝑜 = 𝑇𝑉𝑡 + 𝑇𝑉𝑓 be the number of observed transversions (11,840,651).  
(3) Based on findings from other large-scale sequencing studies, the true positive Ts/Tv ratio, 
𝑇𝑆𝑇𝑉𝑇 =
𝑇𝑆𝑡
𝑇𝑉𝑡
 is expected to be between 2.0 and 2.1 [54]. 
(4) Because there are 8 possible transversions and 4 possible transitions, if errors have 
occurred at random, the Ts/Tv ratio for random false positive errors (𝑇𝑆𝑇𝑉𝜖) should be 
0.5, that is, 
𝑇𝑆𝑓
𝑇𝑉𝑓
= 0.5, assuming no systematic sequencing error biases. 
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Solving this system of four equations, it follows that 𝑇𝑉𝑓 =
𝑇𝑆𝑇𝑉𝑇×𝑇𝑉𝑜−𝑇𝑆𝑜
𝑇𝑆𝑇𝑉𝑇−0.5
 and 𝑇𝑆𝑓 =
0.5 × 𝑇𝑉𝑓, so the false discovery rate, 
𝑇𝑆𝑓+𝑇𝑉𝑓
𝑇𝑆𝑜+𝑇𝑉𝑜
, can be estimated as: 
𝑇𝑆𝑓 + 𝑇𝑉𝑓
𝑇𝑆𝑜 + 𝑇𝑉𝑜
=
0.5 (
𝑇𝑆𝑇𝑉𝑇 × 𝑇𝑉𝑜 − 𝑇𝑆𝑜
𝑇𝑆𝑇𝑉𝑇 − 0.5
) +
𝑇𝑆𝑇𝑉𝑇 × 𝑇𝑉𝑜 − 𝑇𝑆𝑜
𝑇𝑆𝑇𝑉𝑇 − 0.5
𝑇𝑆𝑜 + 𝑇𝑉𝑜
 
Assuming the true Ts/Tv ratio (𝑇𝑆𝑇𝑉𝑇) is between 2.0 and 2.1, by this calculation we estimate a 
false discovery rate of 0.1-2.9% among the BRIDGES ERVs. 
Potential sources of bias among ERVs 
Motif-specific error rates 
Certain sequence motifs may be more susceptible to sequencing error, which could lead 
to a non-random distribution of false positive singleton calls and subsequently bias our analyses 
[131, 163]. Allhoff et al. [131] reported context-specific errors for the Illumina HiSeq platform, 
noting that the most common of these are strand-specific T>N errors at 5’-GGGT-3’ motifs (i.e., 
there is no evidence of an excess of A>N errors at the reverse complement 5’-ACCC-3’ motifs). 
We reason that if the BRIDGES ERVs are enriched for such context-specific errors, we should 
see significantly more T>N ERVs at the 5’-GGGT-3’ motif than A>N ERVs at the 5’-ACCC-3’ 
and motif. Of the 127,831 ERVs that occur at this motif, 63,861 were 5’-[A>N]CCC-3’ variants, 
and 63,970 were 5’-GGG[T>N]-3’ variants; this difference was not significant, indicating there 
is no evidence for an enrichment of T>N ERVs at this error-prone motif (exact binomial test; 
P=0.67). Allhoff et al. remark that the variants called at error-prone positions tended to have low 
base quality scores as well as significant strand bias, both of which are detectable with standard 
filtering protocols [131]. We therefore assume that most motif-specific errors are filtered by the 
default strand-bias and quality filters used in our variant calling pipeline, and any undetected 
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errors have a negligible impact on our calculation of relative mutation rates and downstream 
analyses. 
Mapping error 
We expect the majority of ERVs in our data are mapped with high confidence, as the pre-
filtering steps in our variant calling pipeline remove sites occurring on reads with average phred-
scaled mapping quality score (MQ) <20 and/or where more than 10% of reads were ambiguously 
mapped (MQ0>10). This filtering strategy is similar to the filters employed by other large-scale 
sequencing projects that have demonstrated well-controlled error rates among singleton calls [56, 
95]. Because mapping errors are more likely to occur in highly-repetitive regions, such as 
centromeric and pericentromeric loci [164], including these regions in our analyses might bias 
our estimates of motif-specific mutation rates and/or the impact of genomic features. However, 
excluding these regions entirely might have detrimental side effects: dropping ERVs in these 
regions will reduce the precision of our estimates, and removing hard-to-map regions might 
preclude our ability to assess mutation patterns unique to these regions, as they may have many 
levels of heterogeneous overlap with genomic features. 
To determine if excluding repeat-rich regions systematically influenced our inferred 
rates, we compared the 7-mer relative mutation rates estimated from the full, unfiltered set of 
ERVs with 7-mer rates estimated if we only count ERVs and reference motifs within the 1000 
Genomes strict accessibility mask, which delineates the most uniquely mappable regions of the 
genome (covering ~72% of non-N bases). These two sets of estimates were very well-correlated: 
within-type correlations were >0.96, indicating the estimated rates were highly consistent 
regardless of whether hard-to-map regions were removed (Fig. A.6a). Moreover, subtypes with 
larger differences between the two estimates tended to have fewer ERVs (Fig. A.6b), suggesting 
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that most observed discrepancies might simply be an artifact of reduced precision among rare 
mutation classes. 
When we applied the masked rates to predict the set of de novo mutations, we found 
these estimates had worse predictive performance than the unmasked estimates (Table 2.1). This 
result leads us to conclude that aggressively filtering for the highest-confidence call set comes at 
a cost of substantially reducing the precision of the relative mutation rate estimates, and 
potentially causing greater bias by ignoring the information captured by ERVs in the masked 
regions. Although we cannot entirely exclude the possibility of mapping error biases among the 
unmasked estimates, the benefits of having more numerous singletons across more contiguous 
genomic regions in the unmasked data outweigh the concerns about errors caused by poor 
mapping quality. 
Mispolarization of ERVs 
While most singletons in the BRIDGES sample are the true derived allele, population 
genetic theory suggests that <1/N=0.014% of singletons in a sample are the ancestral allele, and 
hence subject to the same evolutionary biases we wish to avoid. These mispolarized singletons 
may be hard to detect, as we expect ~0.25% of all singletons to carry the same allele in human 
and chimpanzee due to parallel mutations that have occurred since splitting from a common 
ancestor. Intuitively, these parallel mutations are especially likely to occur in hypermutable loci, 
so removing the 0.25% “ancestral” alleles created by parallel mutation may create a bigger bias 
than including the 0.015% truly ancestral alleles.  
To understand the impact of removing all putatively ancestral alleles, we used an 
ancestral genome inferred by 6-way primate alignment [89] to annotate each allele with the 
putative ancestral state. We identified 363,705 singletons (~1% of all singletons) where the 
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alternative allele was the same as the ancestral allele, and recalculated 7-mer relative mutation 
rates after removing these putatively mispolarized singletons. We found that this polarization 
filter did not strongly affect estimated rates: across all types combined as well as within each 
type, the rates before and after removal of these sites were nearly perfectly correlated 
(Spearman’s r>0.999). Further, we found that only 9 of the 24,576 7-mer rates differed 
significantly after applying this filter, and the re-estimated rates for these 9 subtypes differed 
from the original rates by no more than 10%. More importantly, 8 of these 9 subtypes were 
hypermutable CpG>TpG subtypes, consistent with our intuition that many putatively 
mispolarized sites are in fact parallel mutations in the human and chimpanzee lineages. 
As a final analysis of the potential effects of mispolarization on our estimates, we applied 
these filtered rates to predict the GoNL/ITMI de novo mutations [14, 42] in the same logistic 
regression framework used to compare other estimation strategies. Goodness-of-fit statistics 
indicated that the filtered rates predicted de novo mutations better than 7-mer rates estimated 
without the polarization filter (ΔAIC=298). However, when comparing goodness-of-fit between 
type-specific models, these differences largely disappeared, with seven types showing negligible 
differences in AIC (ΔAIC < 7), and the unfiltered rates had lower AIC for three of these (non-
CpG C>T, CpG>GpG, and CpG>ApG). Only two types had differences in AIC greater than 10: 
A>T types were predicted slightly better by the filtered rates (ΔAIC=16), but CpG>TpG types 
were predicted better by the unfiltered rates (ΔAIC=22), suggesting the accuracy of the filtered 
rates is particularly affected by parallel mutations at hypermutable CpG sites.  Given this lack of 
consistent type-specific improvement when applying the polarization filter, we performed all 
subsequent analyses using the full set of 35.6 million ERVs. 
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Curation of MAC10+-derived mutation rate estimates  
A potential concern with comparisons between our ERV-derived mutation rate estimates 
and Aggarwala and Voight’s 1000G-based estimates [12] is that discrepancies might be partially 
attributable to technical differences between the two samples, not necessarily because the 1000G 
estimates are based on ancestrally older SNVs. For a more direct comparison, we curated a set of 
higher-frequency SNVs found in the BRIDGES data, removing the possibility that the dissimilar 
estimates are a result of differences in sequencing platform, variant calling, QC methods, and 
sampled individuals.  
Aggarwala and Voight’s mutation rate estimates are based on 7,051,667 intergenic 
variants observed in N=379 Europeans from the 1000 Genomes Phase I study [12]. Aggarwala 
and Voight do not state the exact site frequency spectrum for the European intergenic variants, 
but claim 26% of intergenic variants in the 1000G Phase I African sample are singletons or 
doubletons [12]. Thus, it is reasonable to assume that >80% of European intergenic SNVs in the 
1000G data occur at a frequency greater than 1/(379*2)=0.0013 (i.e., the sample MAF of a 
singleton in the 1000G sample). To obtain SNVs in the BRIDGES sample in a frequency range 
comparable to this, we selected all SNVs with a minor allele count ≥10 (MAF≥0.0014). We 
identified 12,088,037 MAC10+ variants in our data, from which we estimated 7-mer relative 
mutation rates. We compared these estimates to 1) a set of ERV-derived 7-mer estimates 
calculated after randomly downsampling to an equivalent number (12,088,037 ERVs), and 2) the 
1000G estimates. These comparisons show that the MAC10+ estimates are more closely 
correlated with the 1000G estimates (Fig. A.3) than with the downsampled ERV-derived 
estimates (Fig. A.4). We also used the MAC10+ estimates to predict the GoNL/ITMI de novo 
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mutations and found that this model tended to perform comparably to the 1000G model (Table 
A.5). 
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Figure A.1 High-resolution heatmaps of relative mutation rates for mutation subtypes up to a 7-mer resolution, 
estimated from the BRIDGES ERVs (a) estimates for 3-mer mutation subtypes. (b) estimates for 5-mer mutation subtypes. (c) 
estimates for 7-mer mutation subtypes. Each cell delineates a subtype defined by the upstream sequence (y-axis) and downstream 
sequence (x-axis) from the central (mutated) nucleotide.  
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Figure A.2 Density plots comparing the distribution of ratios between the 1000G and ERV rate estimates 
For each type, we grouped 7-mer subtypes by the number of G:C base pairs in the +/-3 flanking sequence, and plotted the 
distribution of ratios separately for each of these group. Mass to the right of the dashed line indicates estimated rates tend to be 
higher in the 1000G data, while mass to the left shows subtypes where estimated rates are higher in the BRIDGES ERV data. 
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Figure A.3. Comparison of 7-mer relative mutation rates estimated from BRIDGES MAC10+ variants and 1000G 
Intergenic SNVs (a) Scatterplot of 7-mer subtype rates estimated from the BRIDGES MAC10+ data (x-axis), and 1000G 
intergenic SNV data (y-axis) (b) Type-specific 2D-density plots, as situated in the scatterplot of a. The dashed line indicates an 
expected least-squares regression line if there is no bias present. (c) Heatmap shows ratio between relative mutation rates 
calculated on MAC10+ variants and 1000G variants for each 7-mer mutation subtype. Subtypes with higher 1000G-derived rates 
relative to MAC10+-derived rates are shaded gold, and subtypes with lower 1000G-derived rates relative to MAC10+-derived 
rates are shaded green. 1000G-derived rates shown here are scaled relative to the MAC10+-derived rates.  
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Figure A.4 Comparison of 7-mer relative mutation rates estimated from BRIDGES ERVs and BRIDGES MAC10+ 
variants (a) Scatterplot of 7-mer subtype rates estimated from the BRIDGES ERV data, after randomly downsampling the ERVs 
to 12,088,037 (x-axis) and the BRIDGES MAC10+ data (y-axis). (b) Type-specific 2D-density plots, as situated in the scatterplot 
of a. The dashed line indicates an expected least-squares regression line if there is no bias present. (c) Heatmap shows ratio 
between relative mutation rates calculated on MAC10+ variants and ERVs for each 7-mer mutation subtype. Subtypes with 
higher MAC10+-derived rates relative to ERV-derived rates are shaded gold, and subtypes with lower MAC10+-derived rates 
relative to ERV-derived rates are shaded green.  
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Figure A.5 Similar mutation spectra of the GoNL and ITMI data  
Scatterplot shows the 3-mer mutational spectra (i.e., the proportion of all mutations falling within each of the 96 3-mer subtypes), 
calculated among de novo mutations from the ITMI (x-axis) GoNL (y-axis) trio sequencing studies. 
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Figure A.6 Genome-wide estimates for ERV-based 7-mer subtypes are consistent with estimates from ERVs restricted to 
uniquely-mappable regions 
(a) Relationship between masked and unmasked 7-mer relative mutation rate estimates, separated by type. (b) Relationship 
between number of ERVs per subtype (x axis) and discordance between the masked and unmasked rates, measured as the log 
ratio between the estimates (y axis).  
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Figure A.7 Distributions of effect sizes on mutability for 14 genomic features and depth of sequencing. For each feature, 
we plotted the empirical distributions of the subtype-specific odds ratios for each basic mutation type, as estimated by our logistic 
regression models. *Replication timing is coded with negative values indicating later replicating regions, so an OR<1 means 
mutation rate increases in late-replicating regions.   
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a.  
 
 
 
 
 
b. 
 
Figure A.8 Predicted mutation distributions under ERV-based models are more accurate than 1000G model (a) 
Distribution of the GoNL/ITMI de novo mutations across basic mutation types compared to the distributions predicted under the 
1000G 7-mer model and each of the BRIDGES ERV-based models. (b) Difference between model-predicted and observed 
number of mutations per 3-mer subtype for the 7-mer+features model (green bars) and 1000G 7-mer model (purple bars). The 
number of observed mutations for each subtype is indicated along the x-axis. In each panel, subtypes are sorted in increasing 
order of differences under the 1000G 7-mers model.  
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Supplementary Tables 
 
Table A.1 Quality comparison between filtered partitions of BRIDGES singletons  
Partition # Singletons Ts/Tv 
ratio 
%dbSNP 
(b142) 
% of Full 
Set 
Full Set 35,574,417 2.00 17.4 100 
Filter 2 (MQ>56) 33,550,098 2.01 17.3 94 
Filter 3 (passed 1000G strict mask) 26,810,791  1.97 17.5 75 
All Filters (MQ>56, 1000G strict 
mask) 
16,535,856 2.00 17.6 46 
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Table A.2. Rate estimates in GC-rich motifs are biased in 1000G data 
Type 
Mean 1000G/ERV 
ratio 
(≤3 C/G bases) 
Mean 1000G/ERV 
ratio 
(≥4 C/G bases) 
P-value 
A>C 0.97 1.12 8.00e-30 
A>G 1.00 1.28 2.37e-161 
A>T 0.89 0.89 0.81 
C>A (non-CpG) 0.76 0.72 2.61e-09 
C>G (non-CpG) 0.89 0.93 2.98e-04 
C>T (non-CpG) 0.93 0.85 1.75e-39 
CpG>ApG 1.15 0.96 4.97e-22 
CpG>GpG 1.46 1.33 2.80e-04 
CpG>TpG 1.02 0.98 1.01e-09 
For each mutation subtype, we calculated the ratio between 1000G-derived and ERV-derived 
relative mutation rates. Then, for each of the 9 basic types, we grouped 7-mer subtypes into low 
C/G subtypes (≤3 C/G bases in the +/-3 flanking positions) and high C/G subtypes (≥4 C/G bases 
in the +/-3 flanking positions) and performed t-tests for differences in the mean 1000G/ERV 
ratios of these two groups.  
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Table A.3 Comparison of observed and simulated goodness-of-fit for de novo prediction 
models under different sized non-mutated backgrounds 
Model 
Observed Simulated Background 
size AIC R^2 AIC R^2* 
1-mers 292542 .109 272925 .185 
500,000 
3-mers 284889 .139 241863 .299 
5-mers 282995 .146 239672 .307 
7-mers 282491 .148 238967 .310 
7-mers (BRIDGES MAC10+ SNVs) 283599 .144 240434 .304 
7-mers (1000G intergenic SNVs)  284764 .139 241724 .300 
1-mers 353896 .088 344108 .117 
1,000,000 
3-mers 343716 .118 317322 .197 
5-mers 341778 .124 315400 .202 
7-mers 341295 .126 314760 .204 
7-mers (BRIDGES MAC10+ SNVs) 342886 .121 316791 .198 
7-mers (1000G intergenic SNVs)  344003 .118 317953 .195 
1-mers 416998 .072 414016 .080 
2,000,000 
3-mers 404738 .102 392367 .132 
5-mers 402853 .107 390698 .136 
7-mers 402375 .108 390051 .138 
7-mers (BRIDGES MAC10+ SNVs) 404378 .103 392509 .132 
7-mers (1000G intergenic SNVs)  405523 .100 393741 .129 
1-mers 454267 .066 452950 .069 
3,000,000 
3-mers 441042 .095 434665 .109 
5-mers 439153 .099 433243 .112 
7-mers 438700 .100 432517 .114 
7-mers (BRIDGES MAC10+ SNVs) 441059 .095 435270 .108 
7-mers (1000G intergenic SNVs)  442181 .092 436443 .105 
*The simulated R^2 of the best possible model for each background size, indicated in bold, 
represents the optimal performance we can expect. 
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Table A.4 Comparison of model AIC specific to GoNL or ITMI de novo mutations 
 
Model 
GoNL DNMs  
(11,020 mutations) 
ITMI DNMs  
(35,793 mutations) 
1-mers 114945 288707 
3-mers 111952 280025 
5-mers 111507 278542 
7-mers 111381 278201 
7-mers (BRIDGES MAC10+ 
SNVs) 
111913 279580 
7-mers (1000G intergenic SNVs)  112185 280401 
Models fitted to a background of 1 million non-mutated sites, as described previously. Note that 
the difference in AIC between the two datasets is due to the difference in number of DNMs, and 
is not comparable between the GoNL and ITMI studies. Goodness of fit statistics for both 
datasets have the same rank order. 
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Table A.5 Type-specific model fit statistics for mutation rate estimation strategies applied 
to the de novo testing data. Each type is shown in a sub-table, with the number of de novo 
mutations and non-mutated sites used in the partitioned testing data indicated in the subheading. 
 
A>C (2920 de novo mutations; 198481 non-mutated sites) 
Model Nagelkerke's R2 AIC 
3-mers 0.002 32831 
5-mers 0.007 32701 
7-mers 0.009 32641 
7-mers+features 0.009 32636 
7-mers (downsampled BRIDGES ERVs) 0.008 32670 
7-mers (BRIDGES MAC10+ SNVs) 0.003 32809 
7-mers (1000G intergenic SNVs)  0.004 32775 
 
A>G (11400 de novo mutations; 198793 non-mutated sites) 
Model Nagelkerke's R2 AIC 
3-mers 0.039 91474 
5-mers 0.065 89455 
7-mers 0.068 89212 
7-mers+features 0.069 89111 
7-mers (downsampled BRIDGES ERVs) 0.064 89505 
7-mers (BRIDGES MAC10+ SNVs) 0.061 89732 
7-mers (1000G intergenic SNVs)  0.061 89746 
 
A>T (2455 de novo mutations; 198320 non-mutated sites) 
Model Nagelkerke's R2 AIC 
3-mers 0.015 28130 
5-mers 0.016 28114 
7-mers 0.016 28106 
7-mers+features 0.016 28105 
7-mers (downsampled BRIDGES ERVs) 0.007 28350 
7-mers (BRIDGES MAC10+ SNVs) 0.001 28498 
7-mers (1000G intergenic SNVs)  0.003 28463 
 
non-CpG C>A (3620 de novo mutations; 128765 non-mutated sites) 
Model Nagelkerke's R2 AIC 
3-mers 0.012 35362 
5-mers 0.022 35039 
7-mers 0.03 34794 
7-mers+features 0.032 34743 
7-mers (downsampled BRIDGES ERVs) 0.029 34823 
7-mers (BRIDGES MAC10+ SNVs) 0.024 35000 
7-mers (1000G intergenic SNVs)  0.027 34892 
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non-CpG C>G (3561 de novo mutations; 128746 non-mutated sites) 
Model 
Nagelkerke's 
R2 
AIC 
3-mers 0.006 35889 
5-mers 0.018 35490 
7-mers 0.024 35321 
7-mers+features 0.024 35321 
7-mers (downsampled BRIDGES ERVs) 0.023 35350 
7-mers (BRIDGES MAC10+ SNVs) 0.019 35480 
7-mers (1000G intergenic SNVs)  0.018 35489 
 
non-CpG C>T (10321 de novo mutations; 128774 non-mutated sites) 
Model 
Nagelkerke's 
R2 
AIC 
3-mers 0.005 79879 
5-mers 0.012 79502 
7-mers 0.014 79379 
7-mers+features 0.014 79353 
7-mers (downsampled BRIDGES ERVs) 0.013 79395 
7-mers (BRIDGES MAC10+ SNVs) 0.012 79487 
7-mers (1000G intergenic SNVs)  0.013 79434 
 
 
CpG>ApG (304 de novo mutations; 6108 non-mutated sites) 
Model 
Nagelkerke's 
R2 
AIC 
3-mers 0.014 2788 
5-mers 0.024 2767 
7-mers 0.027 2763 
7-mers+features 0.029 2761 
7-mers (downsampled BRIDGES ERVs) 0.025 2763 
7-mers (BRIDGES MAC10+ SNVs) 0.022 2771 
7-mers (1000G intergenic SNVs)  0.025 2762 
 
CpG>GpG (270 de novo mutations; 6292 non-mutated sites) 
Model 
Nagelkerke's 
R2 
AIC 
3-mers 0.013 2560 
5-mers 0.015 2557 
7-mers 0.022 2545 
7-mers+features 0.026 2538 
7-mers (downsampled BRIDGES ERVs) 0.015 2556 
7-mers (BRIDGES MAC10+ SNVs) 0.015 2556 
7-mers (1000G intergenic SNVs)  0.011 2564 
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CpG>TpG (6960 de novo mutations; 6289 non-mutated sites) 
Model 
Nagelkerke's 
R2 
AIC 
3-mers 0.011 20321 
5-mers 0.02 20232 
7-mers 0.025 20173 
7-mers+features 0.06 19777 
7-mers (downsampled BRIDGES ERVs) 0.024 20182 
7-mers (BRIDGES MAC10+ SNVs) 0.027 20151 
7-mers (1000G intergenic SNVs)  0.027 20148 
 
Table A.6  Genomic features used in mutation models 
Feature Source Cell Type Resolution 
H3K4me1, H3K4me3, 
H3K9ac, H3K9me3, 
H3K27ac, H3K27me3, 
H3K36me3 
Roadmap Epigenomics 
Project [68] 
Peripheral Blood 
Mononuclear 
Primary Cells 
1bp (inside vs. outside 
of broad peak) 
Replication timing Koren et al., 2012 [165] Lymphoblastoid 1kbp window 
Recombination rate Kong et al., 2010 [93] 
(deCODE sex-averaged 
recombination rate map) 
— 10kbp window 
Lamin B1 domains Guelen et al., 2008 [166] Tig3ET normal 
human 
embryonic lung 
fibroblasts 
1bp (inside vs. outside 
of LAD) 
DNase hypersensitivity 
sites 
ENCODE [167]  multiple 1bp (inside vs. outside 
of DHS region) 
Exonic site RefSeq gene database — 1bp (inside vs. outside 
of exon) 
CpG island Wu et al., 2010 [168] — 1bp (inside vs. outside 
of CpG island) 
% GC content Calculated from 
reference genome 
— 10kbp 
A script to download the exact external data files used in this paper is available at 
https://github.com/carjed/smaug-genetics    
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Table A.7 Chi-squared tests for enrichment or depletion of de novo mutations occurring in 
feature-associated subtypes 
Feature 
Expected 
direction of 
effect 
de novo relative mutation rate 
p-value 
aInside feature bOutside feature 
H3K9me3† Increased 1.98E-05 1.73E-05 4.87E-05 
High Recombination 
rate (> 2) 
Increased 3.66E-05 3.43E-05 0.18 
H3K27me3† Decreased 5.44E-06 3.14E-06 0.99 
H3K27ac Decreased 1.22E-04 1.23E-04 0.50 
Exons Decreased 1.20E-04 8.66E-05 0.99 
H3K4me1 Decreased 1.10E-04 1.40E-04 1.84E-10 
H3K4me3† Decreased 1.00E-04 1.50E-04 4.92E-23 
H3K9ac† Decreased 1.49E-05 7.49E-06 0.99 
Lamin-associated 
domains 
Increased 6.91E-05 7.46E-05 0.75 
High GC content  
(> 0.55) 
Decreased 1.23E-05 9.74E-06 0.82 
Increased 1.14E-05 4.65E-06 6.61E-04 
H3K36me3 
Decreased 4.73E-06 6.14E-06 2.59E-03 
Increased 1.99E-05 1.51E-05 5.50E-10 
CpG Islands 
Decreased 3.68E-05 1.60E-04 5.00E-117 
Increased 5.39E-06 6.69E-06 0.79 
Late replication timing 
(< -1.25)* 
Increased 6.18E-06 5.48E-06 0.026 
Early replication timing 
(> 1.25)* 
Increased 1.55E-05 8.06E-06 2.25E-02 
DHS 
Decreased 5.03E-05 3.08E-05 0.99 
Increased 1.75E-05 1.21E-05 4.92E-04 
Significant differences that are consistent with the expected direction of effect are indicated by a 
one-sided p-value in bold. †Four features had associations in the opposite direction, but these 
predicted effects could not be tested due to a lack of de novo mutations observed within the 
associated subtypes. *Some subtypes showed a significant negative association with replication 
timing, such that the mutation rate would be higher in early- rather than late-replicating regions, 
so we tested these subtypes separately. 
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Appendix B: Supplementary Material for Chapter III
Table B.1 T-tests for population differences in parameter estimates from mixture models 
Mixture 
component 
rate lambda 
AFR EUR  AFR EUR  
mean rate mean rate p.value mean lambda mean lambda p.value 
1 1/27 1/17 1.06E-01 0.0075 0.0092 2.87E-04 
2 1/5716 1/2202 6.07E-295 0.1128 0.0595 1.40E-206 
3 1/60869 1/78123 7.23E-158 0.4485 0.3150 0.00E+00 
4 1/260723 1/282923 1.50E-78 0.4312 0.6164 0.00E+00 
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Figure B.1 Mixture models accurately describe observed inter-singleton distance distribution. Observed distributions are 
shown in solid lines, and expected distributions under a 4-component exponential mixture model are shown in dashed lines. 
Parameters for the 4-component mixture model were taken to be the median rate and lambda from each ancestry subsample. 
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Figure B.2 Genome-wide distribution of component 1 singleton density, in 1Mbp windows. Windows are shaded according 
to the inferred state (hot, neutral, cold) from a 3-state HMM. 
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Figure B.3 Genome-wide distribution of component 2 singleton density, in 1Mb windows. Windows are shaded according to 
the inferred state (hot, neutral, cold) from a 3-state HMM. 
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Figure B.4 Genome-wide distribution of component 3 singleton density, in 1Mbp windows. Windows are shaded according 
to the inferred state (hot, neutral, cold) from a 3-state HMM. 
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Figure B.5 Genome-wide distribution of component 4 singleton density, in 1Mbp windows. Windows are shaded according 
to the inferred state (hot, neutral, cold) from a 3-state HMM. 
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Appendix C: Supplementary Material for Chapter IV
Performance of other mutation signature analysis tools 
In addition to the R packages we evaluated in the main paper, we considered several 
other mutation signature analysis tools which provide functions for generating mutation spectra 
matrices from VCF or Mutation Annotation Format (MAF) files. Where applicable, we used the 
small and full 1000 Genomes chromosome 22 VCF files described in the main paper. In our 
tests, each of these tools showed substantial performance bottlenecks compared to Helmsman or 
were subject to other limitations that made them infeasible for applying to our test datasets. 
Mutagene and Mutalisk 
Mutagene [30] and Mutalisk [31] are implemented as web servers and provide graphical 
interfaces for users to upload their data, with all data processing performed on the server end. We 
successfully uploaded the 158.6MB uncompressed small VCF file to Mutalisk, and the uploading 
and processing took approximately 60 seconds (compared to 8 seconds with Helmsman). 
Mutagene would not accept the small VCF file in either compressed or uncompressed format. 
Neither tool would accept the full VCF file when we attempted to upload it. Moreover, although 
Mutalisk at first appeared to offer reasonably fast performance for the small VCF file, we found 
that it did not properly parse the data into 2,504 unique samples as expected, and incorrectly 
assumed the SNVs were all from a single sample. Mutalisk does allow users to upload multiple 
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single-sample VCF files, but limits input to 300 files, and is therefore only feasible for relatively 
small sample sizes. 
 
MutSpec 
MutSpec is implemented as a Galaxy toolbox, enabling users with limited programming 
expertise to perform mutation signature analysis with a graphical interface [155]. Though we did 
not have a Galaxy server available to directly evaluate MutSpec’s performance on our test 
datasets, the authors reported that it takes ~7 minutes to annotate a VCF file containing 100,000 
variants (in an unstated sample size) using 24 CPUs, and 4 hours using a single CPU. Assuming 
MutSpec’s runtime scales linearly with the number of SNVs, we estimate that it would take at 
least 60 seconds using 24 CPUs and over 40 minutes using a single CPU to parse the 15,971 
SNVs in the small VCF file, compared to 8 seconds on a single CPU when using Helmsman. 
Similarly, to parse the 1,055,454 SNVs contained in the full chromosome 22 VCF file used in 
our tests, we estimate that MutSpec would take over an hour when using 24 CPUs, and over 40 
hours on a single CPU, compared to 8 minutes on a single CPU when using Helmsman.  
We note that these performance estimates for MutSpec are based on the reported runtime 
only for the annotation step of the MutSpec pipeline, which generates an intermediate tab-
delimited file containing functional and structural annotations for each SNV in the input VCF 
file. Our estimates did not take into account the additional processing time required to parse this 
intermediate file into the Nx96 mutation spectra matrix, so our estimates represent a lower bound 
for the runtime necessary to generate the mutation spectra matrix using MutSpec.  
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Maftools and Mutation-Signatures 
Somatic mutation data are sometimes represented in Mutation Annotation Format (MAF) 
files, a tab-delimited format with one variant per row, and several dozen additional annotation 
columns (described in detail at https://docs.gdc.cancer.gov/Data/File_Formats/MAF_Format/). 
Unlike VCF files, MAF files do not indicate the genotypes of each individual in the sample, so a 
variant present in two or more individuals must be indicated as multiple rows. We considered 
two programs  designed specifically for applying mutation signature analysis to MAF files: 
maftools, an R package [159], and Mutation-Signatures, an unpublished collection of Python 
scripts developed by researchers at Memorial Sloan Kettering Cancer Center in New York, NY 
(https://github.com/mskcc/mutation-signatures). 
We evaluated the performance of these MAF-specific tools using a MAF file with data 
from 377 Liver Hepatocellular Carcinoma (LIHC) samples, available from The Cancer Genome 
Atlas at https://portal.gdc.cancer.gov/legacy-archive/files/15ce66c6-0211-4f03-bd41-
568d0818a044. This file was 1.4GB in size and contained 60,691 somatic SNVs (interspersed 
with 1,415,224 non-SNV variants that are not considered in this type of analysis). 
Helmsman generated the mutation spectra matrix from this MAF file in 96 seconds and 
required less than 130MB of memory (Fig. C.1). Both Mutation-Signatures and maftools 
generated output identical to that of Helmsman. Mutation-Signatures performs this task in two 
steps, first creating an intermediate MAF file with each SNV annotated with the surrounding 
trinucleotide context, then parsing this file to generate the mutation spectra matrix and, in the 
same step, performing supervised decomposition of each sample into 30 pre-specified signatures. 
Mutation-Signatures took a total of 402 seconds to run these scripts (145 seconds to generate the 
intermediate MAF file, and 377 seconds to generate the mutation spectra matrix and perform the 
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signature decomposition), with a maximum memory footprint of 6.5GB (memory usage peaked 
when generating the intermediate MAF file) (Fig. C.1). Maftools took 207 seconds and required 
9.2GB of memory to read the same input MAF file and generate the mutation spectra matrix, 
using the functions read.maf and trinucleotideMatrix, respectively (Fig. C.1). Like the VCF-
specific R packages we evaluated in the main paper, we note that maftools is memory-intensive, 
even for relatively small input files, and susceptible to memory bottlenecks as the input file size 
increases. Maftools’ high memory usage and longer processing time is largely attributable to the 
inherently high dimensionality of MAF files: although only five columns (Chromosome, 
Position, Reference Allele, Alternative Allele, and Sample ID) are necessary to generate the 
mutation spectra matrix, Maftools requires the input MAF file to contain many additional 
mandatory columns. 
 
 
Figure C.1. Performance comparison for generation of the mutation spectra matrix from a MAF file. The MAF file used 
contained 60,691 SNVs (in addition to 1,415,224 non-SNV variants that were present in the file but not analyzed) in 377 
samples.  
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Appendix D: Supplementary Material for Chapter V
 
 
 
 
 
Figure D.1. Singleton SNV spectra differ according to DNA source in 1000 Genomes data. We obtained data for the DNA 
source (either fresh blood or LCL cell lines) of 870 of the 2,504 1000 Genomes Phase 3 samples from 
ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/working/20130606_sample_info/20130606_sample_info.txt. Each point in this 
figure represents a sample, colored according to the DNA source, and the x and y axes correspond to principal components 2 and 
3, determined from applying PCA to the 2,504x96 3-mer singleton SNV spectra matrix. The remaining 1634 samples had 
missing information for their DNA source, so are excluded from this figure. 
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Figure D.2. Summary of outliers detected in the Framingham Heart Study data. Heatmap showing the relative enrichment 
or depletion for each of the 96 3-mer subtypes (columns) in each of the 27 flagged outliers (rows). The color in each cell 
indicates the fold-difference of the contribution of the subtype in that sample, calculated relative to the mean contribution of that 
subtype across all non-outlier samples. The scale is truncated to +/-5-fold difference. Only outlier cluster 4 (indicated by the red 
bar to the left of the heatmap), containing 7 samples, was found to have multiple statistically significant differences in spectra 
when compared to the non-outlier samples, as implemented in the secondary cluster-based filtering. These outliers show higher-
than-expected rates of T>A and T>G transversions at NTT and NTA motifs, with a particularly strong enrichment at the 
C[T>G]T subtype. 
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Table D.1. Frequencies of BRIDGES outliers by sequencing plate 
Outlier cluster Plate # Samples 
outlier cluster 1 plate33B 1 
outlier cluster 1 plate35 7 
outlier cluster 1 plate36 11 
outlier cluster 1 plate37 19 
outlier cluster 1 plate38 2 
outlier cluster 1 plate42 1 
outlier cluster 1 plate43 24 
outlier cluster 1 plate44 9 
outlier cluster 1 <NA> 1 
outlier cluster 2 plate01 14 
outlier cluster 2 plate02 10 
outlier cluster 2 plate19 1 
outlier cluster 2 plate33B 2 
outlier cluster 2 plate37 1 
outlier cluster 2 plate42 2 
outlier cluster 2 plate43 5 
outlier cluster 2 <NA> 3 
outlier cluster 3 plate05 1 
outlier cluster 3 plate06 3 
outlier cluster 3 plate08 1 
outlier cluster 3 plate09 1 
outlier cluster 3 plate10 2 
outlier cluster 3 plate36 2 
outlier cluster 3 plate37 25 
 
 
  
153 
 
Table D.2. Summary of outliers detected in 1000 Genomes Phase 3 dataset 
 
ID Family ID Population 
HG00182 HG00182 FIN 
HG00186 HG00186 FIN 
HG00272 HG00272 FIN 
HG00373 HG00373 FIN 
HG01149 CLM12 CLM 
HG01377 CLM38 CLM 
HG02582 GB23 GWD 
HG02645 GB38 GWD 
HG02839 GB74 GWD 
HG03127 NG35 ESN 
HG04131 BD44 BEB 
NA12340 1330* CEU 
NA12341 1330* CEU 
NA12342 1330* CEU 
NA12748 1444 CEU 
NA12890 1463 CEU 
NA18498 Y003 YRI 
NA18608 NA18608 CHB 
NA19175 Y044 YRI 
*Three CEU samples, indicated in italics, were members of a single parent-offspring trio (Family 
ID 1330). 
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Table D.3. 1-mer spectra of non-transmitted SNVs in non-outlier parents compared to 
SNVs transmitted from outlier parents to offspring in the FHS dataset 
SNV Type Frequency in non-transmitted SNVs 
in non-outlier parents (% of total) 
Frequency in SNVs transmitted 
from outlier parents to offspring 
(% of total) 
C>A 3183 (9.8%) 2495 (9.8%) 
C>G 2968 (9.2%) 2328 (9.1%) 
C>T 12860 (39.7%) 9888 (38.7%) 
T>A 2124 (6.6%) 1718 (6.7%) 
T>C 8869 (27.4%) 7193 (28.2%) 
T>G 2389 (7.4%) 1928 (7.5%) 
Total 32393 25550 
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